##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
   FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES ACT OF 1934 For the Fiscal Year Ended
December 31, 2004
    
    Commission File Number
0-26272
 Natural Health Trends Corp.  Florida
(State or other jurisdiction of
incorporation or organization)
    
    59-2705336
(I.R.S. Employer
Identification No.)
 12901 Hutton Drive
Dallas, Texas 75234
(Address of principal executive offices) (972) 241-4080
(Registrants telephone number) Securities registered pursuant to Section 12(b) of the Act:None Securities registered pursuant to Section 12(g) of the Act: Title of each class
    
    Name of exchange on which registeredCommon Stock, par value $.001
    
    The NASDAQ National Market
   Indicate by check mark whether the registrant (1) filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation
S-K is not contained herein, and will not be contained, to the best of registrants knowledge, in
definitive proxy or information statements incorporated by reference in Part III of this Form 10-K
or any amendment to this Form 10-K. o Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule
12b-2 of the Act). Yes o No þ The aggregate market value of the voting stock held by non-affiliates of the registrant as of
June 30, 2004 was approximately $68,033,255 based upon a closing price of $11.20 per share. The number of shares of common stock of the registrant outstanding as of March 24, 2005 was
6,819,667 shares. Documents Incorporated by Reference Certain information required for Part III of this report is incorporated by reference from
registrants proxy statement for the 2005 annual meeting of the Companys shareholders to be held
during the second quarter of 2005.




---



##### Table of Contents



TABLE OF CONTENTS  
 PagePART IItem 1.
    
    BUSINESS
    
    
    1Overview of Business
    
    
    1Our Products
    
    
    1Operations of the Business
    
    
    2Working with Distributors
    
    
    9Recent Developments
    
    
    12Private Placement of Units
    
    
    14Government Regulations
    
    
    15Our Industry
    
    
    18Forward Looking Statements
    
    
    19Risk Factors
    
    
    21Item 2.
    
    PROPERTIES
    
    
    35Item 3.
    
    LEGAL PROCEEDINGS
    
    
    37Item 4.
    
    SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
    
    
    39PART II
    
    
    
    
    
    
    40Item 5.
    
    MARKET FOR REGISTRANTS COMMON EQUITY AND
RELATED STOCKHOLDER MATTERS
    
    
    40Item 6.
    
    SELECTED FINANCIAL DATA
    
    
    42Item 7.
    
    MANAGEMENTS DISCUSSION AND ANALYSIS OF
FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
    
    
    43Item 7A.
    
    QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK
    
    
    55Item 8.
    
    FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
    
    
    57Item 9.
    
    CHANGES IN AND DISAGREEMENTS WITH
ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
    
    
    87Item 9A.
    
    CONTROLS AND PROCEDURES
    
    
    87Item 9B.
    
    OTHER INFORMATION
    
    
    91PART
III
    
    
    
    
    
    
    91PART IVItem 15.
    
    EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
    
    
    92SIGNATURES
    
    
    
    
    94Option Agreement - Sir Brian WolfsonOption Agreement - Randall A. MasonFounder Compensation AgreementDatabase Purchase AgreementKGC AgreementStock Purchase AgreementEmployment AgreementEmployment AgreementEmployment AgreementAmendment to Registration Rights AgreementAmend No. 1 to Founder Compensation AgreementRoyalty AgreementCode of Business ConductCode of Ethics for Senior Financial OfficersSubsidiariesCertification of the PresidentCertification of CFOCertification of the President Pursuant to Section 906Certification of CFO Pursuant to Section 906




---



##### Table of Contents



Part I 
 Item 1. BUSINESS 
 Overview of Business Natural Health Trends Corp. (the Company) is an international direct selling organization.
We control subsidiaries that distribute products through two separate direct selling businesses
that promote health, wellness and vitality. Lexxus International, Inc., our wholly-owned
subsidiary (Lexxus U.S.), and other Lexxus subsidiaries (collectively, Lexxus), sell certain
cosmetic products, consumer as well as quality of life products, which accounted for
approximately ninety-nine (99%) percent of our consolidated net revenues in 2004. eKaire.com, Inc.
(eKaire), our wholly-owned subsidiary, distributes nutritional supplements aimed at general
health and wellness. Lexxus commenced operations in January 2001 and has experienced tremendous growth, as we are
currently conducting business in at least 30 countries through approximately 130,000 active
distributors as of December 31, 2004. (We consider a distributor active if he or she has placed
at least one product order with us during the preceding year). The Lexxus business includes KGC
Networks Pte. Ltd. (KGC), a Singapore company owned 51% by the Company and 49% by a European
private investor. KGC sells Lexxus products into a separate network with distributors primarily in
Russia and other Eastern European countries. eKaire has been in business since 2000 and is
operating in four countries through approximately 3,600 active distributors. We seek to be a leader in the direct selling industry serving the health and wellness
marketplace by driving our products into as many venues and into as many markets as possible
through our direct selling marketing operations. Our objectives are to enrich the lives of the
users of our products and enable our distributors to benefit financially from the sale of our
products. We maintain executive offices at 12901 Hutton Drive, Dallas, Texas 75234 and our telephone
number is (972) 241-4080. Our website is located at www.naturalhealthtrendscorp.com. The
information provided on our website should not be considered part of this prospectus. 
 Our Products Lexxus We offer several Lexxus branded lifestyle enhancement products:  Skindulgence® is a skin care system marketed as a 30-Minute Non-Surgical FaceLift
designed to create a more youthful appearance by helping to tone and firm facial muscles, by
helping to diminish fine lines and wrinkles and by helping to improve skin tone and color. The
facelift masque is coupled with a cleanser and moisturizer. 1




---



##### Table of Contents



 Alurais an intimacy cream designed to increase the sexual satisfaction of women.  Premium Noni Juiceis a reconstituted morinda citrifolia fruit juice, made from
organic noni puree. Noni is a fruit native in the Samoan Islands of the South Islands of the South
Pacific. Marketed as a refreshing and energizing beverage, its naturally offensive flavor has been
neutralized with white grape concentrate, concord grape concentrate, pineapple juice puree and
other natural flavors.  LexLipsis a lip enhancing gloss for women, designed to create the effect of fuller
lips and to help reduce fine lines and wrinkles around the mouth.  La Vieis a dietary supplement described as a non-alcoholic red wine. It is marketed
as an energizing supplement containing aloe.  180° Life System Carb-Blockeris marketed as a weight management product based upon
over 30 years of research. eKaire We offer Kaire branded products, generally nutritional supplements, which are organized into
several broad categories such as antioxidant support, immune support, bone & joint support,
digestive and dietary support, weight management, OmegaKaire hemp products, Sakaira Spa with Moor
Mud, Sakaira Skin & Hair Care, Kaire Essentials and ecoKaire Home Care. Among the products offered by eKaire, Pycnogenol®, Enzogenol, OptiMSM,
OptiPure®, Phase2 & ActivAloeare trademarks of suppliers of eKaire. 
 Operations of the Business Sourcing of Products The Companys independent research consultants and the executive staff work closely with
research and development personnel of our manufacturers to create product concepts and develop the
product ideas into actual products. Each of the Companys three current major product lines -
Skindulgence®, Alura, and Premium Noni Juice- were originally conceived by our manufacturing
vendors. The Company then enters into standard supply agreements with the vendors pursuant to which
the Company retains trademark rights to the products purchased and the vendors are restricted from
supplying the products to other direct selling companies. Because our current main products all
came to us originally as proposals from our vendors, we have incurred minimal out-of-pocket
research and development costs through December 31, 2004. The Company purchases finished goods from manufacturers and sells them to our distributors for
their resale or personal consumption. Aloe Commodities International 2




---



##### Table of Contents



(for Skindulgence®), 40Js LLC (for Alura) and Two Harbor Trading (for Premium Noni Juice)
are the three most significant vendors, accounting for a majority of the Companys product
purchases. All three of the vendors entered into our standard supply agreements. The agreement
with 40Js LLC contains a minimum annual purchase of $1.35 million for the Company to retain the
exclusivity. The terms of these agreements are between one and three years, with annual automatic
renewal. We believe that, in the event we were unable to source products from these suppliers or the
other suppliers of our other products, our revenue, income and cash flow could be adversely and
materially impacted. Marketing and Distribution Lexxus and eKaire are set up as direct selling companies using a network of distributors to
sell products. Our distributors are independent full-time or part-time contractors who purchase
products directly from our subsidiaries via the Internet for resale to retail consumers or for
personal consumption. The growth of a distributors business depends largely upon their ability to
recruit a down-line network of distributors and the popularity of our products in the marketplace. As of December 31, 2004, we had distributors located in the United States, as well as Puerto
Rico, Canada, Australia, New Zealand, Taiwan, Hong Kong, Macau, Singapore, Indonesia, Philippines,
South Korea, Japan, Brazil, India and countries in Eastern Europe, including Russia. As of
December 31, 2004, we had an active physical presence in only six (the U.S., South Korea, Taiwan,
Australia, Canada and Russia) of the top 15 direct selling markets in the world. The table below
shows the number of active distributors the Company had in each of our major markets. We experienced an 81% increase in active Lexxus distributors during 2004, following a 39%
increase in active distributors in 2003 compared to the prior years. The following table
represents the number of active distributors by market for both Lexxus and eKaire as of December
31, 2002, 2003, and 2004. Year Ended December 31,2002
    
    
    2003
    
    
    2004United States
    
    
    8,336
    
    
    
    5,295
    
    
    
    8,876Canada
    
    
    701
    
    
    
    1,793
    
    
    
    4,020North America
    
    
    9,037
    
    
    
    7,088
    
    
    
    12,896Hong Kong
    
    
    5,752
    
    
    
    28,971
    
    
    
    63,114Taiwan
    
    
    5,492
    
    
    
    2,323
    
    
    
    2,533Greater China
    
    
    11,244
    
    
    
    31,294
    
    
    
    65,647
 3




---



##### Table of Contents



Year Ended December 31,2002
    
    
    2003
    
    
    2004Singapore
    
    
    945
    
    
    
    797
    
    
    
    735Philippines
    
    
    85
    
    
    
    1,139
    
    
    
    2,799Southeast Asia
    
    
    1,030
    
    
    
    1,936
    
    
    
    3,534Australia
    
    
    799
    
    
    
    214
    
    
    
    374New Zealand
    
    
    151
    
    
    
    34
    
    
    
    32Australia/NZ
    
    
    950
    
    
    
    248
    
    
    
    406South Korea
    
    
    702
    
    
    
    3,510
    
    
    
    4,780KGC (Eastern Europe/Central Asia)
    
    
    27,579
    
    
    
    26,775
    
    
    
    40,727Latin America
    
    
    427
    
    
    
    192
    
    
    
    87Central Europe
    
    
    
    
    
    
    
    
    
    
    891Japan
    
    
    
    
    
    
    
    
    
    
    848India
    
    
    700
    
    
    
    883
    
    
    
    25eKaire
    
    
    6,025
    
    
    
    4,671
    
    
    
    3,656Total
    
    
    57,694
    
    
    
    76,597
    
    
    
    133,497Lexxus without KGC
    
    
    24,090
    
    
    
    45,151
    
    
    
    89,114Lexxus with KGC
    
    
    51,669
    
    
    
    71,926
    
    
    
    129,841
 We intend to pursue additional foreign markets in 2005. We anticipate commencing revenue
generation in Mexico (in the second quarter of 2005) and Japan (in the fourth quarter of 2005). We
plan to start opening retail stores in China during the latter half of 2005. To become a Lexxus distributor, a prospective distributor must agree to the terms and
conditions of our distributor agreement (posted on our Lexxus website) and to pay a nominal $100
annual enrollment fee. KGC does not require an enrollment fee for a membership. The distributor
agreement sets forth our policies and procedures, and we may elect to terminate a distributor for
non-compliance. To be eligible to receive bonus compensation, which is based upon sales recorded by
a distributors network of down-line distributors, a distributor may be required to make nominal
monthly purchases of products. As of December 31, 2004, Lexxus had approximately 130,000 active
distributors, including KGCs approximately 40,000 active distributors. Active distributors are
defined as those who made at least one product purchase over the last 12 months. To become an eKaire distributor, a prospective distributor must agree to the terms and
conditions of our distributor agreement (posted on our eKaire website). To be considered active,
the distributor must have placed an order for product within the 4




---



##### Table of Contents



preceding year. As of December
31, 2004, eKaire had approximately 3,600 active distributors and customers. We pay commissions to eligible distributors based on sales by such distributors down-line
distributors during a given commission period. We believe, based upon our knowledge of our
competitors compensation plans, that we offer one of the highest
commission payouts in the direct selling industry. We also believe that the uniqueness and
efficacy of our products, combined with a high commission rate, creates a highly desirable business
opportunity and work environment for our distributors. See Compensation Plans. Distributors generally pay for products by credit card in connection with orders placed
through their own Internet page at www.mylexxus.com or www.mykaire.com prior to shipment.
Accordingly, we carry minimal accounts receivable and credit losses are historically minimal. We regularly sponsor promotional meetings and participate in motivational training events in
key cities around the world. These events are designed to inform prospective and existing
distributors about both existing and new product lines as well as selling techniques. Distributors
typically share their direct selling experiences, their individual selling styles and their
recruiting methods at these promotional or training events. Prospective distributors are educated
about the structure, dynamics and benefits of the direct selling industry. We are continually
developing or updating our marketing strategies and programs to motivate our distributors. These
programs are designed to increase distributors monthly product sales and the recruiting of new
distributors in their down-lines. Management Information Systems The Lexxus business, with the exception of KGC, uses our proprietary MarketVision software to
maintain a web-based system to process orders, to communicate volume and commissions to
distributors. KGC, a majority owned subsidiary, uses a third-party service provider, Septuor
Consulting (Septuor), and its software for functionalities similar to those provided by
MarketVision. See Recent Developments. The eKaire commission system uses a third-party software package, Infotrax, and provides each
independent distributor with a detailed monthly accounting of all sales and recruiting activity.
These statements eliminate the need for substantial record keeping on behalf of the distributor. Other than MarketVision, which handles order processing seamlessly for all applicable markets,
the Company has not automated and integrated other critical business processes such as inventory
management and accounting. The Company is currently evaluating business systems to automate more of
the business functions and to improve their linkage to MarketVision. 5




---



##### Table of Contents



Corporate History The Companys current business can be traced back to Kaire Neutraceutical Inc. (Kaire), a
privately owned Colorado company in direct selling. Mr. Mark Woodburn, engaged by Kaires
investors, became an advisor to, and subsequently the President of, Kaire in 1999 and engaged Mr.
Terry LaCore as a direct selling consultant to turn around the struggling Kaire business. Mr.
Woodburn assisted Kaire with its acquisition of an inactive publicly traded entity, Natural Health
Trends Corp. (the Company), originally incorporated in Florida in 1988, and reverse-merged Kaire
into the Company in 1999. In 2000, Kaire Nutraceutical Inc. was sold to certain private investors.
Also in 2000, the Company was relocated to Dallas. The relocation was an ultimately successful
effort in reducing cost and improving the Companys coordination with key vendors. In January 2001, the Company with certain minority investors launched the Lexxus business in
the U.S. The move was followed by a string of international expansions of the Lexxus business that
significantly fueled the growth of the Company. The following is a summary of the years Lexxus entered into various international markets:  
    Canada, Australia, New Zealand: 2001
    Russia and Eastern Europe: January 2002. The business in this region was
re-organized into KGC in November 2003.
    Hong Kong: March 2002.
    India: April 2002. (Due to poor operating performance, management terminated
the Indian operations in the second quarter of 2004.)
    Singapore: June 2002.
    The Philippines: November 2002.
    South Korea: June 2003.
    Mexican: November 2004.
    Colombia: November 2004.
    Japan: December 2004.
    Indonesia: December 2004.
    Malaysia: January, 2005. I Luv My Pet (ILMP) was formed as a wholly owned subsidiary in the fourth quarter of 2003
to launch a new line of business focused on the pet food and supplement market. Sales of ILMP
products were substantially below expectations and total revenue from ILMP operations was
insignificant. After an evaluation in the third quarter of 2004, the Company elected to wind down
the operations of ILMP. As of December 2004, the operations of ILMP were terminated. 6




---



##### Table of Contents



Geographic Locations The Company operates in more than 30 countries. The Companys business is generally organized
along geographic lines within the two different brands:  
    Lexxus has active physical presence in the following markets:  o
    North America (The United States and Canada)o
    Greater China (Hong Kong, Taiwan and China) and
Southeast Asia (Singapore, Malaysia, the Philippines and Indonesia)o
    Eastern Europe (Russia and other former Soviet Union republics)o
    Australia and New Zealando
    South Koreao
    Japano
    Mexico  
    eKaire has active physical presence in the following markets  o
    North America (The United States and Canada)o
    Australia and New Zealand  
    Natural Health Trends Corp., the corporate entity is mainly staffed in Dallas,
Texas and Minneapolis, Minnesota. Please also see Item 2. Properties for specific cities of our facilities. Employees The combined total number of world-wide employees for our company was 143, at December 31,
2004, including 21 management, 65 sales and customer support, 7 marketing, 18 administrative, 14
accounting and 18 warehouse positions. The Company had 138 full-time and 5 part-time employees. Out of the 143 worldwide employees, the offices in the U.S. had 31 employees, Canada 9, Hong
Kong 30, Taiwan 29, the Philippines 11, Singapore 7, Indonesia 1, South Korea 17, Mexico 2, Japan
1, and Australia 5. Seasonality We believe that the seasonality of the recruitment of distributors and the general sales
volume do not correlate with that of traditional retail sales. For instance, most of our
distributors operate as a home-based business. Distributors tend to take typical vacations such
as summer and winter holidays, thus, decreasing our sales volume during such vacation periods. 7




---



##### Table of Contents



Intellectual Property Most of the eKaire and Lexxus products are packaged under a private label arrangement. We
have applied for trademark registration for names, logos and various product names in several
countries into which eKaire and Lexxus are doing business or considering expanding into. We
currently have three trademark registrations in the United States and two trademark applications
pending with the United States Patent and Trademark Office. Our registered trademarks expire or
become renewable in 2007 and 2008, and we rely on common law trademark rights to protect our
unregistered trademarks. These common law trademark rights do not provide us with the same level
of protection as afforded by a United States federal registration trademark. Common law trademark
rights are limited to the geographic area in which the trademark is actually utilized, while a
United States federal registration of a trademark enables the registrant to discontinue the
unauthorized use of the trademark by a third party anywhere in the United States even if the
registrant has never used the trademark in the geographic area where the trademark is being used,
provided, however, that the unauthorized third party user has not, prior to the registration date,
perfected its common law rights in the trademark within that geographic area. In November 2001, the inventor of our Aluraproduct, from whom we have a license to
distribute Alura, was awarded a patent for the formulation of that product. On November 1, 2004, Toyota Motor Sales, U.S.A. filed a lawsuit against the Company and Lexxus
which alleges that by using the name Lexxus we have diluted and infringed upon Toyotas Lexus
trademark. Toyota seeks to enjoin the Company and Lexxus from using the Lexxus mark and otherwise
competing unfairly with Toyota, to transfer the ownership of the mylexxus.com and
lexxusinternational.com Internet sites to Toyota, and reimbursement of costs and reasonable
attorney fees incurred by Toyota in connection with this matter. If the Company is unsuccessful in
defending this action, the Company may be required to change the name of some or all of its Lexxus
subsidiaries, certain products and domain names. See Legal Proceedings. Insurance The Company currently carries general liability insurance in the amount of $1,000,000 per
occurrence and $2,000,000 in the aggregate as well as customary cargo and other insurance coverage,
including on international subsidiaries. We do not carry product liability insurance, but may be
covered by the insurance maintained by our principal suppliers. There can be no assurance,
however, that product liability insurance would be available, and if available, that it would be
sufficient to cover potential claims or that an adequate level of coverage would be available in
the future at a reasonable cost, if at all. A successful product liability claim could have a
material adverse effect on our business, financial condition and results of operations. In
November 2004, Dorothy Porter filed a complaint against the Company for strict liability, breach of
warranty and negligence in the U.S. District Court for the Southern District of Illinois, alleging
that she sustained a brain hemorrhage after taking Formula One, an ephedra-containing product 8




---



##### Table of Contents



marketed by Kaire Nutraceuticals Inc., a former subsidiary of the Company. See Legal
Proceedings. 
 Working with Distributors Sponsorship The sponsoring of new distributors creates multiple levels in a direct selling structure. The
persons that a distributor sponsors within the network are referred to as down-line or
sponsored distributors. If down-line distributors also sponsor new distributors, they create
additional levels within the structure, but their down-line distributors remain in the same
down-line network as their original sponsoring distributor. We rely on our distributors to recruit and sponsor new distributors. Our top up-line
distributors tend to focus on building their network of down-line distributors. While we provide
product samples, brochures and other sales materials, distributors are primarily responsible for
recruiting and educating their new distributors with respect to products, the compensation plan and
how to build a successful distributorship network. Distributors are not required to sponsor other distributors as their down-line, and we do not
pay any commissions for sponsoring new distributors. However, because of the financial incentives
provided to those who succeed in building a distributor network that consumes and resells products,
we believe that many of our distributors attempt, with varying degrees of effort and success, to
sponsor additional distributors. Because they are seeking new opportunities for income, people are
often attracted to become distributors after using our products and becoming regular customers or
after attending introductory seminars. Once a person becomes a distributor, he or she is able to
purchase products directly from us at wholesale prices via the Internet. The distributor is also
entitled to sponsor other distributors in order to build a network of distributors and product
users. Compensation Plans We believe that one of our key competitive advantages within the direct selling industry is
our distributor compensation plan. Under our compensation plan, distributors are paid weekly
commissions in the distributors home country, in their local currency, for product sold by that
distributors down-line distributor network across all geographic markets. Distributors are not
paid commissions on purchases or sales of our products made directly by them. This seamless
compensation plan enables a distributor located in one country to sponsor other distributors
located in other countries where we are authorized to do business. Based upon managements knowledge of our competitors distributor compensation plans, we
believe that our compensation plan is among the most financially 9




---



##### Table of Contents



rewarding plans offered to distributors by any direct selling company. Currently, there are
two fundamental ways in which our distributors can earn income:  
    Through retail markups on sales of products purchased by distributors at
wholesale prices; and
    Through a series of commissions paid on product purchases made by their
down-line distributors. Each of our products carries a specified number of sales volume points. Commissions are based
on total personal and group sales volume points per sales period. Sales volume points are
essentially based upon a percentage of a products wholesale cost. As the distributors business
expands from successfully sponsoring other distributors who in turn expand their own businesses by
sponsoring other distributors, the distributor receives higher commissions. To be eligible to
receive commissions, a distributor may be required to make nominal monthly purchases of our
products. Certain of our subsidiaries do not require these nominal purchases for a distributor to
be eligible to receive commissions. In determining commissions, the number of levels of down-line
distributors included within the distributors commissionable group increases as the number of
distributorships directly below the distributor increases. Distributor Support We are committed to providing a high level of support services tailored to the needs of our
distributors in each marketplace we are serving. We attempt to meet the needs and build the loyalty
of distributors by providing personalized distributor services and by maintaining a generous
product return policy. See Product Warranties and Returns. Because many of our distributors are
working on a part-time basis and have only a limited number of hours each week to concentrate on
their business, we believe that maximizing a distributors efforts by providing effective
distributor support has been, and could continue to be, important to our success. Through training meetings, annual conventions, web-based messages, distributor focus groups,
regular telephone conference calls and other personal contacts with distributors, we seek to
understand and satisfy the needs of our distributors. Via our websites, we provide product
fulfillment and tracking services that result in user-friendly and timely product distribution.
Most of our offices maintain meeting rooms, which our distributors may utilize for training and
sponsoring activities. We do not believe that most of our distributors maintain a significant
inventory of our products. To help maintain communication with our distributors, we offer the following support programs: Teleconferences.Lexxus and eKaire hold teleconferences with company management and associate
field leadership on various subjects such as technical product discussions, distributor
organization building and management techniques. 10




---



##### Table of Contents



Internet.We maintain websites at www.naturalhealthtrendscorp.com, www.kaire.com,
www.lexxusinternational.com, www.kgcnetworks.com, www.mylexxus.com, and www.mykaire.com.
On each website, the user can read company news, learn more about various products, sign up to be a
distributor, place orders, and track the fulfillment and delivery of their order. Product Literature.We offer a variety of literature to distributors, including product
catalogs, informational brochures, pamphlets and posters for individual products. Toll Free Access.eKaire offers a toll free number to place orders and to sponsor new
distributors. Lexxus offers these services only through its websites. Both eKaire and Lexxus offer
live consumer support where a customer service representative can address general questions or
concerns. Broadcast E-mail.Announcements about Lexxus and eKaire are sent via e-mail to all active
distributors. Technology and Internet Initiatives We believe that the Internet has become increasingly important to our business as more
consumers communicate online and purchase products over the Internet as opposed to traditional
retail and direct sales channels. As a result, we have committed significant resources to our
e-commerce capabilities and the abilities of our distributors to take advantage of the Internet.
Substantially all of our sales during 2003 and 2004 occurred via the Internet. eKaire has a
personalized website for its distributors to purchase products via the Internet at www.mykaire.com.
Lexxus offers a global web page that allows a distributor to have a personalized website at
www.mylexxus.com through which he or she can sell products in more than 30 international markets. Rules Affecting Distributors We monitor regulations in each country in which we do business as well as the activity of
distributors to ensure that our distributors comply with local laws. Our distributor policies and
procedures establish the rules that distributors must follow in each country. We also monitor
distributor activity in an attempt to provide our distributors with a level playing field so that
one distributor may not be disadvantaged by the activities of another. We require our distributors
to present products and business opportunities in an ethical and professional manner. Distributors
further agree that their presentations to customers must be consistent with, and limited to, the
product claims and representations made in our literature. We require that we produce or pre-approve all sales aids used by distributors such as
videotapes, audiotapes, brochures and promotional clothing. Further, distributors may not use any
form of media advertising to promote products unless it is pre-approved by the Company. Products
may be promoted only by personal contact or by literature 11




---



##### Table of Contents



produced or approved by us. Distributors are not entitled to use our trademarks or other
intellectual property without our prior consent. Our compliance department reviews reports of alleged distributor misbehavior. If we determine
that a distributor has violated our distributor policies or procedures, we may terminate the
distributors rights completely. Alternatively, we may impose sanctions, such as warnings,
probation, withdrawal or denial of an award, suspension of privileges of the distributorship,
fines, withholding commissions, until specified conditions are satisfied or other appropriate
injunctive relief. Our distributors are independent contractors, not employees, and may act
independently of us. Further, our distributors may resign or terminate their distributorship at any
time without notice. See Risk Factor  Although Our Distributors Are Independent Contractors,
Improper Distributor Actions That Violate Laws or Regulations Could Harm Our Business. 
 Recent Developments On March 29, 2004, the Company purchased shares of common stock owned by the minority
stockholders of Lexxus U.S. (representing the 49% interest not owned by the Company) in exchange
for 100,000 shares of the Companys common stock. The total purchase price, including acquisition
related costs of approximately $7,000, was approximately $1,969,000 based upon the average closing
price of the Companys common stock of $23.08 discounted by 15%. See Acquisitions and Related
Party Transactions in Item 8. On March 31, 2004, the Company entered into a merger agreement with MarketVision
Communications Corp. (MarketVision), the exclusive provider of the direct selling software used
by our Lexxus businesses around the world since mid-2001. See Acquisitions and Related Party
Transactions in Item 8. On April 12, 2004, an investigative television program was aired in the Peoples Republic of
China with respect to the operations of the Companys Hong Kong subsidiary and the representative
office located in Beijing. The television program alleged that Lexxuss Hong Kong operations
engaged in fraudulent activities and sold products without proper permits. After a thorough
internal investigation of the issues raised in the television program, the Company nonetheless
concluded that additional training and development of certain Lexxus independent distributors
located in Hong Kong was warranted. The Company then began to require intensive training of its
independent distributors with respect to:  
    The applicable Chinese legal requirements, and
    The need for distributors to accurately and fairly describe business opportunities
available to potential distributors. 12




---



##### Table of Contents



In May 2004, the Company elected to suspend shipment of product to certain Hong Kong
distributors until they had completed the required training. This resulted in an unshipped sales
backlog of orders to be shipped of approximately $6,598,000 as of June 30, 2004. By September 30,
2004, training of the distributors was substantially completed. Furthermore, to accommodate the
concerns of many independent distributors, Lexxus extended its existing 14-day return policy in
Hong Kong to 180 days to allow distributors and customers who purchased products during the
two-week period prior to, and the two-week period after, the airing of the television program to
return purchased merchandise for a full refund. In addition, the Company decided not to seek
recovery for any commissions already paid to its distributors related to product sales recorded
during this period that were subsequently returned. Due to the adverse publicity caused by the
airing of the television program, revenues from Hong Kong declined significantly during the second
and third quarters of 2004. On April 19, 2004, the Company purchased 510,000 shares of common stock owned by the minority
stockholders of Lexxus International Co., Ltd. (Taiwan), a Taiwan limited liability corporation
(Lexxus Taiwan) which represented the 30% interest in Lexxus Taiwan not owned by the Company.
For these shares of Lexxus Taiwan, the Company paid $136,000 in cash. On October 6, 2004, the Company entered into a securities purchase agreement with certain
institutional and accredited investors as well as certain officers and directors of the Company.
Pursuant to the agreement, the Company agreed to sell 1,369,704 units at a price of $12.595 per
unit, raising approximately $16 million proceeds, net of transaction costs. See Private Placement
of Units. The Company intends to generate revenue in both the Mexican and Japanese markets in 2005. As
of December 2004, management teams were recruited and new entities were established for both
markets. The Company expects that the Mexican operations could start to generate revenue by the
second quarter of 2005, and the Japanese operations should begin to generate revenue sometime by
the fourth quarter of 2005. In June 2004, Lexxus obtained a business license in China. The license stipulates a capital
requirement of $12 million over a three-year period, including a $1.8 million initial payment the
Company made in January 2005. In planning for a retail operation, the Company estimates that each
retail store will cost approximately $50,000 to $100,000 and is evaluating the number, location,
timing, and format of store openings. The Company is evaluating ways to develop a retail-based
operation in China. Direct selling is currently prohibited in China. Though the Chinese government
is drafting the pertinent legislation and has published preliminary versions of the new laws, the
Company cannot be sure when the new laws could become effective or whether the Company will satisfy
the requirements necessary to obtain a direct selling license in the near future. In the interim,
the Company plans to follow the path of some of our peer companies that have already commenced
selling in China by selling products from company-owned or 13




---



##### Table of Contents



franchised retail stores. The Company is assessing where to open the first stores and how
to structure its business in China. On February 22, 2005, the Companys common stock began trading on The NASDAQ National Market
under the ticker symbol BHIP. On March 23, 2005, the Company filed a Current Report on Form 8-K to report, after
consultantion with its audit committee, that an amendment to its financial statements for the year
ended December 31, 2003 and for the first quarter of 2004 is warranted as certain commission and
transportation-related expenses incurred as of December 31, 2003 were under-accrued and certain
revenues not earned until 2004 were improperly recorded as revenue by its Eastern European
business, KGC Networks Ptd. Ltd., for the year ended December 31, 2003. The restatement of the
financial statements for the year ended December 31, 2003 will reduce the Companys revenue by
approximately $310,000, increase cost of goods sold by approximately $180,000, increase distributor
commission expense by approximately $460,000, reduce minority interest expense by approximately
$300,000, and reduce after-tax net income by approximately $650,000 for the quarter as well as the
year ended December 31, 2003. For the quarter ended March 31, 2004, the restatement will increase the Companys revenue by
approximately $310,000, reduce cost of goods sold by approximately $180,000, reduce distributor
commission expense by approximately $460,000, increase minority interest expense by approximately
$300,000, and increase after-tax net income by approximately $650,000 for the quarter ended March
31, 2004. Although the financial statements for the three month periods ended June 30, 2004 and
September 30, 2004 are unaffected by this error, the consolidated financial statements for the
second and third quarters of 2004 include inaccurate information on a year to date basis because
they include the erroneous information from the first quarter of 2004 which financial statements
should not be relied upon. The Company also intends to file in the near future an amended annual
report on Form 10-KSB for the year ended December 31, 2003, and amended quarterly reports on Form
10-Q for the first three quarters of 2004. 
 Private Placement of Units In October 2004, the Company entered into a securities purchase agreement (and subscription
agreements with respect to certain Canadian investors) and a registration rights agreement with
certain institutional and accredited investors as well as certain officers and directors of the
Company. Pursuant to the purchase and subscription agreements, the Company agreed to sell, and the
buyers agreed to purchase, a total of 1,369,704 units of the Companys securities at a price of
$12.595 per unit. Each unit consists of one share of common stock, and one common stock purchase
warrant exercisable for one share of common stock at any time through October 6, 2009 at an
exercise price of $12.47 per share. Assuming the exercise of all the warrants, the net proceeds to
the Company will be an additional $17 million. 14




---



##### Table of Contents



Pursuant to the registration rights agreement, the Company has agreed to register the shares
included in the units and the shares issuable upon exercise of the Warrants for resale under the
Act. The registration rights agreement provides for the payment of certain liquidated damages in
the event that delays are experienced in the Securities and Exchange Commissions declaring that
registration statement effective. The Company agrees to use commercially reasonable effort to
effect and maintain the effectiveness of a registration statement. If the registration statement is
not effective 180 days after the closing date, or approximately April 4, 2005, the Company will pay
the buyers approximately $85,000, which also applies to any of Companys possible failure to
maintain the effectiveness of the registration statement after its initial effectiveness. The
Company does not expect an effective registration statement within the required 180 day period.
The registration rights agreement also provides indemnification and contribution remedies to the
buyers in connection with the resale of shares pursuant to such registration statement. Each of (i) Sir Brian Wolfson, Chairman of the Board of the Company, (ii) Mark D. Woodburn,
President and a director of the Company, (iii) Terry LaCore, an executive officer and a director of
the Company, (iv) Chris Sharng, Executive Vice President and Chief Financial Officer of the
Company, (v) John Cavanaugh, President of MarketVision, and (vi) Robert Hesse, a director of the
Company, invested approximately $25,000 and purchased 1,984 units upon the same terms and
conditions as the other buyers in the private placement. See Principal Shareholders  Security
Ownership of Certain Beneficial Owners and Management. 
 Government Regulations Government Regulation of Direct Selling Activities Direct selling activities are regulated by various federal, state and local governmental
agencies in the United States and foreign countries. These laws and regulations are generally
intended to prevent fraudulent or deceptive schemes often referred to as pyramid schemes, that
compensate participants for recruiting additional participants irrespective of product sales, use
high pressure recruiting methods and/or do not involve legitimate products. The laws and
regulations in our current markets often:  
    impose cancellation/product return, inventory buy backs and cooling off
rights for consumers and distributors;
    require us or our distributors to register with governmental agencies;
    impose reporting requirements; and
    impose upon us requirements, such as requiring distributors to maintain
levels of retail sales to qualify to receive commissions, to ensure that distributors
are being compensated for sales of products and not for recruiting new distributors. The laws and regulations governing direct selling are modified from time to time to address
concern of regulators. For example, in South Korea new regulations were adopted that, among other
things, restrict direct selling marketing companies from 15




---



##### Table of Contents



imposing certain personal sales quota to obtain or maintain distributorship or favorable
compensation rates, modify product return requirements so that product must be returned within a
shorter period of time, and require the companies to show sufficient insurance or guarantee to
reimburse customers and/or distributors for cancelled or unfilled orders. We have had to make some
modifications to our compensation plan and policies in order to be in compliance with all of these
rules. Based on research conducted in opening our existing markets, the nature and scope of inquiries
from government regulatory authorities, and our history of operations in such markets to date, we
believe that our methods of distribution are in compliance in all material respects with the laws
and regulations relating to direct selling activities of the countries in which we currently
operate. Many countries currently still have laws in place that would prohibit us from conducting
business in such markets. There can be no assurance that we would be allowed to continue to
conduct business in each of our existing markets that we currently service or any new market we may
enter in the future. Regulation of Our Products Our products and related promotional and marketing activities are subject to extensive
governmental regulation by numerous domestic and foreign governmental agencies and authorities,
including the FDA, the FTC, the Consumer Product Safety Commission, the United States Department of
Agriculture, state attorneys general and other state regulatory agencies, and similar government
agencies in each country in which we operate. For example, in Taiwan, all medicated cosmetic and
pharmaceutical products require registration. These regulations can limit our ability to import
products into new markets and can delay introductions of new products into existing markets as we
comply with the registration and approval process for our products. During the fall of 2003, the customs agency of the government of South Korea brought a charge
against LXK, Ltd., the Companys wholly owned subsidiary operating in South Korea, with respect to
the importation of the Companys Aluraproduct. The customs agency alleges that Alurais not a
cosmetic product, but rather should be categorized and imported as a pharmaceutical product. This
allegation prevailed in a Seoul district court ruling in February 2005. In the verdict, the Company
was fined and prohibited from marketing Alura. The
Company is evaluating an appeal. See Note 8
Legal Matters in Commitments and Contingencies of our Consolidated Financial Statements. Some of our products are strictly regulated in certain markets in which we operate. These
markets have varied regulations that apply to and distinguish nutritional health supplements from
drugs or pharmaceutical products. For example, the FDA of the United States under the Federal
Food, Drug and Cosmetic Act regulates our products. The Federal Food, Drug and Cosmetic Act has
been amended several times with respect to nutritional supplements, most recently by the Nutrition
Labeling and Education Act and the Dietary Supplement Health and Education Act. The Dietary
Supplement Health and Education Act establishes rules for determining whether a product is a
dietary 16




---



##### Table of Contents



supplement. Under this statute, dietary supplements are regulated more like foods than drugs,
are not subject to the food additive provisions of the law, and are generally not required to
obtain regulatory approval prior to being introduced to the market. None of this limits, however,
the FDAs power to remove an unsafe substance from the market. In the event a product, or an
ingredient in a product, is classified as a drug or pharmaceutical product in any market, we would
generally not be able to distribute that product in that market through our distribution channel
because of strict restrictions applicable to drug and pharmaceutical products. Most of our existing major markets also regulate product claims and advertising regarding the
types of claims and representations that can be made regarding the efficacy of products,
particularly dietary supplements. Accordingly, these regulations can limit our ability and that of
our distributors to inform consumers of the full benefits of our products. For example, in the
United States, we are unable to make any claim that any of our nutritional supplements will
diagnose, cure, mitigate, treat or prevent disease. The Dietary Supplement Health and Education
Act permits only substantiated, truthful and non-misleading statements of nutritional support to be
made in labeling, such as statements describing general well-being resulting from consumption of a
dietary ingredient or the role of a nutrient or dietary ingredient in affecting or maintaining a
structure or a function of the body. In addition, all product claims must be substantiated. Other Regulatory Issues As a company incorporated in the United States and operating through subsidiaries in foreign
jurisdictions, we are subject to foreign exchange control, various forms of withholding taxes and
transfer pricing laws that regulate the flow of funds between our subsidiaries and us for product
purchases, management services and contractual obligations such as the payment of distributor
commissions. Product Warranties and Returns Lexxus. The Lexxus refund policies and procedures closely follow industry and
country-specific standards, which vary greatly by country. For example, in the United States, the
Direct Selling Association recommends that direct sellers permit returns during the twelve-month
period following the sale, while in Hong Kong the standard return policy is 14 days following the
sale. We have conformed our return policies to local laws or the recommendation of the local
direct selling association. In most cases, distributors may return unopened product that is in
resalable condition for a partial refund. Lexxus must be notified of the return in writing and such
written requests would be considered a termination notice of the distributorship. From time to time we alter our return policy in response to special circumstances. For
example, in April 2004, an investigative television program was aired in the Peoples Republic of
China with respect to the operations of the Companys Hong Kong subsidiary and the Lexxus
representative office located in Beijing. The television program made allegations that Lexxuss
Hong Kong operations engaged in fraudulent 17




---



##### Table of Contents



activities and sold products without proper permits. In order to address the concerns of many
independent distributors, Lexxus extended its existing 14-day return policy in Hong Kong to 180
days to allow distributors and customers who purchased products during the two-week period prior
to, and the two-week period after, the airing of the television program to return purchased
merchandise for a full refund. See Recent Developments in Item 1. In October 2004, this special
extended product return policy expired. 
 eKaire.eKaire product warranties and refund policies are similar to those of other companies
in the industry. If a distributor is not satisfied with the product then he/she can return the
product to eKaire for a full refund within ninety (90) days of the first time the product was
purchased. A distributor may return or exchange products that are unopened and in resalable
condition thirty (30) days after the date of purchase. Our Industry We are engaged in the direct selling industry, selling life-style enhancement products,
cosmetics, personal care and nutritional supplements. Direct selling is also referred to as network
marketing or multi-level marketing. This type of organizational structure and approach to
marketing and sales has proven to be extremely successful for several other direct selling
companies, particularly companies selling life-style-enhancement products, cosmetics and
nutritional supplements, or selling other types of consumer products, such as Tupperware
Corporation and Amway Corp. Generally, direct selling is based upon an organizational structure in
which independent distributors of a companys products are compensated for sales made directly to
consumers. Distributors are compensated for sales generated by distributors they recruited and all
subsequent distributors recruited by their down-line network of distributors. The experience of
the direct selling industry has been that once a sizeable network of distributors is established,
new and alternative products and services can be offered to those distributors for sale to
consumers and additional distributors. The successful introduction of new products can
dramatically increase sales and profits for both distributors and the direct selling marketing
organization. According to information contained on the Direct Selling Associations website, direct selling
is one of the fastest growing segments for the distribution of products on a worldwide basis. The
Direct Selling Association reports that approximately 50 million individuals are now involved in
direct selling worldwide, and that those involved in direct selling generate approximately $93
billion in annual sales around the world. In the United States, the direct selling channel has
generated sales of approximately $29.6 billion of goods and services in 2003, making the United
States the largest direct selling market in the world. 18




---



##### Table of Contents



Top Direct Selling Markets Worldwide Num. OfNumber of
    
    
    Population (000s)
    
    
    Distrib./1000
    
    
    Revenue PerMarket
    
    Revenue ($MM)
    
    
    Distributors (000s)
    
    
    FY2002
    
    
    Population
    
    
    DistributorUSA
    
    $
    29,550
    
    
    
    13,300
    
    
    
    287,676
    
    
    
    46
    
    
    $
    2,222Japan
    
    
    24,500
    
    
    
    2,000
    
    
    
    127,066
    
    
    
    16
    
    
    $
    12,250Korea
    
    
    4,620
    
    
    
    3,050
    
    
    
    47,963
    
    
    
    64
    
    
    $
    1,515China
    
    
    4,230
    
    
    
    n.a.
    
    
    
    1,279,161
    
    
    
    n.a.
    
    
    
    n.a.Mexico
    
    
    3,106
    
    
    
    1,820
    
    
    
    103,400
    
    
    
    18
    
    
    $
    1,707UK
    
    
    3,092
    
    
    
    542
    
    
    
    59,912
    
    
    
    9
    
    
    $
    5,702France
    
    
    2,884
    
    
    
    300
    
    
    
    59,925
    
    
    
    5
    
    
    $
    9,613Brazil
    
    
    2,815
    
    
    
    1,201
    
    
    
    179,914
    
    
    
    7
    
    
    $
    2,345Germany
    
    
    2,615
    
    
    
    213
    
    
    
    82,351
    
    
    
    3
    
    
    $
    12,289Italy
    
    
    2,353
    
    
    
    260
    
    
    
    57,927
    
    
    
    4
    
    
    $
    9,050Taiwan
    
    
    1,255
    
    
    
    3,200
    
    
    
    22,454
    
    
    
    143
    
    
    $
    392Australia
    
    
    1,155
    
    
    
    650
    
    
    
    19,547
    
    
    
    33
    
    
    $
    1,777Malaysia
    
    
    1,030
    
    
    
    3,000
    
    
    
    22,662
    
    
    
    132
    
    
    $
    343Canada
    
    
    950
    
    
    
    898
    
    
    
    31,902
    
    
    
    28
    
    
    $
    1,057Russia
    
    
    896
    
    
    
    1,611
    
    
    
    144,979
    
    
    
    11
    
    
    $
    556Thailand
    
    
    800
    
    
    
    4,000
    
    
    
    63,645
    
    
    
    63
    
    
    $
    200Top 16
    
    
    85,851
    
    
    
    36,045
    
    
    
    2,590,484
    
    
    
    14
    
    
    $
    2,382Other
    
    
    6,872
    
    
    
    12,937
    
    
    
    3,637,910
    
    
    
    4
    
    
    $
    531World
    
    $
    92,723
    
    
    
    48,982
    
    
    
    6,228,394
    
    
    
    8
    
    
    $
    1,893
  Source: World Federation of Direct Selling Associations Competition We compete with a significant number of other retailers that are engaged in similar lines of
business, including sellers of health-related products and other direct sellers such as Nu Skin
Enterprises, Inc., USANA Health Sciences, Inc., Mannatech, Inc., Reliv International, Inc, and
Herbalife, Ltd.. Many of the competitors have greater name recognition and financial resources
than us as well as many more distributors. Two of the most well known and established of direct
sellers are Mary Kay, Inc. and Amway Corp., each with over three million distributors worldwide.
The direct selling channel tends to sell products at a higher price compared to traditional
retailers, which poses a degree of competitive risk. There is no assurance that we would continue
to compete effectively against retail stores, internet based retailers or other direct sellers. 
 Forward-looking Statements Certain statements contained in this prospectus constitute forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. All statements included in this prospectus, other than
statements of historical facts, regarding our strategy, future operations, financial position,
estimated revenues, projected costs, prospects, plans and objectives are forward-looking
statements. When used in this prospectus, the words believe, anticipate, intend, estimate,
expect, project, could, would, may, plan, predict, pursue, continue, feel and
similar expressions are intended to identify forward-looking statements, although not all
forward-looking statements contain these identifying words. 19




---



##### Table of Contents



We cannot guarantee future results, levels of activity, performance or achievements, and you
should not place undue reliance on our forward-looking statements. Our actual results could differ
materially from those anticipated in these forward-looking statements as a result of various
factors, including the risks described in Risk Factors, and elsewhere in this prospectus. Our
forward-looking statements do not reflect the potential impact of any future acquisitions, mergers,
dispositions, joint ventures or strategic investments. In addition, any forward-looking statements
represent our expectation only as of the date of this prospectus and should not be relied on as
representing our expectations as of any subsequent date. While we may elect to update
forward-looking statements at some point in the future, we specifically disclaim any obligation to
do so, even if our expectations change. Although we believe that the expectations reflected in any of our forward-looking statements
are reasonable, actual results could differ materially from those projected or assumed in any of
our forward-looking statements. Our future financial condition and results of operations, as well
as any forward-looking statements, are subject to change and to inherent risks and uncertainties,
such as those disclosed in this prospectus. Important factors that could cause our actual results,
performance and achievements, or industry results to differ materially from estimates or
projections contained in forward-looking statements include, among others, the following:  
    our relationship with our distributors;
    our need to continually recruit new distributors;
    our internal controls and accounting methods may require further modification;
    regulatory matters governing our products and network marketing system;
    our relationship with our majority owned subsidiary operating in Russia;
    our ability to recruit and maintain key management,
    adverse publicity associated with our products or direct selling organizations;
    product liability claims;
    our reliance on outside manufacturers;
    risks associated with operating internationally, including foreign exchange
risks;
    product concentration;
    dependence on increased penetration of existing markets;
    the competitive nature of our business; and
    our ability to generate sufficient cash to operate and expand our business. Market data and other statistical information used throughout this report is based on
independent industry publications, government publications, reports by market research firms or
other published independent sources and on our good faith estimates, which are derived from our
review of internal surveys and independent sources. Although we believe that these sources are
reliable, we have not independently verified the information and cannot guarantee its accuracy or
completeness. 20




---



##### Table of Contents



Risk Factors Investing in our common stock involves a high degree of risk. You should carefully consider
the following risk factors in addition to the other information contained in thisForm 10-Kbefore
deciding whether to invest in our shares of common stock. If any of the following risks actually
occurs, our business, financial condition and results of operations would suffer. In this case, the
trading price of our shares of common stock would likely decline and you might lose all or part of
your investment in our common stock. The risks described below are not the only ones we face. Other
risks, including those that we do not currently consider material or may not currently anticipate,
may impair our business. Risks Related to Our Business Our Failure To Maintain and Expand Our Distributor Relationships Could Adversely Affect Our
Business. We distribute our products through independent distributors, and we depend upon them directly
for all of our sales. Accordingly, our success depends in significant part upon our ability to
attract, retain and motivate a large base of distributors. Our direct selling organization is
headed by a relatively small number of key distributors. The loss of a significant number of
distributors, including any key distributors, could materially and adversely affect sales of our
products and could impair our ability to attract new distributors. Moreover, the replacement of
distributors could be difficult because, in our efforts to attract and retain distributors, we
compete with other direct selling organizations, including but not limited to those in the personal
care, cosmetic product and nutritional supplement industries. Our distributors may terminate their
services with us at any time and, in fact, like most direct selling organizations, we have a high
rate of attrition. If The Number Or Productivity Of Independent Distributors Does Not Increase, Our Revenue Could Not
Increase. To increase revenue, we must increase the number and/or the productivity of our distributors.
We can provide no assurances that distributor numbers could increase or remain constant or that
their productivity could increase. We experienced an 81% increase in active Lexxus distributors
during 2004, following a 39% increase in active distributors in 2003 compared to the prior years.
See table on Page 4. The number of active distributors may not increase and could decline in the
future. Distributors may terminate their services at any time, and, like most direct selling
companies, we experience a high turnover among distributors from year to year. We cannot accurately
predict any fluctuation in the number and productivity of distributors because we primarily rely
upon existing distributors to sponsor and train new distributors and to motivate new and existing
distributors. Operating results could be adversely affected if our existing and new business
opportunities and products do not generate sufficient 21




---



##### Table of Contents



economic incentive or interest to retain existing distributors and to attract new
distributors. Because Our Hong Kong Operations Account For A Majority Of Our Business, Any Adverse Changes In Our
Business Operations In Hong Kong Would Harm Our Business. In 2003 and 2004, approximately 49% and 56% of our revenue, respectively, was generated in
Hong Kong. Various factors could harm our business in Hong Kong, such as worsening economic
conditions or other events that are out of our control. For example, on April 12, 2004, an
investigative television program was aired in the Peoples Republic of China with respect to the
operations of the Companys Hong Kong subsidiary and the Lexxus representative office located in
Beijing. The television program alleged that Lexxuss Hong Kong operations engaged in fraudulent
activities and sold products without proper permits. Due to the adverse publicity caused by the
airing of the television program, revenues from Hong Kong declined significantly. See Recent
Developments. Our financial results could be harmed if our products, business opportunity or
planned growth initiatives fail to retain and generate continued interest and enthusiasm among our
distributors and consumers in this market. Our Plan to Expand Operations In China May Result In More Governmental Scrutiny, And Our Business
In Hong Kong May Be Harmed By The Results Of Such Scrutiny. The Chinese government banned direct selling activities in China in 1998. The government has
rigorously monitored and enforced this ban. In the past, the government has taken significant
actions against companies that the government found engaging in violation of applicable law.
Governmental actions included shutting down their businesses and arresting alleged perpetrators.
Consequently, a few of our direct selling peer companies have modified their business models and
started selling to Chinese consumers through owned, leased or franchised retail outlets. We have
not implemented our direct sales model in China. We intend to follow the path of some of our
competitors and implement a business model that utilizes retail stores and an employee sales force
that we believe will comply with applicable regulations. Some of our Hong Kong distributors have engaged in activities that violated our policies in
this market and resulted in some regulatory concern and some adverse publicity such as the negative
television documentary aired on April 12, 2004. Reviews and investigations by government
regulators could restrict our ability to conduct business. Although we would attempt to work closely with both national and local governmental agencies
in implementing our plans, our efforts to comply with national and local laws may be harmed by a
rapidly evolving regulatory climate, concerns about activities resembling direct selling and any
subjective interpretation of laws. Any determination that our operations or activities, or the
activities of our employee sales representatives or distributors living outside of China, are not
in compliance with 22




---



##### Table of Contents



applicable regulations could result in the imposition of substantial fines, extended
interruptions of business, restrictions on our future ability to open new stores or expand into new
locations, substantially diminishing our ability to retain existing sales representatives and
attract new sales representatives, changes to our business model, the termination of required
licenses to conduct business, or other actions, all of which would harm our business. If China Fails To Adopt New Direct Selling Regulations, Or If These Regulations Are Not Favorable
To Us, Our Future Growth Could Be Harmed. The Chinese government has published a draft of the new direct selling regulations. None of
these regulations have been adopted and there can be no assurance that these regulations will be
adopted or, if adopted, that they will benefit our company. While we intend to apply for a direct
selling license under any newly adopted regulations, there can be no assurance that a license will
be granted. Although we currently do not operate a direct selling business in China, our future
growth could be harmed if the regulations are not adopted or are unfavorable, or if we are unable
to obtain a license for direct selling under these regulations. Intellectual Property Rights Are Difficult To Enforce In China. Chinese commercial law is relatively undeveloped compared to most other major markets, and, as
a result, we may have limited legal recourse in the event we encounter significant difficulties
with patent or trademark infringers. Limited protection of intellectual property is available under
Chinese law, and the local manufacturing of our products may subject us to an increased risk that
unauthorized parties may attempt to copy or otherwise obtain or use our product formulations. As a
result, we cannot assure you that we would be able to adequately protect our product formulations. Our Continued Influence Over Our KGC Networks Subsidiary And Its Success Depends In Large Part On A
Good Working Relationship With The Minority Shareholder. The Company owns 51% of the outstanding capital stock of KGC and has the right to appoint a
majority of the Board of Directors of KGC. In 2004, KGC accounted for 22% of our total revenue,
compared to 21% in 2003. We have limited influence over KGCs day-to-day operations, which are
actively managed by a European private investor that owns 49% of the outstanding capital stock of
KGC, and Septuor. We work with the management of KGC and Septuor on supply chain management, cash
flow management, product development and financial reporting. But our influence over KGC is not as
much as that over our other subsidiaries. There can be no assurance that this subsidiary will
continue to grow under the current ownership structure. There is also no guarantee that the
interests of the minority shareholder will always be aligned with our interests. Deterioration in
our relationship with the minority shareholder or Septuor, or a failure to work cooperatively by
either party, could result in a slow-down of the business 23




---



##### Table of Contents



growth, disruption in timely financial reporting, or other business problems that could
materially harm our business. As We Continue To Expand Into Foreign Markets Our Business Becomes Increasingly Subject To
Political and Economic Risks. Changes In These Markets Could Adversely Affect Our Business. We believe that our ability to achieve future growth is dependent in part on our ability to
continue our international expansion efforts. However, there can be no assurance that we would be
able to grow in our existing international markets, enter new international markets on a timely
basis, or that new markets would be profitable. We must overcome significant regulatory and legal
barriers before we can begin marketing in any foreign market. Also, it is difficult to assess the extent to which our products and sales techniques would be
accepted or successful in any given country. In addition to significant regulatory barriers, we
may also encounter problems conducting operations in new markets with different cultures and legal
systems from those encountered elsewhere. We may be required to reformulate certain of our
products before commencing sales in a given country. Once we have entered a market, we must adhere
to the regulatory and legal requirements of that market. No assurance can be given that we would
be able to successfully reformulate our products in any of our current or potential international
markets to meet local regulatory requirements or attract local customers. The failure to do so
could have a material adverse effect on our business, financial condition, and results of
operations. There can be no assurance that we would be able to obtain and retain necessary permits
and approvals. In many markets, other direct selling companies already have significant market penetration,
the effect of which could be to desensitize the local distributor population to a new opportunity,
or to make it more difficult for us to recruit qualified distributors. There can be no assurance
that, even if we are able to commence operations in foreign countries, there would be a
sufficiently large population of potential distributors inclined to participate in a direct selling
system offered by us. We believe our future success could depend in part on our ability to
seamlessly integrate our business methods, including distributor compensation plan, across all
markets in which our products are sold. There can be no assurance that we would be able to further
develop and maintain a seamless compensation program. An Increase In The Amount Of Compensation Paid To Distributors Would Reduce Profitability. A significant expense is the payment of compensation to our distributors. We paid
approximately 46% and 44% in 2002 and 2003, of our net revenues as compensation to our
distributors. In 2004, we paid approximately 51% of our net revenues as compensation to our
distributors. The increase is due to the growth of the distributor network, an elevated level of
promotions, and the Companys decision of not seeking 24




---



##### Table of Contents



recovery of commissions paid on returned products in Hong Kong during the second quarter of
2004. We compensate our distributors by paying commissions, bonuses, and certain awards and
prizes. We closely monitor the amount of compensation to distributors paid as a percentage of net
sales and may need to adjust our compensation plan to prevent distributor compensation from having
a significant adverse effect on earnings. There can be no assurance that these changes or future
changes to our compensation plan or product pricing would be successful in maintaining the level of
distributor compensation expense as a percentage of net sales. Furthermore, these changes may make
it difficult to recruit and retain qualified and motivated distributors. An increase in
compensation payments to distributors as a percentage of net sales will reduce our profitability.
See Working with Distributors  Compensation Plans. We May be Required to Change the Name of our Lexxus Subsidiaries, Internet Sites and Certain
Products. On November 1, 2004, Toyota Motor Sales, U.S.A. filed a lawsuit against the Company and Lexxus
alleging that our use of the name Lexxus dilutes and infringes upon Toyotas Lexus trademark.
Toyota wants to enjoin the Company and Lexxus from using the Lexxus mark and otherwise competing
unfairly with Toyota, to transfer the ownership of the mylexxus.com and lexxusinternational.com
Internet sites to Toyota, and reimbursement of costs and reasonable attorney fees incurred by
Toyota in connection with this matter. See Legal Proceedings. If the Company is unsuccessful in
defending this action, the Company may be required to change the name of some or all of its Lexxus
subsidiaries, and certain product and website domain names which could have a material adverse
effect on the financial condition, results of operations, cash flow or business prospects of the
Company. Further, even if the Company is successful in defeating all or some of Toyotas claims,
legal costs and expenses incurred by the Company could be substantial. We Do Not Have Product Liability Insurance And Product Liability Claims Could Hurt Our Business. Currently, we do not have product liability insurance, although the insurance carried by our
suppliers may cover certain product liability claims against us. Nevertheless, we do not conduct or
sponsor clinical studies of our products. As a marketer of nutraceuticals, cosmetics and other
products that are ingested by consumers or applied to their bodies, we may become subjected to
various product liability claims, including that:  
    our products contain contaminants;
    our products include inadequate instructions as to their uses; or
    our products include inadequate warnings concerning side effects and interactions
with other substances. Especially since we do not have direct product liability insurance, it is possible that
product liability claims and the resulting adverse publicity could negatively affect 25




---



##### Table of Contents



our business. In November 2004, Dorothy Porter filed a complaint against the Company for
strict liability, breach of warranty and negligence in the U.S. District Court for the Southern
District of Illinois, alleging that she sustained a brain hemorrhage after taking Formula One, an
ephedra-containing product marketed by Kaire Nutraceuticals, Inc., a former subsidiary of the
Company. See Legal Proceedings. If our suppliers product liability insurance fails to cover product liability claims or other
product liability claims, or any product liability claims exceeds the amount of coverage provided
by such policies or if we are unsuccessful in any third party claim against the manufacturer or if
we are unsuccessful in collecting any judgment that may be recovered by the Company against the
manufacturer, we could be required to pay substantial monetary damages which could materially harm
our business, financial condition and results of operations. As a result, we may become required
to pay higher premiums and accept higher deductibles in order to secure adequate insurance coverage
in the future. Our Internal Controls and Accounting Methods May Require Further Modification. The Company modified certain of its accounting policies and made other adjustments to our
accounting for past transactions, which resulted in the restatement of the Companys financial
statements for each quarter in 2001, 2002, and 2003, for the years ended December 31, 2001, 2002,
and 2003, as well as the first quarter in 2004. In connection with the restatement of our
financial statements, the Company has been informed by its independent auditors that many of the
restatement items are the result of material weaknesses in the Companys internal controls and
procedures. The Company has implemented new controls and procedures and plans to implement
additional controls and procedures sufficient to accurately report our financial performance on a
timely basis in the foreseeable future. If we are unable to implement these additional controls
and procedures, we may not be able to report our financial performance on a timely basis and our
business and stock price would be adversely affected. See Item 9A. Non-Compliance with Section 404 of the Sarbanes-Oxley Act of 2002 Could Materially Adversely Affect
Us. The Securities Exchange Commission, as directed by Section 404 of the Sarbanes-Oxley Act of
2002, adopted rules which would require us to include in our annual reports on Form 10-K, beginning
in fiscal 2005, an assessment by management of the effectiveness of our internal controls over
financial reporting. In addition, our independent auditors must attest to and report on
managements assessment of the effectiveness of such internal controls over financial reporting.
While we intend to diligently and thoroughly document, review, test and improve our internal
controls over financial reporting to comply with Section 404 of the Sarbanes-Oxley Act, if our
independent auditors are not satisfied with the adequacy of our internal controls over financial
reporting, or if the independent auditors interpret the requirements, rules and/or regulations
differently than we do, then they may decline to attest to managements 26




---



##### Table of Contents



assessment or may issue a report that is qualified. This could result in an adverse reaction
in the financial marketplace due to a loss of investor confidence in the reliability of our
financial statements, which could negatively impact the price of our common stock. We Rely On And Are Subject To Risks Associated With Our Reliance Upon Information Technology
Systems. Our success is dependent on the accuracy, reliability, and proper use of sophisticated and
dependable information processing systems and management information technology. Our information
technology systems are designed and selected to facilitate order entry and customer billing,
maintain distributor records, accurately track purchases and distributor compensation payments,
manage accounting operations, generate reports, and provide customer service and technical support.
Although we acquired MarketVisionour software service providerduring the first half of 2004, in
part, to gain greater control over its operations, any interruption in these systems could have a
material adverse effect on our business, financial condition, and results of operations. Our Lexxus Subsidiaries Have a Limited Operating History Which May Not be Indicative of Future
Performance. Although our Lexxus subsidiaries accounted for approximately 99% of our consolidated net
revenues during fiscal 2004, it has been operating only since January 2001. Therefore, Lexxus is
still in the early stage of its development. Our business and prospects must be considered in light of the risk, expense and difficulties
frequently encountered by companies in an early stage of development, particularly companies in new
and rapidly evolving international markets. If we are unable to effectively allocate our resources
and help grow our Lexxus subsidiaries, our stock price may be adversely affected and we may be
unable to execute our strategy of expanding our network of independent distributors. Our business
depends upon the performance of our Lexxus subsidiaries and, due to its relatively short operating
history, past performance may not be indicative of future results. Our success has been, and could continue to be, significantly dependent on our ability to
manage rapid growth through expansions and enhancements of our worldwide personnel and management,
order processing and fulfillment, inventory and shipping systems, financial reporting and other
aspects of operations. As we continue to expand our operations, the ability to manage this growth
could represent an increasing challenge and our failure to properly manage this growth may
materially and adversely affect our results of operation. 27




---



##### Table of Contents



Regulatory Matters Governing Our Industry Could Have A Significant Negative Effect On Our Business. In both our United States and foreign markets, we are affected by extensive laws, governmental
regulations, administrative determinations, court decisions and similar constraints. Such laws,
regulations and other constraints may exist at the federal, state or local levels in the United
States and at all levels of government in foreign jurisdictions. Product Regulations The formulation, manufacturing, packaging, labeling, distribution, importation, sale and
storage of certain of our products are subject to extensive regulation by various federal agencies,
including the Food and Drug Administration (FDA), the Federal Trade Commission (the FTC), the
Consumer Product Safety Commission and the United States Department of Agriculture and by various
agencies of the states, localities and foreign countries in which our products are manufactured,
distributed and sold. Failure by our distributors or us to comply with those regulations could lead
to the imposition of significant penalties or claims and could materially and adversely affect our
business. In addition, the adoption of new regulations or changes in the interpretation of existing
regulations may result in significant compliance costs or discontinuation of product sales and may
adversely affect the marketing of our products, resulting in significant loss of sales revenues. Product Claims, Advertising and Distributor Activities Our failure to comply with FTC or state regulations, or with regulations in foreign markets
that cover our product claims and advertising, including direct claims and advertising by us, as
well as claims and advertising by distributors for which we may be held responsible, may result in
enforcement actions and imposition of penalties or otherwise materially and adversely affect the
distribution and sale of our products. Distributor activities in our existing markets that violate
applicable governmental laws or regulations could result in governmental or private actions against
us in markets where we operate. Given the size of our distributor force, we cannot assure that our
distributors would comply with applicable legal requirements. Direct Selling System Our direct selling system is subject to a number of federal and state regulations administered
by the FTC and various state agencies as well as regulations in foreign markets administered by
foreign agencies. Regulations applicable to direct selling organizations generally are directed at
ensuring that product sales ultimately are made to consumers and that advancement within the
organizations is based on sales of the organizations products rather than investments in the
organizations or other non-retail sales related criteria. We are subject to the risk that, in one
or more markets, our marketing system could be found not to be in compliance with applicable
regulations. 28




---



##### Table of Contents



The failure of our direct selling system to comply with such regulations could have a material
adverse effect on our business in a particular market or in general. We are also subject to the risk of private party challenges to the legality of our direct
selling system. The regulatory requirements concerning direct selling systems do not include
bright line rules and are inherently fact-based. An adverse judicial determination with respect
to our direct selling system, or in proceedings not involving us directly but which challenge the
legality of other direct selling marketing systems, could have a material adverse effect on our
business. Transfer Pricing and Similar Regulations In many countries, including the United States, we are subject to transfer pricing and other
tax regulations designed to ensure that appropriate levels of income are reported as earned by our
United States or local entities and are taxed accordingly. In addition, our operations are subject
to regulations designed to ensure that appropriate levels of customs duties are assessed on the
importation of our products. Our principal domicile is the United States. Under tax treaties, we are eligible to receive
foreign tax credits in the United States for taxes paid abroad. As our operations expand outside
the United States, taxes paid to foreign taxing authorities may exceed the credits available to us,
resulting in the payment of a higher overall effective tax rate on our worldwide operations. We have adopted transfer pricing agreements with our subsidiaries to regulate intercompany
transfers, which agreements are subject to transfer pricing laws that regulate the flow of funds
between the subsidiaries and the parent corporation for product purchases, management services, and
contractual obligations, such as the payment of distributor compensation. We have begun the
initial steps of implementing a foreign holding and operating company structure for our non-United
States businesses. This new structure is expected to re-organize our non-United States
subsidiaries in the Cayman Islands. Though our goal is to improve the overall tax rate, there is
no assurance that the new tax structure could be successful. If the United States Internal Revenue
Service or the taxing authorities of any other jurisdiction were to successfully challenge these
agreements, plans, or arrangements, or require changes in our transfer pricing practices, we could
be required to pay higher taxes, interest and penalties, and our earnings would be adversely
affected. We believe that we operate in compliance with all applicable transfer pricing laws and we
intend to continue to operate in compliance with such laws. However, there can be no assurance
that we will continue to be found to be operating in compliance with transfer pricing laws, or that
those laws would not be modified, which, as a result, may require changes in our operating
procedures. 29




---



##### Table of Contents



Taxation Relating To Distributors Our distributors are subject to taxation, and in some instances legislation or governmental
agencies impose an obligation on us to collect the taxes, such as value added taxes, and to
maintain appropriate records. In addition, we are subject to the risk in some jurisdictions of
being responsible for social security and similar taxes with respect to our distributors. Other Regulations We are also subject to a variety of other regulations in various foreign markets, including
regulations pertaining to employment and severance pay requirements, import/export regulations and
antitrust issues. Our failure to comply, or assertions that we fail to comply, with these
regulations could have a material adverse effect on our business in a particular market or in
general. To the extent we decide to commence or expand operations in additional countries, government
regulations in those countries may prevent or delay entry into or expansion of operations in those
markets. In addition, our ability to sustain satisfactory levels of sales in our markets is
dependent in significant part on our ability to introduce additional products into the markets.
However, government regulations in both our domestic and international markets can delay or prevent
the introduction, or require the reformulation or withdrawal, of some of our products. Currency Exchange Rate Fluctuations Could Lower Our Revenue And Net Income. In 2004, approximately 87% of our revenue was recorded in markets outside the United States.
However, that figure does not accurately reflect our foreign currency exposure mainly because the
Hong Kong dollar is pegged to the U.S. dollar. Our European business, KGC, sold products in U.S.
dollars and paid distributors commissions in U.S. dollars, until the fourth quarter of 2004, when
KGC switched to euro for both selling products and paying commissions. We also purchase all
inventories in U.S. dollars. Therefore, our currency exposure, mainly to Korean won, Singapore
dollar, New Taiwan dollar and Australia dollar, representing approximately 10% of our revenue in
the first nine months of 2004 before KGC switched to euro from U.S. dollar, was relatively
insignificant, compared to our overall geographic reach. In the fourth quarter of 2004, with KGC
doing business in euro, approximately 27% of our net revenue was generated in functional currencies
in or pegged to U.S. dollar. Our exposure to foreign currency fluctuation is expected to increase, as KGC switched to euro
from U.S. dollar, and the Company opens for business in Japan and Mexico. In the fourth quarter of
2004, with KGC doing business in euro, approximately 27% of our net revenue was generated in
functional currencies not denominated in or pegged to U.S. dollar. In preparing our consolidated
financial statements, we translate revenue and expenses in foreign countries from their local
currencies into U.S. dollars 30




---



##### Table of Contents



using the average exchange rates for the period. The effect of the translation of the
Companys foreign operations is included in accumulated other comprehensive income within
stockholders equity and do not impact the statement of operations. Given our inability to predict the degree of exchange rate fluctuations, we cannot estimate
the effect these fluctuations may have upon future reported results, product pricing or our overall
financial condition. Further, to date we have not attempted to reduce our exposure to short-term
exchange rate fluctuations by using foreign currency exchange contracts. Although Our Distributors Are Independent Contractors, Improper Distributor Actions That Violate
Laws Or Regulations Could Harm Our Business. Distributor activities that violate governmental laws or regulations could result in
governmental actions against us in markets where we operate. Our distributors are not employees and
act independently of us. Some of our distributors may be doing business in countries without proper
registration or authority to do so. We implement strict policies and procedures to ensure our
distributors comply with applicable legal requirements. However, given the size and diversity of
our distributor force, we experience problems with distributors from time to time, especially with
respect to our distributors in foreign markets. Distributors often desire to enter a market before
we have received approval to do business to gain an advantage in the marketplace. Improper
distributor activity in new geographic markets could result in adverse publicity and can be
particularly harmful to our ability to ultimately enter these markets. See Recent Development in
Item 1 regarding events in April 2004 in Hong Kong. Failure Of New Products To Gain Distributor And Market Acceptance Could Harm Our Business. An important component of our business is our ability to develop new products that create
enthusiasm among our distributor force. If we fail to introduce new products on a timely basis, our
distributor productivity could be harmed. In addition, if any new products fail to gain market
acceptance, are restricted by regulatory requirements, or have quality problems, this would harm
our results of operations. Factors that could affect our ability to continue to introduce new
products include, among others, limited capital resources, government regulations, proprietary
protections of competitors that may limit our ability to offer comparable products and any failure
to anticipate changes in consumer tastes and buying preferences. System Failures Could Harm Our Business. Because of our diverse geographic operations and our internationally applicable distributor
compensation plans, our business is highly dependent on efficiently functioning information
technology systems provided by MarketVision (for Lexxus) and Septuor (for KGC). The MarketVision
and Septuor systems and operations are vulnerable to damage or interruption from fires,
earthquakes, telecommunications failures, computer 31




---



##### Table of Contents



viruses and worms, software defects and other events. They are also subject to break-ins,
sabotage, acts of vandalism and similar misconduct. Despite precautions implemented by the staff of
MarketVision, problems could result in interruptions in services and materially and adversely
affect our business, financial condition and results of operations. Three Of Our Products Constitute A Significant Portion Of Our Sales. Our Skindulgence®, Aluraand Premium Noni Juiceproducts constitute a significant
portion of our sales. If demand for either of these products decreases significantly, government
regulation restricts the sale of these products, we are unable to adequately source or deliver
these products, or we cease offering any of these products for any reason without a suitable
replacement, our business, financial condition and results of operations could be materially and
adversely effected. We Do Not Manufacture Our Own Products So We Must Rely On Independent Third Parties For The
Manufacturing And Supply Of Our Products. All of our products are manufactured by independent third parties. There is no assurance that
our current manufacturers will continue to reliably supply products to us at the level of quality
we require. In the event any of our third-party manufacturers become unable or unwilling to
continue to provide the products in required volumes and quality levels at acceptable prices, we
will be required to identify and obtain acceptable replacement manufacturing sources. There is no
assurance that we will be able to obtain alternative manufacturing sources or be able to do so on a
timely basis. An extended interruption in the supply of our products will result in a substantial
loss of sales. In addition, any actual or perceived degradation of product quality as a result of
our reliance on third party manufacturers may have an adverse effect on sales or result in
increased product returns and buybacks. The High Level Of Competition In Our Industry Could Adversely Affect Our Business. The business of marketing personal care, cosmetic, nutraceutical, and lifestyle enhancement
products is highly competitive. This market segment includes numerous manufacturers, distributors,
marketers, and retailers that actively compete for the business of consumers both in the United
States and abroad. The market is highly sensitive to the introduction of new products, which may
rapidly capture a significant share of the market. Sales of similar products by competitors may
materially and adversely affect our business, financial condition and results of operations. We are subject to significant competition for the recruitment of distributors from other
direct selling organizations, including those that market similar products. Many of our
competitors are substantially larger than we are, offer a wider array of products, have far greater
financial resources and many more active distributors than we have. Our ability to remain
competitive depends, in significant part, on our success in recruiting and retaining distributors
through an attractive compensation plan and other incentives. We 32




---



##### Table of Contents



believe that our compensation and incentive programs provide our distributors with significant
earning potential. However, we cannot be sure that our programs for recruitment and retention of
distributors would be successful. Terrorist Attacks, Acts Of War, Epidemics Or Other Communicable Diseases Or Any Other Natural
Disasters May Seriously Harm Our Business. Terrorist attacks, or acts of war or natural disasters may cause damage or disruption to our
Company, our employees, our facilities and our customers, which could impact our revenues, expenses
and financial condition. The potential for future terrorist attacks, the national and international
responses to terrorist attacks, and other acts of war or hostility, such as the Chinese objection
to the Taiwan independence movement and its resultant tension in the Taiwan Strait, could
materially and adversely affect our business, results of operations, and financial condition in
ways that we currently cannot predict. Additionally, natural disasters less severe than the Indian
Ocean tsunami that occurred in December 2004 may adversely affect our business, financial condition
and results of operations. Loss Of Key Personnel Could Adversely Affect Our Business. Our future success depends to a significant degree on the skills, experience and efforts of
Mark D. Woodburn, our President, and Terry A. LaCore, Chief Executive Officer of Lexxus U.S. The
loss of the services of either Mr. Woodburn or Mr. LaCore could have a material adverse effect on
our business, results of operations and financial condition. We also depend on the ability of our
executive officers and other members of senior management to work effectively as a team. The loss
of one or more of our executive officers and other members of senior management could have a
material adverse effect on our business, results of operations and financial condition. We May Be Unable To Protect Our Proprietary Technology Rights. Our success depends to a significant degree upon the protection of our MarketVision software
and other proprietary technology rights. We rely on trade secret, copyright and trademark laws and
confidentiality agreements with employees and third parties, all of which offer only limited
protection. Moreover, the laws of some countries in which we market our products may afford little
or no effective protection of our proprietary technology. The reverse engineering, unauthorized
copying or other misappropriation of our proprietary technology could enable third parties to
benefit from our technology without paying us for it. This could have a material adverse effect on
our business, operating results and financial condition. If we resort to legal proceedings to
enforce our intellectual property rights, the proceedings could be burdensome and expensive and
could involve a high degree of risk. 33




---



##### Table of Contents



Risks Related To Our Common Stock Disappointing Quarterly Revenue Or Operating Results Could Cause The Price Of Our Common Stock To
Fall. Our quarterly revenue and operating results are difficult to predict and may fluctuate
significantly from quarter to quarter. If our quarterly revenue or operating results fall below
the expectations of investors or securities analysts, the price of our common stock could fall
substantially. Our Common Stock Is Particularly Subject To Volatility Because Of The Industry That We Are In. The market prices of securities of direct selling companies, have been extremely volatile, and
have experienced fluctuations that have often been unrelated or disproportionate to the operating
performance of such companies. These broad market fluctuations could adversely affect the market
price of our common stock. Substantial Dilution May Occur From The Exercise of Outstanding Options or Warrants As of March 11, 2005, the Company had outstanding (i) options to purchase an aggregate of
1,674,124 shares of our common stock at exercise prices between $1.00 and $18.11, and (ii) warrants
outstanding from the October 2004 private placement of units exercisable for 1,369,704 shares of
our common stock of at an exercise price equal to $12.47 per share. In the event that these
options and warrants are exercised, and the shares issued upon such exercise are sold, the market
price of our shares of common stock could decline. In addition, holders of such options and
warrants are likely to exercise them when, in all likelihood, the Company could obtain additional
capital on terms more favorable to the Company than those provided by the options and warrants.
Further, while our options and warrants are outstanding, they may adversely affect the terms on
which the Company could obtain additional capital. Future Sales By the Company or Existing Security Holders Could Depress The Market Price Of Our
Common Stock. If the Company or our existing stockholders sell a large number of shares of our common stock,
the market price of the common stock could decline significantly. Further, even the perception in
the public market that the Company or our existing stockholders might sell shares of common stock
could depress the market price of the common stock. 34




---



##### Table of Contents



There is No Assurance That an Active Public Trading Market Would Continue. There was an extremely limited public trading market for our common stock. Commencing in the
fourth quarter of 2003, a more active trading market for our shares developed and the price of our
shares of common stock increased considerably. The Companys common stock was listed on the OTC
Bulletin Board and commencing on February 22, 2005 began trading on The NASDAQ National Market
under the ticker symbol BHIP. There can be no assurance that an active public trading market for
our common stock will be sustained. If for any reason an active public trading market does not
continue, purchasers of the shares of our common stock may have difficulty in selling their
securities should they desire to do so and the price of our common stock may decline. If Securities Analysts Do Not Publish Research Or Reports About Our Business Or If They Downgrade
Our Stock, The Price Of Our Stock Could Decline. The trading market for our shares of common stock could rely in part on the research and
reporting that industry or financial analysts publish about us or our business. We do not control
these analysts. Furthermore, if one or more of the analysts who do cover us downgrades our stock,
the price of our stock could decline. If one or more of these analysts ceases coverage of our
company, we could lose visibility in the market, which in turn could cause our stock price to
decline. 
 Item 2. PROPERTIES The Company currently has leased office and warehouse facilities in the following locations:  
    Dallas, Texas: approximately 16,000 square feet of office and warehouse space.
Rent is currently approximately $155,000 per year. The Company also has rented a
second warehouse of approximately 21,000 square feet in Dallas for approximately
$8,000 per month. Both leases expire on September 30, 2005. The Company
anticipates relocating by September 2005 to a new location in the Dallas/Fort
Worth Metroplex area. The warehouses in the Dallas area are mostly storing
products that are bound for the international markets.
    Hollister, Missouri: approximately 1,500 square feet of warehouse space. See
Related Party Transactions in Item 8. The lease term is on a month-to-month
basis at a rent of $18,000 per year. This facility picks and packs products for
individual fulfillment for the Lexxus U.S. business.
    Minneapolis, Minnesota: for MarketVisions office cubicles and server racks,
rented on a month-to-month basis for $1,600 a month. We are looking for more space
in the same area. 35




---



##### Table of Contents




    Langley, British Columbia: office and warehouse leased in totaling
approximately 5,000 square feet. The lease term is 36 months, expiring on January
2007 and the current rent is approximately $22,000 per year. This facility
services the Kaire business for North America as well as the Lexxus business in
Canada.
    Queensland, Australia: office space and warehouse facilities for the Australian
and New Zealand markets in approximately 2,000 square feet. The lease term is 46
months, expiring in October 2008, and the current rent is approximately $16,500
per year.
    Hong Kong: two leases, expiring in July 2005, combined for approximately 8,500
square feet of office space in the same building at a current rate of
approximately $286,000 per year. The Company is evaluating plans to expand the
current location as well as looking for more office space near its current
location.
    Kaohsiung Taiwan: approximately 10,000 square feet of office space at a current
rate of approximately $59,000 per year. This lease expires August 2005. The
Company is evaluating whether to continue its presence in this location. The
Company leases a 1,700-square-foot apartment for visiting expatriates at
approximately $11,000 a year. The apartment lease expired January 2005.
    Taipei, Taiwan: a 36-month agreement expiring March 2005 for approximately
4,600 square feet of office space at a current rate of approximately $92,000 per
year. The Company is assessing its office needs in Taipei for a possible change.
    Singapore: a 24-month agreement through January 2007 for 1,500 square feet of
office space at a current rate of approximately $31,000 per year.
    Seoul, South Korea: a 12-month agreement through May 2005 for approximately
4,100 square feet of office space at a current rate of approximately $270,000 per
year. The Company also leases an apartment for its expatriate and his family at
approximately $44,000 a year.
    Mexico City, Mexico: a 60-month agreement through December 2009 for
approximately 2,700 square feet of office space at a current rate of approximately
$96,000 per year. 36




---



##### Table of Contents



Item 3. LEGAL PROCEEDINGS From time to time, the Company is involved in legal proceedings incidental to the course of
its business. Except for the following matters, the Company is not subject to any material claims
or proceedings. During the fall of 2003, the customs agency of the government of South Korea brought a charge
against LXK, Ltd., the Companys wholly owned subsidiary operating in South Korea, with respect to
the importation of the Companys Aluraproduct. The customs agency alleges that Alurais not a
cosmetic product, but rather should be categorized and imported as a pharmaceutical product. During
recent and ongoing hearings, LXK presented evidence that it imported the Aluraproduct as a
cosmetic in reliance on the expertise and advise of its South Korean import consultant, that it
followed all normal processes and procedures for obtaining the requisite approval, and that it was
correct in categorizing Aluraas a cosmetic because its ingredients are all accepted in South
Korea as ingredients of a cosmetic product and not a pharmaceutical product, and therefore, LXK
should be permitted to sell and distribute Alurain South Korea. On February 18, 2005, the Seoul
Central District Court issued a ruling against LXK and fined it a total of approximately $200,000.
LXK also incurred approximately $40,000 related cost as a result of the judgment. The Company is
currently evaluating whether to appeal the ruling and recorded a reserve of $240,000 as part of its
2004 financial statements. The failure to sell Alurain South Korea is not anticipated to have a
material adverse effect on the financial condition, results of operations, cash-flow or business
prospects of LXK. On or around March 31, 2004, Lexxus U.S. received a letter from John Loghry, a former Lexxus
distributor, alleging that Lexxus had wrongfully terminated an alleged oral distributorship
agreement with Mr. Loghry and that the Company had breached an alleged oral agreement to issue
shares of the Companys common stock to Mr. Loghry. After Mr. Loghry threatened to commence suit
against Lexxus U.S. and the Company in Nebraska, on May 13, 2004, Lexxus U.S. and the Company filed
an action for declaratory relief against Mr. Loghry in the United States District Court for the
Northern District of Texas seeking, inter alia, a declaration that Mr. Loghry was not wrongfully
terminated and is not entitled to recover anything from Lexxus U.S. or the Company. Mr. Loghry has
filed counterclaims against the Company and Lexxus U.S. asserting his previously articulated
claims. In September 2004, Mr. Loghry filed third party claims against certain officers of the
Company and Lexxus U.S., including against Terry LaCore and Mark Woodburn for fraud, LaCore,
Woodburn, and a certain Lexxus distributor for conspiracy to commit the same and tortuous
interference with contract. In February 2005, the court dismissed all of Mr. Loghrys claims
against the individual defendants, except the claims for fraud and conspiracy to commit fraud.
Discovery is ongoing and the Company intends to vigorously defend itself in this case. On November 1, 2004, Toyota Jidosha Kabushiki Kaisha (d/b/a Toyota Motor Corporation) and
Toyota Motor Sales, U.S.A. filed a complaint against the Company and 37




---



##### Table of Contents



Lexxus U.S. in United States District Court for the Central District of California
(CV04-9028). The complaint alleges trademark and service mark dilution, unfair competition,
trademark and service mark infringement, and trade name infringement, each with respect to Toyotas
Lexus trademark. Toyota seeks to enjoin the Company and Lexxus U.S. from using the Lexxus mark and
otherwise competing unfairly with Toyota, to transfer the ownership of the mylexxus.com and
lexxusinternational.com Internet sites to Toyota, and reimbursement of costs and reasonable
attorney fees incurred by Toyota in connection with this matter. The Company filed a motion to
dismiss all counts in the complaint, which was denied by the court. The Company intends to
vigorously defend this action. In the event that the Company is unsuccessful in defending this
action, the Company may be required to change the name of some or all of its Lexxus subsidiaries
and domain names which could have a material adverse effect on the financial condition, results of
operations, cash flow or business prospects of the Company. Toyota is not seeking monetary damages
in this matter, other than reimbursement of legal fees and expenses. On November 12, 2004, Dorothy Porter filed a complaint against the Company in the United
States District Court for the Southern District of Illinois alleging that she sustained a brain
hemorrhage after taking Formula One, an ephedra-containing product marketed by Kaire
Nutraceuticals, Inc., a former subsidiary of the Company, and, thereafter, eKaire. Ms. Porter has
sued the Company for strict liability, breach of warranty and negligence. The Company intends to
defend this case vigorously and on December 27, 2004 filed an answer denying the allegations
contained in the complaint. Recently, the plaintiff demanded $2 million in damages to settle the
case. On March 7, 2005, a Notice of Tag-Along Action was filed by Ms. Porter with the Judicial
Panel on Multidistrict Litigation. It is anticipated that this case will be place on the next
Conditional Transfer Order and, ultimately, transferred to the consolidated Ephedra Products
Liability proceedings in the United States District Court for the Southern District of New York.
The Company does not believe that the plaintiff can demonstrate that its products caused the
alleged injury and intends to vigorously defend this action. On January 13, 2005, Natures Sunshine Products, Inc. and Natures Sunshine Products de Mexico
S.A. de C.V. (collectively Natures Sunshine) filed suit against the Company in the Fourth
Judicial District Court, Utah County, State of Utah seeking injunctive relief and unspecified
damages against the Company, Lexxus U.S., the Companys Mexican subsidiary, and the Companys
Mexico management team, Oscar de la Mora Romo and Jose Villarreal Patino, alleging among other
things that the Companys employment of De la Mora and Villarreal violated or could lead to the
violation of certain non-compete, non-solicitation, and confidentiality agreements allegedly in
effect between De la Mora and Villarreal and Natures Sunshine. Upon request by Natures Sunshine,
the state court entered a temporary restraining order against De la Mora and Villarreal on January
14, 2005 restraining them from violating the non-compete, non-solicitation and confidentiality
provisions of the agreements, including continuing their employment with the Company, and
restrained the Company from interfering with the agreements alleged by Natures Sunshine to exist
with De la Mora and Villarreal. On January 17, 2005, the Company removed the case from Utah 38




---



##### Table of Contents



state court to the United States District Court for the Northern District of Utah. The
restraining order expired on its own terms and on January 20, 2005 the federal judge declined to
extend the restraining order entered in state court. On January 21, 2005, the Company, De la Mora,
Villarreal, and Natures Sunshine entered into a stipulation and agreed order restraining De la
Mora and Villarreal from using or disclosing any confidential information of Natures Sunshine,
restraining the Company from attempting to obtain any confidential information of Natures
Sunshine, and restraining all parties from soliciting Natures Sunshine employees and distributors.
De la Mora and Villarreal were not restrained from their continued employment with the Company,
however, Natures Sunshine may seek such restraint at any future point in the litigation, whether
in federal court or, if the federal court remands the case to state court as Natures Sunshine has
requested, by the state court. On January 19, 2005, Natures Sunshine requested the federal court
to remand the case to state court on the basis on alleged lack of federal court jurisdiction. On
February 17, 2005, the federal court denied Nature Sunshines motion to remand. On March 15, 2005,
Natures Sunshine filed an Amended Complaint against De la Mora and Villarreal and purportedly the
Companys Mexican subsidiary, although not properly named. The previously asserted claims against
the Company and Lexxus U.S. were dropped by Natures Sunshine. The Company intends to vigorously
defend this case on its own behalf, to the extent the Company remains a party, and on behalf of De
la Mora and Villarreal. If the Company or De la Mora and Villarreal are unsuccessful in defending
this action, the Company may be required to change its Mexico management team, at least during the
unexpired term of any enforceable non-compete period. 
 Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS None. 39




---



##### Table of Contents



Part II 
 Item 5. MARKET FOR REGISTRANTS COMMON EQUITY AND RELATED STOCKHOLDER MATTERS In March 2003, in order to enhance the price of our common stock and to enable us to better
use our capital stock to compensate management and motivate employees, and as consideration for
future acquisition transactions, our stockholders approved and we effected a 1-for-100 reverse
stock split with respect to our outstanding shares of common stock. As a result, on March 19,
2003, the number of outstanding shares of common stock declined from 462,873,100 to 4,628,731 and
the closing price per share increased from $0.01 on March 18, 2003 to $1.50 on March 19, 2003, as
reported on the NASD over-the-counter bulletin board. In addition, the trading symbol for the
shares of our Common Stock changed from NHTC to NHLC.OB. All share references in this
prospectus give effect to the reverse stock split. Since February 22, 2005, our common stock has been quoted on The NASDAQ National Market, under
the symbol, BHIP. The following table sets forth the range of high and low bid quotations for our common stock
from January 1, 2003 through December 31, 2004, and for each of the quarterly periods indicated as
reported on the NASD over-the-counter bulletin board. Bid quotations reflect inter-dealer prices
without retail markup, markdown, or commission and may not represent actual transactions. HIGH
    
    
    LOW2003:First quarter
    
    $
    2.30
    
    
    $
    0.99Second quarter
    
    $
    6.30
    
    
    $
    1.60Third quarter
    
    $
    11.40
    
    
    $
    5.63Fourth quarter
    
    $
    11.10
    
    
    $
    4.802004:First quarter
    
    $
    21.10
    
    
    $
    10.80Second quarter
    
    $
    25.75
    
    
    $
    11.40Third quarter
    
    $
    18.60
    
    
    $
    11.99Fourth Quarter
    
    $
    12.70
    
    
    $
    9.15
 As of March 24, 2005, the closing price of our common stock was $13.70 per share. As of
December 31, 2004, we had approximately 440 record holders of our
common stock. We estimate that as of such date there were more than 2,500 beneficial holders
of our common stock. 40




---



##### Table of Contents



DIVIDEND POLICY We have never paid or declared any cash dividend on our common stock. We currently intend to
retain earnings, if any, to finance the growth and development of our business. We do not expect to
pay dividends in the near future. Payment of future dividends, if any, will be at the direction of
our Board of Directors. Equity Compensation Plan Information The following table provides information as of December 31, 2004 with respect to the Companys
common stock that may be issued under its existing equity compensation plans. The table shows the
number of securities to be issued under compensation plans that have been approved by shareholders
and those that have not been so approved. The footnotes and other information following the table
are intended to provide additional detail on the compensation plans. Equity Compensation Plan Information (b)
    
    
    (c)Weighted-
    
    
    Number of securities(a)
    
    
    average
    
    
    remaining available forNumber of securities
    
    
    exercise price
    
    
    futureto be issued upon
    
    
    of outstanding
    
    
    issuance under equityexercise of
    
    
    options,
    
    
    compensation plansoutstanding options,
    
    
    warrants and
    
    
    (excluding securitiesPlan category
    
    warrants and rights
    
    
    rights
    
    
    reflected in column (a))Equity compensation plans
or arrangements approved
by security holders
    
    
    344,124
    (1)
    
    $
    17.44
    
    
    
    880,876
    (2)Equity compensation plans
or arrangements not
approved by security
holders
    
    
    1,331,419
    (3)
    
    $
    1.20
    
    
    
    Total
    
    
    1,675,543
    
    
    $
    4.54
    
    
    
    880,876
   (1)
    
    Includes shares of options issued to three employees: John Cavanaugh (253,580), Jason
Landry (56,420) and Chris Sharng (34,124). See Acquisitions in regards to Mr.
Cavanaugh and Mr. Landry.(2)
    
    Includes 1,225,000 shares of common stock reserved under our 2002 Stock Option Plan, as
amended, which was approved by our shareholders in May 2003, offset by 344,124 shares of
options issued to the three employees.(3)
    
    Includes (i) options exercisable for 570,000 shares of common stock
issued to the LaCore and Woodburn Partnership, (ii) options
exercisable for 570,000 shares of common stock issued to Mr. LaCore,
(iii) options exercisable for 30,000 shares of common stock issued to
Benchmark Consulting Group (which was subsequently assigned to the
LaCore and Woodburn Partnership), (iv) options exercisable for 30,000
shares of common stock issued to Mr. LaCore, (v) options exercisable
for 125,000 shares of common stock issued to certain members of the
Companys board of directors, (vi) warrants exercisable for 1,419
shares of common stock issued as Series J Warrant on March 3, 2000
exercisable at $141.00 per share through March 31, 2005, (vii) options
exercisable for 5,000 shares of common stock issued to an unrelated
party on April 9, 2003 exercisable at $1.80 per share through April 9,
2006. 41




---



##### Table of Contents



Item 6. SELECTED FINANCIAL DATA The following data has been derived from the audited consolidated financial statements of the
Company and should be read in conjunction with those statements. Historical results are not
necessarily indicative of future results. Year Ended December 31,2000
    
    
    2001
    
    
    2002
    
    
    2003
    
    
    2004As Restated(In Thousands, Except Per Share Data)Consolidated Statement of
Operations Data:Net sales
    
    $
    8,320
    
    
    $
    22,989
    
    
    $
    36,968
    
    
    $
    62,576
    
    
    $
    133,225Gross profit
    
    
    5,910
    
    
    
    17,691
    
    
    
    29,216
    
    
    
    48,900
    
    
    
    103,904Distributor commissions
    
    
    3,682
    
    
    
    12,449
    
    
    
    16,834
    
    
    
    27,555
    
    
    
    68,759Selling, general and administrative
expenses
    
    
    5,777
    
    
    
    5,187
    
    
    
    10,710
    
    
    
    15,770
    
    
    
    33,102Income (loss) from operations
    
    
    (12,552
    )
    
    
    (65
    )
    
    
    238
    
    
    
    5,575
    
    
    
    2,223Net income (loss)
    
    
    (10,669
    )
    
    
    466
    
    
    
    2,139
    
    
    
    4,728
    
    
    
    1,241Diluted income (loss) from
continuing operations per
share1:
    
    $
    (146.83
    )
    
    $
    (0.98
    )
    
    $
    (0.11
    )
    
    $
    0.83
    
    
    $
    0.18Diluted weighted-average number of
shares outstanding1:
    
    
    96
    
    
    
    1,342
    
    
    
    3,118
    
    
    
    5,688
    
    
    
    6,822Consolidated Balance Sheet Data (at
end of period):Cash and cash equivalents
    
    $
    108
    
    
    $
    324
    
    
    $
    3,864
    
    
    $
    11,133
    
    
    $
    22,324Working capital
    
    
    (5,865
    )
    
    
    (4,858
    )
    
    
    (1,187
    )
    
    
    2,889
    
    
    
    17,519Total assets
    
    
    591
    
    
    
    3,075
    
    
    
    10,319
    
    
    
    20,340
    
    
    
    62,105Total debt
    
    
    679
    
    
    
    1,021
    
    
    
    684
    
    
    
    199
    
    
    
    818Total stockholders equity (deficit)
    
    
    (5,737
    )
    
    
    (4,370
    )
    
    
    (398
    )
    
    
    4,824
    
    
    
    37,029
   1
    
    All share and earnings per share data gives
effect to a 1-for-100 reverse stock split, which took effect in March 2003. 42




---



##### Table of Contents



Item 7. DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Business Overview Natural Health Trends Corp. (the Company) is an international direct selling organization.
We control subsidiaries that distribute products through two separate direct selling businesses
that promote health, wellness and vitality. Lexxus International, Inc., our wholly-owned
subsidiary (Lexxus U.S.), and other Lexxus subsidiaries (collectively, Lexxus), sell certain
cosmetic products, consumer as well as quality of life products, which accounted for
approximately 99% percent of our consolidated net revenues in 2004. eKaire.com, Inc. (eKaire),
our wholly-owned subsidiary, distributes nutritional supplements aimed at general health and
wellness. Lexxus commenced operations in January 2001 and has experienced tremendous revenue growth, as
we are currently conducting business in at least 30 countries through approximately 130,000 active
distributors as of December 31, 2004. (We consider a distributor active if they have placed at
least one product order with us during the preceding year). The Lexxus business includes KGC
Networks Pte. Ltd. (KGC), a Singapore company owned 51% by the Company and 49% by a European
private investor. KGC sells Lexxus products into a separate network with distributors primarily in
Russia and other Eastern European countries. eKaire has been in business since 2000 and is
operating in four countries through approximately 3,600 active distributors. We have experienced significant revenue growth over the last few years due in part to our
efforts to expand into new markets. We intend to pursue additional foreign markets in 2005. We
anticipate commencing revenue generation in Mexico (in the second quarter of 2005) and Japan (in
the fourth quarter of 2005). We plan to start opening retail stores in China during 2005. In 2004, we generated approximately 87% of our revenue from outside North America, with sales
in Hong Kong representing approximately 56% of revenue. Because of the size of our foreign
operations, operating results can be impacted negatively or positively by factors such as foreign
currency fluctuations, and economic, political and business conditions around the world. In
addition, our business is subject to various laws and regulations, in particular regulations
related to direct selling activities that create certain risks for our business, including improper
claims or activities by our distributors and potential inability to obtain necessary product
registrations. Income Statement Presentation The Company derives its revenue from sales of its products, sales of its enrollment packages,
and from shipping charges. Substantially all of its product sales are to independent distributors
at published wholesale prices. We translate revenue from each markets local currency into U.S.
dollars using average rates of exchange during the 43




---



##### Table of Contents



period. The following table sets forth revenue by market and product line for the time periods
indicated (in thousands). Year Ended December 31,2002
    
    
    2003
    
    
    2004North America
    
    $
    11,239
    
    
    $
    8,779
    
    
    $
    15,631Hong Kong
    
    
    6,067
    
    
    
    30,763
    
    
    
    74,293Taiwan
    
    
    5,579
    
    
    
    3,097
    
    
    
    3,261Southeast Asia
    
    
    556
    
    
    
    1,570
    
    
    
    1,786Eastern Europe
    
    
    8,999
    
    
    
    13,157
    
    
    
    30,248South Korea
    
    
    
    
    
    
    2,492
    
    
    
    5,524Australia/New Zealand
    
    
    876
    
    
    
    226
    
    
    
    623Other
    
    
    171
    
    
    
    175
    
    
    
    41Total Lexxus
    
    
    33,487
    
    
    
    60,259
    
    
    
    131,407North America
    
    
    2,213
    
    
    
    1,889
    
    
    
    1,283Australia/New Zealand
    
    
    1,268
    
    
    
    428
    
    
    
    535Total Kaire
    
    
    3,481
    
    
    
    2,317
    
    
    
    1,818$
    36,968
    
    
    $
    62,576
    
    
    $
    133,225
 Cost of sales consist primarily of products purchased from third-party manufacturers,
freight cost of shipping products to distributors and import duties for the products, costs of
promotional materials sold to the Companys distributors at or near cost, provisions for slow
moving or obsolete inventories and, prior to the closing of the merger with MarketVision
Communications Corp. as of March 31, 2004, the amortization of fees charged by the Companys third
party software service provider. Cost of sales also includes purchasing costs, receiving costs,
inspection costs and warehousing costs. Certain prior year amounts have been re-classified into
cost of sales so that the financial statements are comparable between periods. Distributor commissions are our most significant expense and are classified as operating
expenses. Under our compensation plan, distributors are paid weekly commissions in the
distributors home country, in their local currency, for product sold by that distributors
down-line distributor network across all geographic markets. Distributors are not paid commissions
on purchases or sales of our products made directly by them. This seamless compensation plan
enables a distributor located in one country to sponsor other distributors located in other
countries where we are authorized to do business. Currently, there are two fundamental ways in
which our distributors can earn income:  
    Through retail markups on sales of products purchased by distributors at
wholesale prices; and
    Through a series of commissions paid on product purchases made by their
down-line distributors. Each of our products carries a specified number of sales volume points. Commissions are based
on total personal and group sales volume points per sales period. 44




---



##### Table of Contents



Sales volume points are essentially based upon a percentage of a products wholesale cost. To
be eligible to receive commissions, a distributor may be required to make nominal monthly purchases
of our products. Certain of our subsidiaries do not require these nominal purchases for a
distributor to be eligible to receive commissions. In determining commissions, the number of
levels of down-line distributors included within the distributors commissionable group increases
as the number of distributorships directly below the distributor increases. Distributor
commissions are dependent on the sales mix and, for 2004, typically ranged between 42% and 55% of
net sales. From time to time we make modifications and enhancements to our compensation plan to
help motivate distributors, which can have an impact on distributor commissions. Selling, general and administrative expenses consist of administrative compensation and
benefits, travel, credit card fees and assessments, professional fees, certain occupancy costs,
depreciation and amortization, and other corporate administrative expenses. In addition, this
category includes selling, marketing, and promotion expenses including costs of distributor
conventions which are designed to increase both product awareness and distributor recruitment.
Because our various distributor conventions are not always held at the same time each year, interim
period comparisons will be impacted accordingly. Provision for income taxes depends on the statutory tax rates in each of the jurisdictions in
which we operate. We have begun the initial steps of implementing a foreign holding and operating
company structure for our non-United States businesses. This new structure is expected to
re-organize our non-United States subsidiaries in the Cayman Islands. Though our goal is to
improve the overall tax rate, there is no assurance that the new tax structure could be successful.
If the United States Internal Revenue Service or the taxing authorities of any other jurisdiction
were to successfully challenge these agreements, plans, or arrangements, or require changes in our
transfer pricing practices, we could be required to pay higher taxes, interest and penalties, and
our earnings would be adversely affected. Critical Accounting Policies In response to SEC Release No. 33-8040, Cautionary Advice Regarding Disclosure about Critical
Accounting Policies and SEC Release Number 33-8056, Commission Statement about Managements
Discussion and Analysis of Financial Condition and Results of Operations, the Company has
identified certain policies that are important to the portrayal of its consolidated financial
condition and consolidated results of operations. These policies require the application of
significant judgment by the Companys management. The most significant accounting estimates inherent in the preparation of the Companys
financial statements include estimates associated with obsolete inventory and the fair value of
acquired intangible assets and goodwill, as well as those used in the determination of liabilities
related to sales returns, distributor commissions, and income taxes. Various assumptions and other
factors prompt the determination of these 45




---



##### Table of Contents



significant estimates. The process of determining significant estimates is fact specific and
takes into account historical experience and current and expected economic conditions.
Historically, actual results have not significantly deviated from those determined using the
estimates described above. If circumstances change relating to the various assumptions or other
factors used in such estimates the Company could experience an adverse effect on its consolidated
financial condition, changes in financial condition, and results of operations. The Companys
critical accounting policies at December 31, 2004 include the following: Inventory Valuation.The Company reviews its inventory carrying value and compares it to the
net realizable value of its inventory and any inventory value in excess of net realizable value is
written down. In addition, the Company reviews its inventory for obsolescence and any inventory
identified as obsolete is reserved or written off. The Companys determination of obsolescence is
based on assumptions about the demand for its products, product expiration dates, estimated future
sales, and managements future plans. Also, if actual sales or management plans are less favorable
than those originally projected by management, additional inventory reserves or write-downs may be
required. The Companys inventory value at December 31, 2004 was approximately $13,991,000.
Inventory write-downs for years 2002, 2003, and 2004 were not significant. Asset Impairment.The Company reviews the book value of its property and equipment and
intangible assets whenever an event or change in circumstances indicates that the net book value of
an asset or group of assets may be unrecoverable. The Companys impairment review includes a
comparison of future projected cash flows (undiscounted and without interest charges) generated by
the asset or group of assets with its associated carrying value. The Company believes its expected
future cash flows approximate or exceed its net book value. However, if circumstances change and
the net book value of the asset or group of assets exceeds expected cash flows, the Company would
have to recognize an impairment loss to the extent the net book value of the asset exceeds its fair
value. At December 31, 2004, the net book value of the Companys property and equipment and
intangible assets were approximately $579,000 and $5,474,000, respectively. No such losses were
recognized for the years ended December 31, 2003 and 2004. Allowance for Sales Returns.An allowance for sales returns is provided during the period the
product is shipped. The allowance is based upon the return policy of each country, which varies
from 14 days to one year, and their historical return rates, which range from approximately 1% to
approximately 18% of product sales. Sales returns are approximately 4% and 5% of product sales for
the years ended December 31, 2003 and 2004, respectively. The allowance for sales returns was
approximately $381 thousand and $1,541 thousand at December 31, 2003 and 2004, respectively. No
material changes in estimates have been recognized for the years ended December 31, 2003 and 2004. Revenue Recognition.Product sales are recorded when the products are shipped and title passes
to independent distributors. Product sales to distributors are made pursuant to a distributor
agreement that provides for transfer of both title and risk of loss 46




---



##### Table of Contents



upon our delivery to the carrier, which is commonly referred to as F.O.B. Shipping Point.
The Company primarily receives payment by credit card at the time distributors place orders. The
Companys sales arrangements do not contain right of inspection or customer acceptance provisions
other than general rights of return. Amounts received for unshipped product are recorded as
deferred revenue. Such amounts totaled $4.3 million and $4.8 million at December 31, 2003 and
2004, respectively. Enrollment package revenue, including any nonrefundable set-up fees, is deferred and
recognized over the term of the arrangement, generally twelve months. Enrollment packages provide
distributors access to both a personalized marketing website and a business management system.
Prior to the acquisition of MarketVision Communications Corp. (MarketVision) on March 31, 2004,
the Company paid MarketVision a fixed amount in exchange for MarketVision creating and maintaining
individual web pages for such distributors. These payments to MarketVision were deferred and
recorded as a prepaid expense. The related amortization was recorded to cost of sales over the
term of the arrangement. The remaining unamortized costs were included in the determination of the
purchase price of MarketVision. Subsequent to the acquisition of MarketVision, no upfront costs
are deferred as the amount is nominal. At December 31, 2004, enrollment package revenue totaling
$4.7 million was deferred. Although the Company has no immediate plans to significantly change the
terms or conditions of enrollment packages, any changes in the future could result in additional
revenue deferrals or could cause us to recognize its deferred revenue over a longer period of time. Tax Valuation Allowance.The Company evaluates the probability of realizing the future
benefits of any of its deferred tax assets and records a valuation allowance when it believes a
portion or all of its deferred tax assets may not be realized. At December 31, 2003, the Company
established a valuation allowance for the entire amount of its net deferred tax assets of
approximately $4.0 million. At December 31, 2004, the Company recognized net deferred tax assets
of approximately $515 thousand as it expects to utilize a portion of its net operating loss
carryforward in connection with the implementation of a foreign holding and operating company
restructure. A valuation allowance of $1.5 million was established for the remainder of its net
deferred tax assets. If the Company is unable to realize the expected future benefits of its
deferred tax assets, it would be required to provide an additional valuation allowance. 47




---



##### Table of Contents



Results of Operations The following table sets forth our operating results as a percentage of net sales for the
periods indicated. Year Ended December 31,2002
    
    
    2003
    
    
    2004Net sales
    
    
    100.0
    %
    
    
    100
    %
    
    
    100
    %Cost of sales
    
    
    21.0
    
    
    
    21.9
    
    
    
    22.0Gross profit
    
    
    79.0
    
    
    
    78.1
    
    
    
    78.0Operating expenses:Distributor commissions
    
    
    45.5
    
    
    
    44.0
    
    
    
    51.5Selling, general and administrative expenses
    
    
    29.0
    
    
    
    25.2
    
    
    
    24.8Stock-based compensation
    
    
    3.9
    
    
    
    
    
    
    
    Total operating expenses
    
    
    78.4
    
    
    
    69.2
    
    
    
    76.3Income from operations
    
    
    0.6
    
    
    
    8.9
    
    
    
    1.7Other income (expense)
    
    
    0.1
    
    
    
    
    
    
    
    0.1Income before income taxes and minority interest
    
    
    0.7
    
    
    
    8.9
    
    
    
    1.8Income tax provision
    
    
    (0.8
    )
    
    
    (1.4
    )
    
    
    (0.5
    )Minority interest
    
    
    (0.6
    )
    
    
    
    
    
    
    (0.4
    )Income (loss) before discontinued operations
    
    
    (0.7
    )
    
    
    7.5
    
    
    
    0.9Gain from discontinued operations
    
    
    6.5
    
    
    
    
    
    
    
    Net income
    
    
    5.8
    %
    
    
    7.5
    %
    
    
    0.9
    %
 2004 Compared to 2003 Net Sales.Net sales were approximately $133.2 million for the twelve months ended December
31, 2004 compared to $62.6 million for the twelve months ended December 31, 2003. This net
increase of approximately $70.6 million or 113% was primarily attributable to the increased number
of active Lexxus distributors, approximately $46.5 million or approximately two thirds of the sales
increase, as well as more sales generated per distributor, $24.1 million or approximately one third
of the increase. Increases in net sales mainly occurred in Hong Kong ($43.5 million), Eastern
Europe ($17.1 million) and North America ($6.2 million). As of December 31, 2004, the Company had
deferred revenue of approximately $9.5 million of which $4.8 million pertained to goods shipped in
the first quarter of 2005 and recognized as revenue at that time and $4.7 million pertained to
enrollment package revenue. Cost of Sales.Cost of sales was approximately $29.3 million or 22.0% of net sales for the
twelve months ended December 31, 2004 compared with approximately $13.7 million or 21.9% of net
sales for the twelve months ended December 31, 2004. This increase of approximately $15.6 million
or 114% was primarily driven by increased sales. Cost of sales as a percentage of net sales was
flat with a year ago. Greater air freight costs to ship product from the US to Asia and Europe in
2004 were largely offset by the elimination of the commissions paid to MarketVision after its
acquisition by the Company on March 31, 2004. 48




---



##### Table of Contents



Gross Profit.Gross profit was approximately $103.9 million or 78.0% of net sales for the
twelve months ended December 31, 2004 compared with approximately $48.9 million or 78.1% of net
sales for the twelve months ended December 31, 2003. This increase of approximately $55.0 million
or 112% was attributable to the increase in sales. Distributor Commissions.Distributor commissions were approximately $68.6 million or 51.5% of
net sales for the twelve months ended December 31, 2004 compared with approximately $27.6 million
or 44.0% of net sales for the twelve months ended December 31, 2003. This increase of
approximately $41.0 million or 149% and as a percentage of sales was primarily related to the
significant increase in sales as well the depth of the distributor network. Approximately $1.1
million of the increase was due to commissions paid on returns and refunds pertaining to the
special product return privilege granted to certain Hong Kong distributors in the second quarter. Selling, General and Administrative Expenses.Selling, general and administrative costs were
approximately $33.1 million or 24.8% of net sales for the twelve months ended December 31, 2004
compared with approximately $15.8 million or 25.2% of net sales for the twelve months ended
December 31, 2003. This increase of approximately $17.3 million or 110% was mainly attributable to
increases in the following:  
    Marketing and promotional activities world-wide of $7.8 million (The Company
resorted to the increase in marketing activities in most of the Companys markets
around the world to drive the increase in the number of active distributors);
    Credit card charges and assessments totaling $2.7 million;
    Professional fees of $2.3 million;
    Personnel costs mainly in the U.S. and Hong Kong of $2.2 million;
    Costs for building the Chinese market totaling $600 thousand; and
    Amortization of intangibles of $600 thousand related to the MarketVision
acquisition. Other Income (Expense).Other income was approximately $137 thousand for the year ended
December 31, 2004 compared with expense of approximately $1 thousand for the year ended December
31, 2003. This increase of approximately $138 thousand was due to recognized gain on foreign
exchange partly offset by an increase in interest expense resulting from the MarketVision
acquisition. Income Taxes.Income tax expense was approximately $663 thousand or 28.1% of the income before
income taxes and minority interest for the twelve months ended December 31, 2004 compared with $860
thousand or 15.4% of income before income taxes and minority interest for the twelve months ended
December 31, 2003. The increase in effective tax rate was attributable to use of net operating
loss in the U.S. and lower effective tax rates on foreign earnings in 2003 compared to 2004. 49




---



##### Table of Contents



Minority Interest.Minority interest expense was approximately $456 thousand for the twelve
months ended December 31, 2004, compared to a benefit of approximately $14 thousand for the twelve
months ended December 31, 2003. The increase in the expense relates primarily to the increased
profitability of our subsidiary, KGC Networks Pte. Ltd. Net Income.Net income was approximately $1,241 thousand or 0.9% of net sales for the twelve
months ended December 31, 2004 compared to net income of approximately $4.7 million or 7.5% of net
sales for the twelve months ended December 31, 2003. The decrease in net income was primarily due
to higher commissions paid to distributors and marketing-related expenses, partly offset by higher
volume. 2003 Compared to 2002 Net Sales.Net sales were approximately $62.6 million for the year ended December 31, 2003
compared to $37.0 million for the year ended December 31, 2002. This increase of approximately
$25.6 million or 69% was primarily attributable to the increased number of active Lexxus
distributors (approximately $12.1 million or approximately 47% of the increase) including Lexxuss
expansion into new markets, such as South Korea in the second quarter of 2003 (approximately $2.7
million) and more sales per distributor (approximately $13.5 million or 53% of the total increase).
As of December 31, 2003, the Company had deferred revenue of approximately $6.9 million of which
$4.2 million pertained to goods shipped in the first quarter of 2004 and recognized as revenue at
that time. Cost of Sales.Cost of sales was approximately $13.7 million or 21.9% of net sales for the
year ended December 31, 2003 compared with approximately $7.8 million or 21.0% of net sales for the
year ended December 31, 2002. This increase of approximately $5.9 million or 76% was primarily
attributable to the higher sales in 2003. Gross Profit.Gross profit was approximately $48.9 million or 78.1% of net sales for the year
ended December 31, 2003 compared with approximately $29.2 million or 79.0% of net sales for the
year ended December 31, 2002. This increase of approximately $19.7 million or 67% was attributable
to the increase in gross sales of Lexxus products. Distributor Commissions.Distributor commissions were approximately $27.6 million or 44.0% of
net sales for the year ended December 31, 2003 compared with approximately $16.8 million or 45.5%
of net sales for the year ended December 31, 2002. This increase of approximately $10.8 million or
64% was directly related to the increase
in sales. The decrease in commissions as a percentage of revenue is due to the normal
fluctuations that occur in the compensation plan and also due to the amount of revenue allocated to
the compensation plan. Selling, General and Administrative Expenses.Selling, general and administrative costs were
approximately $15.8 million or 25.2% of net sales for the year 50




---



##### Table of Contents



ended December 31, 2003 compared with approximately $10.7 million or 29.0% of net sales for
the year ended December 31, 2002. This increase of approximately $5.1 million or 47% was
attributable to approximately $1.3 million of additional administrative expenses associated with
the new office in Seoul, South Korea and the balance of the increase resulted from sales and
marketing conventions, promotions and trainings. Selling, general and administrative expenses
decreased as a percentage of net sales from 29.0% in 2002 to 25.2% in 2003 due to operating
efficiencies and economies of scale gained with higher volumes of net sales. Stock-Based Compensation.Stock-based compensation expense was zero for the year ended
December 31, 2003 compared to approximately $1.4 million for the year ended December 31, 2002. The
stock-based compensation recorded in 2002 was in connection with the issuance of certain stock
options granted in January 2001 and October 2002 to senior executive officers of the Company which
triggered variable accounting because the options contained a cashless exercise feature. A
cashless exercise feature allows option holders to use the in the money value of the options (or
the spread between the exercise price and the fair market price of the underlying shares as of the
exercise date) as payment for all, or a portion, of the exercise price of an option. The options
were amended in November 2002 to require the option holder to obtain Company approval before the
option holder could use the cashless exercise feature. Under variable accounting, changes in the
market value of a companys shares would generally result in recording a charge or credit to
stock-based compensation expense. Other Income (Expense).Other expense was approximately $1 thousand for the year ended
December 31, 2003 compared with income of approximately $33 thousand for the year ended December
31, 2002. This decrease of approximately $34,000 was due to recognized loss on foreign exchange
offset by an increase in other income. Income Taxes.Income taxes were approximately $860 thousand or 15.4% of income from
continuing operations before taxes for the year ended December 31, 2003 compared with $300 thousand
or 110.7% of income from continuing operations before taxes for the year ended December 31, 2002.
The decrease in effective tax rate was attributable to use of net operating loss in the U.S. and
lower effective tax rates on foreign earnings in 2003. The Companys effective tax rate differs
from the amount that would result from applying the U.S. federal statutory rate for the reasons
identified in Note 11 to the consolidated financial statements contained elsewhere herein. Minority Interest.Minority interest benefit was approximately $14 thousand for the year
ended December 31, 2003 compared with expense of approximately $232
thousand for the year ended December 31, 2002. This decrease was primarily attributable to
the minority interest in KGC since inception in November 2003. Income (Loss) before Discontinued Operations.Income before discontinued operations was
approximately $4.7 million or 7.5% of net sales for the year ended December 31, 2003 compared to a
loss of approximately $261 thousand for the year ended December 31, 2002. Compared to 2002, this
increase in 2003 is due to 51




---



##### Table of Contents



significantly larger net sales and smaller commissions, selling, general and administrative
and stock option based compensation expenses as a percentage of net sales offset by a slight
increase in cost of sales as a percentage of net sales. Gain from Discontinued Operations.Gain from discontinued operations of approximately $2.4
million for the year ended December 31, 2002 was attributable to the recognition of the deferred
gain on the sale of Kaire Nutraceuticals, Inc. (Kaire) recorded at December 31, 2002. See Note 2
of Notes to Consolidated Financial Statements contained elsewhere herein. Net Income.Net income was approximately $4.7 million or 7.5% of net sales for the year ended
December 31, 2003 compared to approximately $2.1 million or 5.8% of net sales for the year ended
December 31, 2002. The Company recorded a gain from discontinued operations of $2.4 million in
2002. Liquidity and Capital Resources Cash generated from operations is the main funding source for the Companys working capital
and capital expenditure. In the past, the Company also borrowed from institutions and individuals
and issued preferred stock. In October 2004, the Company raised approximately $16 million net of
transaction fees through a private equity placement. At December 31, 2004, the ratio of current assets to current liabilities was 1.75 to 1.00 and
the Company had working capital of approximately $17.5 million. Working capital as of December 31,
2004 increased since December 31, 2003 by approximately $14.6 million mainly due to the October
2004 private placement, partly offset by the MarketVision promissory note of approximately $0.7
million remaining to be paid over the 12 months in 2005. Cash provided by operations for the twelve months ended December 31, 2004 was approximately
$428 thousand. The significant sales increase and the Companys anticipation of continued sales
increase in the near future was the most significant underlying trend for cash flows from operating
activities and the change in the Companys working capital. Cash was mainly generated from
earnings, increases in accrued distributor commissions, other accrued expenses such as sales
returns and deferred revenue, all driven by sales increase, partly offset by a significant increase
in inventory attributable to anticipated sales increase in the coming year. But there is no
assurance that the expected sales increase in the near turn would be realized. Cash used in investing activities during the period was approximately $2.6 million, which
primarily relates to the cash payment made to MarketVision as part of the acquisition, purchase of
minority interest and capital expenditures. Cash provided by financing activities during the period
was approximately $13.5 million due to the Companys October 2004 private placement of units offset
by the repayment of 52




---



##### Table of Contents



MarketVision promissory notes payable. Total cash increased by approximately $11.2 million
during the period. With cash generated from profitable business operations and the net proceeds from the private
placement closed in October 2004, the Company believes that its existing liquidity and cash flows
from operations, including its cash and cash equivalents, should be adequate to fund normal
business operations expected in the future. In addition to the Companys current obligations related to its accounts payable and accrued
expenses, the approximate future maturities of the Companys existing commitments and obligations
are as follows: Year Ended December 31,2005
    
    
    2006
    
    
    2007
    
    
    2008
    
    
    2009
    
    
    TotalDebt
    
    $
    796
    
    
    $
    13
    
    
    $
    4
    
    
    $
    5
    
    
    $
    
    
    
    $
    818Minimum commitment
related to
non-cancelable
operating leases
    
    
    720
    
    
    
    166
    
    
    
    114
    
    
    
    110
    
    
    
    96
    
    
    
    1,206Purchase commitment
    
    
    1,350
    
    
    
    1,350
    
    
    
    1,350
    
    
    
    1,350
    
    
    
    1,350
    
    
    
    6,750Totals
    
    $
    2,866
    
    
    $
    1,529
    
    
    $
    1,468
    
    
    $
    1,465
    
    
    $
    1,446
    
    
    $
    8,774
 The Company maintains a purchase commitment with one of its suppliers to purchase its Alura
product. Pursuant to the agreement, the Company is required to
purchase from this supplier a minimum volume of 15 barrels of product per quarter. The total
product cost is $1,350,000 before any volume discounts. The Company has employment agreements with certain members of its management team, the
terms of which expire at various times through December 2009. Such agreements provide minimum
salary levels, as well as incentive bonuses that are payable if specified management goals are
attained. The aggregate commitment for future salaries at
December 31, 2004, assuming continued employment and excluding bonuses,
was approximately $4,358,000 In addition to the above obligations, the shareholders agreement entered into in connection
with the Companys acquisition of MarketVision contains a one time put right related to 240,000
shares of restricted common stock for the benefit of certain former stockholders of MarketVision
that requires the Company, during the six month period commencing eighteen months following the
earlier of (i) the first anniversary of the closing date, or (ii) the date on which the shares are
registered with the Securities and Exchange Commission for resale to the public, to repurchase all
or part of such shares still owned by the such stockholders for $4.00 per share less any amount
previously received by such stockholders from the sale of their shares of restricted common stock.
The Companys maximum put right obligation is $960,000 in the aggregate. See Mezzanine Common
Stock in Item 8. The Company intends to continue to open additional operations in new foreign markets in coming
years. The Company is in the process of planning for its entry into the Mexican and Japanese
markets. The estimated initial cost for entering into the Mexican market is $2 million to $3
million, and $5 million to $7 million for the Japanese market. 53




---



##### Table of Contents



China is currently the Companys most important business development project. Direct
selling, or multi-level marketing, is currently prohibited in China. The Chinese government is
committed to opening the direct selling market and has published drafts of pertinent legislation,
which is expected to be formally adopted some time during 2005 or 2006. Before the formal adoption
of direct selling laws, many of the international direct selling companies have started to operate
in China in a retail format. In June 2004, Lexxus obtained a license to engage in retail business
in China. The license stipulates a capital requirement of $12 million over a three-year period,
including a $1.8 million initial payment the Company made in January 2005. In planning for a retail
operation, the Company estimates that each retail store will cost approximately $50,000 to $100,000
and is evaluating the number, location, timing and format of store openings. Since the airing of a negative program on Chinese television on April 12, 2004, to the
knowledge of the Company, the Chinese government has not initiated any investigation of the Company
or its independent distributors. Nevertheless the Company is also unable to predict whether it will
be successful in obtaining a direct selling license to operate in China, and if it is successful,
when it will be permitted to commence direct selling operations there. Further, even if the
Company is successful in obtaining a direct selling license to do business in China, it is
uncertain as to whether the Company will generate profits from such operations. In connection with the MarketVision acquisition, the Company issued three different promissory
notes in the aggregate principal amount of approximately $3.2 million. As of December 31, 2004,
approximately $0.7 million balance remained to be paid over the 12 months in 2005. Recent Accounting Pronouncements In November 2004, the FASB issued Statement of Financial Accounting Standards No. 151,
Inventory Costs. This statement requires that certain costs such as idle facility expense,
excessive spoilage, double freight, and re-handling costs be recognized as current-period charges
and that allocation of fixed production overheads to the costs of conversion be based on the normal
capacity of the production facilities. The provisions of the statement shall be effective for
inventory costs incurred during fiscal years beginning after June 15, 2005. Adoption of this
statement is not anticipated to have a significant impact on the Companys financial condition,
results of operations, or cash flows. In December 2004, the FASB issued Statement of Financial Accounting Standards No. 123 (Revised
2004), Share-Based Payment. This statement is a revision of FASB Statement No. 123, Accounting
for Stock-Based Compensation and supersedes APB Opinion No. 25, Accounting for Stock Issued to
Employees. This Statement requires that we record compensation expense for stock options issued
based on the estimated fair value of the options at the date of grant. This statement is effective
as of the first interim period beginning after June 15, 2005. We currently are not required to
record stock-based compensation charges if the employees stock option exercise price 54




---



##### Table of Contents



is equal to or exceeds the fair value of the stock at the date of grant. We have not yet
determined what impact, if any, the proposed pronouncement would have on our financial statements. OffBalance Sheet Arrangements The Company does not utilize off-balance sheet financing arrangements other than in the normal
course of business. The Company finances the use of certain facilities, office and computer
equipment, and automobiles under various operating lease agreements. 
 Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK The Company does not utilize off-balance sheet financing arrangements other than in the normal
course of business. The Company finances the use of certain facilities, office and computer
equipment, and automobiles under various operating lease agreements. Foreign Currency Risk In 2004, approximately 87% of our revenue was recorded in markets outside the United States.
However, that figure does not accurately reflect our foreign currency exposure mainly because the
Hong Kong dollar is pegged to the U.S. dollar. Our European business, KGC, sold products in U.S.
dollars and paid distributors commissions in U.S. dollars, until the fourth quarter of 2004, when
KGC switched to euro for both selling products and paying commissions. We also purchase all
inventories in U.S. dollars. Therefore, our currency exposure, mainly to Korean won, Singapore
dollar, New Taiwan dollar and Australia dollar, representing approximately 10% of our revenue in
the first nine months of 2004 before KGC switched to euro from U.S. dollars, was relatively
insignificant, compared to our overall geographic reach. In the fourth quarter of 2004, with KGC
doing business in euro, approximately 27% of our net revenue was generated in functional currencies
denominated in or pegged to U.S. dollar. In preparing our consolidated financial statements, we translate revenue and expenses in
foreign countries from their local currencies into U.S. dollars using the average exchange rates
for the period. The local currency of each subsidiarys primary markets is considered the
functional currency. The effect of the translation of the
Companys foreign operations is included in accumulated other comprehensive income within
stockholders equity and do not impact the statement of operations. As currency rates change, translation of our foreign currency functional businesses into U.S.
dollars affects year-over-year comparability of equity. We do not plan to hedge translation risks
because cash flows from our international operations are generally reinvested locally. Changes in
the currency exchange rates that would have the largest impact on translating our international net
assets included Euro, Korean won, New 55




---



##### Table of Contents



Taiwan dollar, Australian dollar and Canadian dollar. Japanese yen and Mexican peso are
expected to be more significant as we enter those two markets. Hedging Our exposure to foreign currency fluctuation is expected to increase, as KGC switched to euro
from U.S. dollar, and the Company opens for business in Japan and Mexico. The Company currently has
no specific plans but expects to evaluate whether it should use forward or option contracts to
hedge its foreign currency exposure. Seasonality In addition to general economic factors, the Company is impacted by seasonal factors and
trends such as major cultural events and vacation patterns. For example, most Asian markets
celebrate their respective local New Year in the first quarter, which generally has a negative
impact on that quarter. We believe that direct selling in the United States and Europe is also
generally negatively impacted during the month of August, which is in our third quarter, when many
individuals, including our distributors, traditionally take time off for vacations. Interest Rate Risk As of December 31, 2004, we do not think the Company has any exposure to interest rate risk as
the Company has limited borrowings that are interest rate sensitive. 56




---



##### Table of Contents



Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTAL DATA NATURAL HEALTH TRENDS CORP. AND SUBSIDIARIES INDEX TO CONSOLIDATED FINANCIAL STATEMENTS PageReport of Independent Registered Public Accounting Firm of BDO Seidman, LLP
    
    
    58Report of Independent Registered Public Accounting Firm of Sherb & Co., LLP
    
    
    59Consolidated Balance Sheets as of December 31, 2003 and 2004
    
    
    60Consolidated Statements of Operations for the Years Ended December 31, 2002, 2003, and 2004
    
    
    61Consolidated Statements of Stockholders Equity for the Years Ended December 31, 2002,
2003, and 2004
    
    
    62Consolidated Statements of Cash Flows for the Years Ended December 31, 2002, 2003, and 2004
    
    
    63Notes to Consolidated Financial Statements
    
    
    64
 57




---



##### Table of Contents



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Board of Directors and Stockholders
Natural Health Trends Corp.
Dallas, Texas We have audited the accompanying consolidated balance sheets of Natural Health Trends Corp. (the
Company) as of December 31, 2003 and 2004, and the related consolidated statements of operations,
stockholders equity and cash flows for each of the two years in the period ended December 31,
2004. These financial statements are the responsibility of the Companys management. Our
responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement. The
Company is not required to have, nor were we engaged to perform, an audit of its internal control
over financial reporting. Our audits include consideration of internal control over financial
reporting as a basis for designing audit procedures that are appropriate in the circumstances, but
not for the purpose of expressing an opinion on the effectiveness of the Companys internal control
over financial reporting. Accordingly, we express no such opinion. An audit also includes
examining, on a test basis, evidence supporting the amounts and disclosures in the financial
statements, assessing the accounting principles used and significant estimates made by management,
as well as evaluating the overall financial statement presentation. We believe that our audits
provide a reasonable basis for our opinion. In our opinion, the consolidated financial statements referred to above present fairly, in all
material respects, the financial position of Natural Health Trends Corp. at December 31, 2003 and
2004, and the results of its operations and its cash flows for each of the two years ended December
31, 2004, in conformity with accounting principles generally accepted in the United States of
America. The consolidated financial statements for the year ended December 31, 2003 have been restated (see
Note 2). /s/ BDO Seidman, LLP
BDO Seidman, LLP Dallas, Texas
March 30, 2005 58




---



##### Table of Contents



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Board of Directors and Stockholders
Natural Health Trends Corp.
Dallas, Texas We have audited the accompanying consolidated statements of operations, stockholders equity and
cash flows of Natural Health Trends Corp. (the Company) for the year ended December 31, 2002.
These consolidated financial statements are the responsibility of the Companys management. Our
responsibility is to express an opinion on these financial statements based on our audit. We conducted our audit in accordance with the standards of the Public Company Accounting Oversight
Board (United States). Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material
misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its
internal control over financial reporting. Our audit includes consideration of internal control
over financial reporting as a basis for designing audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion on the effectiveness of the
Companys internal control over financial reporting. Accordingly, we express no such opinion. An
audit also includes examining on a test basis, evidence supporting the amounts and disclosures in
the financial statements, assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall financial statement presentation.
We believe that our audit provides a reasonable basis for our opinion. In our opinion, the consolidated financial statements referred to above present, in all material
respects, the consolidated results of operations and cash flows of Natural Health Trends Corp. for
the year ended December 31, 2002, in conformity with accounting principles generally accepted in
the United States of America. The consolidated financial statements for the year ended December 31, 2002 have been restated (see
Note 2). /s/ Sherb & Co., LLP
Sherb & Co., LLP
Certified Public Accountants New York, New York
March 7, 2003 (except for note 2
which is dated as of March 24, 2004) 59




---



##### Table of Contents



NATURAL HEALTH TRENDS CORP. AND SUBSIDIARIES 
 CONSOLIDATED BALANCE SHEETS
(In Thousands, Except Share Data) December 31,2003
    
    
    2004As RestatedASSETSCurrent assets:Cash and cash equivalents
    
    $
    11,133
    
    
    $
    22,324Restricted cash
    
    
    1,363
    
    
    
    2,395Accounts receivable
    
    
    239
    
    
    
    209Inventories, net
    
    
    3,580
    
    
    
    13,991Other current assets
    
    
    1,646
    
    
    
    2,096Total current assets
    
    
    17,961
    
    
    
    41,015Property and equipment, net
    
    
    883
    
    
    
    579Goodwill
    
    
    208
    
    
    
    14,145Intangible assets, net
    
    
    509
    
    
    
    5,474Deferred tax assets
    
    
    
    
    
    
    434Other assets
    
    
    779
    
    
    
    458Total assets
    
    $
    20,340
    
    
    $
    62,105LIABILITIES AND STOCKHOLDERS EQUITYCurrent liabilities:Accounts payable
    
    $
    3,820
    
    
    $
    2,248Income taxes payable
    
    
    1,443
    
    
    
    1,797Accrued distributor commissions
    
    
    1,027
    
    
    
    4,259Other accrued expenses
    
    
    1,012
    
    
    
    3,250Deferred revenue
    
    
    6,943
    
    
    
    9,551Current portion of debt
    
    
    168
    
    
    
    796Other current liabilities
    
    
    659
    
    
    
    1,595Total current liabilities
    
    
    15,072
    
    
    
    23,496Debt
    
    
    31
    
    
    
    22Total liabilities
    
    
    15,103
    
    
    
    23,518Commitments and contingenciesMinority interest
    
    
    413
    
    
    
    598Mezzanine common stock
    
    
    
    
    
    
    960Stockholders equity:Preferred stock, $1,000 par value; 1,500,000
shares authorized; none issued and
outstanding
    
    
    
    
    
    
    Common stock, $0.001 par value; 500,000,000
shares authorized, 4,656,463 and 6,819,667
shares issued and outstanding at December
31, 2003 and 2004, respectively
    
    
    4
    
    
    
    7Additional paid-in capital
    
    
    34,007
    
    
    
    64,933Accumulated deficit
    
    
    (29,040
    )
    
    
    (27,799
    )Accumulated other comprehensive loss:Foreign currency translation adjustment
    
    
    (147
    )
    
    
    (112
    )Total stockholders equity
    
    
    4,824
    
    
    
    37,029Total liabilities and stockholders equity
    
    $
    20,340
    
    
    $
    62,105
 The accompanying notes are an integral part of these consolidated financial statements. 60




---



##### Table of Contents



NATURAL HEALTH TRENDS CORP. AND SUBSIDIARIES 
 CONSOLIDATED STATEMENTS OF OPERATIONS
(In Thousands, Except Per Share Data) Year Ended December 31,2002
    
    
    2003
    
    
    2004As RestatedNet sales
    
    $
    36,968
    
    
    $
    62,576
    
    
    $
    133,225Cost of sales
    
    
    7,752
    
    
    
    13,676
    
    
    
    29,321Gross profit
    
    
    29,216
    
    
    
    48,900
    
    
    
    103,904Operating expenses:Distributor commissions
    
    
    16,834
    
    
    
    27,555
    
    
    
    68,579Selling, general and administrative expenses
    
    
    10,710
    
    
    
    15,770
    
    
    
    33,102Stock-based compensation
    
    
    1,434
    
    
    
    
    
    
    
    Total operating expenses
    
    
    28,978
    
    
    
    43,325
    
    
    
    101,681Income from operations
    
    
    238
    
    
    
    5,575
    
    
    
    2,223Other income (expense), net
    
    
    33
    
    
    
    (1
    )
    
    
    137Income before income taxes and minority interest
    
    
    271
    
    
    
    5,574
    
    
    
    2,360Income tax provision
    
    
    (300
    )
    
    
    (860
    )
    
    
    (663
    )Minority interest
    
    
    (232
    )
    
    
    14
    
    
    
    (456
    )Income (loss) before discontinued operations
    
    
    (261
    )
    
    
    4,728
    
    
    
    1,241Gain from discontinued operations
    
    
    2,400
    
    
    
    
    
    
    
    Net income
    
    
    2,139
    
    
    
    4,728
    
    
    
    1,241Preferred stock dividends
    
    
    70
    
    
    
    1
    
    
    
    Net income available to common stockholders
    
    $
    2,069
    
    
    $
    4,727
    
    
    $
    1,241Basic income per share:Continuing operations
    
    $
    (0.11
    )
    
    $
    1.03
    
    
    $
    0.22Discontinuing operations
    
    
    0.77
    
    
    
    
    
    
    
    Net income
    
    $
    0.66
    
    
    $
    1.03
    
    
    $
    0.22Diluted income per share:Continuing operations
    
    $
    (0.11
    )
    
    $
    0.83
    
    
    $
    0.18Discontinuing operations
    
    
    0.77
    
    
    
    
    
    
    
    Net income
    
    $
    0.66
    
    
    $
    0.83
    
    
    $
    0.18Weighted-average number of shares outstanding:Basic
    
    
    3,118
    
    
    
    4,609
    
    
    
    5,580Diluted
    
    
    3,118
    
    
    
    5,688
    
    
    
    6,822
 The accompanying notes are an integral part of these consolidated financial statements. 61




---



##### Table of Contents



NATURAL HEALTH TRENDS CORP. AND SUBSIDIARIES 
 CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY
(In Thousands, Except Share Data) AccumulatedAdditional
    
    
    
    
    
    
    
    
    
    
    OtherPreferred Stock
    
    
    Common Stock
    
    
    Paid-In
    
    
    Accumulated
    
    
    Deferred
    
    
    ComprehensiveShares
    
    
    Amount
    
    
    Shares
    
    
    Amount
    
    
    Capital
    
    
    Deficit
    
    
    Compensation
    
    
    Loss
    
    
    TotalBALANCE, December, 31, 2001
    
    
    2,324
    
    
    $
    2,324
    
    
    
    2,209,433
    
    
    $
    2
    
    
    $
    29,558
    
    
    $
    (35,836
    )
    
    $
    (416
    )
    
    $
    (2
    )
    
    $
    (4,370
    )Net income
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    2,139
    
    
    
    
    
    
    
    
    
    
    
    2,139Foreign currency translation adjustments
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (7
    )
    
    
    (7
    )Total comprehensive income
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    2,132Conversion of Series F preferred stock
    
    
    (1,201
    )
    
    
    (1,201
    )
    
    
    610,995
    
    
    
    1
    
    
    
    1,200
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    Conversion of Series H preferred stock
    
    
    (150
    )
    
    
    (150
    )
    
    
    137,497
    
    
    
    
    
    
    
    150
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    Conversion of Series J preferred stock
    
    
    (777
    )
    
    
    (777
    )
    
    
    1,025,397
    
    
    
    1
    
    
    
    776
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    Conversion of notes payable to common
stock
    
    
    
    
    
    
    
    
    
    
    236,663
    
    
    
    
    
    
    
    280
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    Conversion of Series F preferred stock
to note payable
    
    
    (180
    )
    
    
    (180
    )
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (180
    )Shares issued for services
    
    
    
    
    
    
    
    
    
    
    19,510
    
    
    
    
    
    
    
    36
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    36Preferred stock dividends
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    70
    
    
    
    (70
    )
    
    
    
    
    
    
    
    
    
    
    Stock-based compensation
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    1,434
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    1,434Deferred compensation
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    270
    
    
    
    
    
    
    
    270BALANCE, December 31, 2002
    
    
    16
    
    
    
    16
    
    
    
    4,239,495
    
    
    
    4
    
    
    
    33,504
    
    
    
    (33,767
    )
    
    
    (146
    )
    
    
    (9
    )
    
    
    (398
    )Net income
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    4,728
    
    
    
    
    
    
    
    
    
    
    
    4,728Foreign currency translation adjustments
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (138
    )
    
    
    (138
    )Total comprehensive income
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    4,590Conversion of Series J preferred stock
    
    
    (16
    )
    
    
    (16
    )
    
    
    28,468
    
    
    
    
    
    
    
    16
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    Shares issued in acquisition
    
    
    
    
    
    
    
    
    
    
    360,000
    
    
    
    
    
    
    
    433
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    433Shares issued for services
    
    
    
    
    
    
    
    
    
    
    28,500
    
    
    
    
    
    
    
    53
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    53Preferred stock dividends
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    1
    
    
    
    (1
    )
    
    
    
    
    
    
    
    
    
    
    Deferred compensation
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    146
    
    
    
    
    
    
    
    146BALANCE, December 31, 2003 (As Restated)
    
    
    
    
    
    
    
    
    
    
    4,656,463
    
    
    
    4
    
    
    
    34,007
    
    
    
    (29,040
    )
    
    
    
    
    
    
    (147
    )
    
    
    4,824Net income
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    1,241
    
    
    
    
    
    
    
    
    
    
    
    1,241Foreign currency translation adjustments
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    35
    
    
    
    35Total comprehensive income
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    1,276Shares issued in acquisitions
    
    
    
    
    
    
    
    
    
    
    790,000
    
    
    
    1
    
    
    
    14,704
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    14,705Exercise of stock options and warrants
    
    
    
    
    
    
    
    
    
    
    3,500
    
    
    
    
    
    
    
    25
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    25Issuance of common stock and common
stock purchase warrants in private
placement
    
    
    
    
    
    
    
    
    
    
    1,369,704
    
    
    
    2
    
    
    
    16,065
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    16,067Imputed compensation
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    132
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    132BALANCE, December 31, 2004
    
    
    
    
    
    $
    
    
    
    
    6,819,667
    
    
    $
    7
    
    
    $
    64,933
    
    
    $
    (27,799
    )
    
    $
    
    
    
    $
    (112
    )
    
    $
    37,029
 The accompanying notes are an integral part of these consolidated financial statements. 62




---



##### Table of Contents



NATURAL HEALTH TRENDS CORP. AND SUBSIDIARIES 
 CONSOLIDATED STATEMENTS OF CASH FLOWS
(In Thousands) Year Ended December 31,2002
    
    
    2003
    
    
    2004As RestatedCASH FLOWS FROM OPERATING ACTIVITIES:Net income
    
    $
    2,139
    
    
    $
    4,728
    
    
    $
    1,241Less gain from discontinued operations
    
    
    (2,400
    )
    
    
    
    
    
    
    Income (loss) from continuing operations
    
    
    (261
    )
    
    
    4,728
    
    
    
    1,241Adjustments to reconcile income (loss) from continuing
operations to net cash provided by operating activities:Depreciation and amortization of property and equipment
    
    
    155
    
    
    
    418
    
    
    
    495Amortization of intangibles
    
    
    44
    
    
    
    115
    
    
    
    801Minority interest
    
    
    232
    
    
    
    (14
    )
    
    
    456Deferred income taxes
    
    
    
    
    
    
    
    
    
    
    (515
    )Imputed compensation
    
    
    
    
    
    
    
    
    
    
    132Stock-based compensation
    
    
    1,434
    
    
    
    
    
    
    
    Common stock issued for services and penalties
    
    
    36
    
    
    
    53
    
    
    
    14Change in deferred compensation
    
    
    270
    
    
    
    146
    
    
    
    Changes in assets and liabilities, excluding acquisitions:Accounts receivable
    
    
    (392
    )
    
    
    301
    
    
    
    50Inventories, net
    
    
    (2,019
    )
    
    
    (364
    )
    
    
    (10,366
    )Other current assets
    
    
    (858
    )
    
    
    43
    
    
    
    (1,630
    )Other assets
    
    
    (4
    )
    
    
    (375
    )
    
    
    330Accounts payable
    
    
    1,476
    
    
    
    482
    
    
    
    230Income taxes payable
    
    
    300
    
    
    
    933
    
    
    
    406Accrued distributor commissions
    
    
    544
    
    
    
    322
    
    
    
    3,213Other accrued expenses
    
    
    690
    
    
    
    (496
    )
    
    
    2,099Deferred revenue
    
    
    2,214
    
    
    
    3,493
    
    
    
    2,560Other current liabilities
    
    
    601
    
    
    
    (160
    )
    
    
    912Net cash provided by operating activities
    
    
    4,462
    
    
    
    9,625
    
    
    
    428CASH FLOWS FROM INVESTING ACTIVITIES:Business acquired
    
    
    
    
    
    
    
    
    
    
    (1,357
    )Purchase of minority interest
    
    
    
    
    
    
    
    
    
    
    (141
    )Purchase of database
    
    
    
    
    
    
    (191
    )
    
    
    Purchases of property and equipment
    
    
    (701
    )
    
    
    (579
    )
    
    
    (150
    )Increase in restricted cash
    
    
    (227
    )
    
    
    (1,022
    )
    
    
    (980
    )Net cash used in investing activities
    
    
    (928
    )
    
    
    (1,793
    )
    
    
    (2,628
    )CASH FLOWS FROM FINANCING ACTIVITIES:Proceeds from debt
    
    
    25
    
    
    
    
    
    
    
    Payments on debt
    
    
    (225
    )
    
    
    (339
    )
    
    
    (2,600
    )Minority interest contribution
    
    
    195
    
    
    
    
    
    
    
    Proceeds from issuance of common stock, net
    
    
    
    
    
    
    
    
    
    
    16,078Net cash provided by (used in) financing activities
    
    
    (5
    )
    
    
    (339
    )
    
    
    13,478Effect of exchange rates on cash and cash equivalents
    
    
    11
    
    
    
    (224
    )
    
    
    (87
    )Net increase in cash and cash equivalents
    
    
    3,540
    
    
    
    7,269
    
    
    
    11,191CASH AND CASH EQUIVALENTS, beginning of year
    
    
    324
    
    
    
    3,864
    
    
    
    11,133CASH AND CASH EQUIVALENTS, end of year
    
    $
    3,864
    
    
    $
    11,133
    
    
    $
    22,324
 The accompanying notes are an integral part of these consolidated financial statements. 63




---



##### Table of Contents



NATURAL HEALTH TRENDS CORP. AND SUBSIDIARIES 
 NOTES TO CONSOLIDATED FINANCIAL STATEMENTS  1.
    NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations Natural Health Trends Corp. (the Company) is an international direct selling organization
headquartered in Dallas, Texas. The Company was incorporated as a Florida corporation in 1988.
Subsidiaries controlled by the Company sell products to a distributor network that either use the
products themselves or resell them to consumers. The Companys products promote health, wellness
and vitality and are sold under the Lexxus and Kaire brands. The Companys majority-owned subsidiaries have an active physical presence in the following
markets: North America, which consists of the United States and Canada; Greater China, which
consists of Hong Kong, Taiwan and China; Southeast Asia, which consists of Singapore, Malaysia, the
Philippines and Indonesia; Eastern Europe, which consists of Russia and other former Soviet Union
Republics; Australia and New Zealand, South Korea, Japan, and Mexico. Principles of Consolidation The consolidated financial statements include the accounts of the Company and all of its
majority-owned subsidiaries. All significant intercompany balances and transactions have been
eliminated in consolidation. Use of Estimates The preparation of financial statements in accordance with accounting principles generally accepted
in the United States of America requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and the disclosure of contingent assets and
liabilities at the date of the consolidated financial statements and the reported amounts of
revenues and expenses during the reported period. Actual results may differ from these estimates. The most significant accounting estimates inherent in the preparation of the Companys financial
statements include estimates associated with obsolete inventory and the fair value of acquired
intangible assets and goodwill, as well as those used in the determination of liabilities related
to sales returns, distributor commissions, and income taxes. Various assumptions and other
factors prompt the determination of these significant estimates. The process of determining
significant estimates is fact specific and takes into account historical experience and current and
expected economic 64




---



##### Table of Contents



conditions. Historically, actual results have not significantly deviated from those determined
using the estimates described above. Reclassification Certain balances have been reclassified in the prior year consolidated financial statements to
conform to current year presentation. Cash and Cash Equivalents The Company considers all highly liquid investments with original maturities of three months or
less, when purchased, to be cash equivalents. Restricted Cash The Company maintains a cash reserve with certain credit card processing companies to provide for
potential uncollectible amounts and chargebacks. The cash reserve is calculated as a percentage of
sales over a rolling monthly time period. Inventories Inventories consist primarily of merchandise purchased for resale and are stated at the lower of
cost or market, using the first-in, first-out method. Property and Equipment Property and equipment is stated at cost and depreciated using the straight-line method over the
following estimated useful lives: Office equipment and software
    
    3  5 yearsFurniture and fixtures
    
    5  7 yearsLeasehold improvements
    
    Shorter of estimated useful life or lease term
 Goodwill and Other Intangible Assets The Company has adopted Statement of Financial Accounting Standards (SFAS) No. 142, Goodwill and
Other Intangible Assets. SFAS No. 142 requires that goodwill and intangible assets with
indefinite useful lives no longer be amortized, but instead be tested for impairment at least
annually or sooner whenever events or changes in circumstances indicate that they may be impaired.
No impairment of goodwill has been identified in any of the periods presented. SFAS No. 142 also requires that intangible assets with definite lives be amortized over their
estimated useful lives. The Company is currently amortizing its acquired intangible assets with
definite lives over periods ranging from 5 to 7 years. 65




---



##### Table of Contents



Impairment of Long-Lived Assets The Company reviews property and equipment and certain identifiable intangibles for impairment
whenever events or changes in circumstances indicate the carrying amount of an asset may not be
recoverable. Recoverability of these assets is measured by comparison of its carrying amounts to
future undiscounted cash flows the assets are expected to generate. If property and equipment and
certain identifiable intangibles are considered to be impaired, the impairment to be recognized
equals the amount by which the carrying value of the asset exceeds its fair market value. The
Company has made no adjustments to its long-lived assets in any of the periods presented. Income Taxes The Company recognizes income taxes under the liability method. Deferred income taxes are
recognized for differences between the financial reporting and tax bases of assets and liabilities
at enacted statutory tax rates in effect for the years in which the differences are expected to
reverse. Valuation allowances are established when necessary to reduce deferred tax assets to the
amounts expected to be ultimately realized. Foreign Currency The functional currency of the Companys international subsidiaries is generally the local
currency. Local currency assets and liabilities are translated at the rates of exchange on the
balance sheet date, and local currency revenues and expenses are translated at average rates of
exchange during the period. The resulting translation adjustments are recorded directly into a
separate component of stockholders equity and represents the only component of accumulated other
comprehensive loss. Revenue Recognition Product sales are recorded when the products are shipped and title passes to independent
distributors. Product sales to distributors are made pursuant to a distributor agreement that
provides for transfer of both title and risk of loss upon our delivery to the carrier, which is
commonly referred to as F.O.B. Shipping Point. The Company primarily receives payment by credit
card at the time distributors place orders. Amounts received for unshipped product are recorded as
deferred revenue. The Companys sales arrangements do not contain right of inspection or customer
acceptance provisions other than general rights of return. Actual product returns are recorded as a reduction to net sales. The Company estimates and accrues
a reserve for product returns based on its return policies and historical experience. Enrollment package revenue, including any nonrefundable set-up fees, is deferred and recognized
over the term of the arrangement, generally twelve months. During the
third quarter of 2004, the Company changed its amortization
methodology from a monthly method to the preferred daily method
whereby revenues for each enrollment package start the day of
enrollment. The change in methodology resulted in additional deferred
revenue of approximately $280,000 during 2004. Enrollment 66




---



##### Table of Contents



packages provide distributors access to both a personalized marketing website and a business
management system. Prior to the acquisition of MarketVision Communications Corp. (MarketVision)
on March 31, 2004, the Company paid MarketVision a fixed amount in exchange for MarketVision
creating and maintaining individual web pages for such distributors. These payments to
MarketVision were deferred and recorded as a prepaid expense. The related amortization was
recorded to cost of sales over the term of the arrangement. The remaining unamortized costs were
included in the determination of the purchase price of MarketVision. Subsequent to the acquisition
of MarketVision, no upfront costs are deferred as the amount is nominal. Shipping charges billed to distributors are included in net sales. Costs associated with shipments
are included in cost of sales. Stock-Based Compensation The Company continues to account for stock-based compensation plans under the recognition and
measurement principles of Accounting Principles Board Opinion No. 25, Accounting for Stock Issued
to Employees, and related Interpretations. The Company recorded stock-based employee compensation
during 2002 of $1,434,000 as a result of certain options held by senior executive officers being
accounted for as variable options. These options were amended in November 2002, and subsequently
are being accounted for as fixed options. The following table illustrates the effect on net income
and earnings per share if the Company had applied the fair value recognition provisions of FASB
Statement No. 123, Accounting for Stock-Based Compensation, to stock-based employee compensation
(in thousands). Year Ended December 31,2002
    
    
    2003
    
    
    2004As RestatedNet income available
to common stockholders, as
reported
    
    $
    2,069
    
    
    $
    4,727
    
    
    $
    1,241Add: Stock-based employee
compensation expense
included in reported net
income, net of related tax
effects
    
    
    1,434
    
    
    
    
    
    
    
    Deduct: Stock-based
employee compensation
expense determined under
fair value based method
for all awards, net of
related tax effects
    
    
    (956
    )
    
    
    (38
    )
    
    
    (3,893
    )Pro forma net income
available to common
stockholders
    
    $
    2,547
    
    
    $
    4,689
    
    
    $
    (2,652
    )Basic income per share:As reported
    
    $
    0.66
    
    
    $
    1.03
    
    
    $
    0.22Pro forma
    
    $
    0.82
    
    
    $
    1.02
    
    
    $
    (0.48
    )Diluted income per share:As reported
    
    $
    0.66
    
    
    $
    0.83
    
    
    $
    0.18Pro forma
    
    $
    0.82
    
    
    $
    0.82
    
    
    $
    (0.48
    )
 67




---



##### Table of Contents



The weighted-average fair value of options granted
was $0.81, $1.05, and $11.91 for 2002, 2003, and 2004, respectively.
The fair value of each option grant is estimated on the date of grant using the Black-Scholes
option pricing model with the following weighted-average assumptions: Year Ended December 31,2002
    
    
    2003
    
    
    2004Risk-free interest rate
    
    
    7.00
    %
    
    
    4.25
    %
    
    
    2.50
    %Expected volatility
    
    
    200
    %
    
    
    100
    %
    
    
    97
    %Expected life (in years)
    
    
    3
    
    
    
    3
    
    
    
    4Dividend yield
    
    
    
    
    
    
    
    
    
    
    
 Income Per Share Basic income per share is computed by dividing net income applicable to common stockholders by the
weighted-average number of common shares outstanding during the period. Diluted income per share
is determined using the weighted-average number of common shares outstanding during the period,
adjusted for the dilutive effect of common stock equivalents, consisting of shares that might be
issued upon the exercise of outstanding stock options and warrants. In periods where losses are
reported, the weighted-average number of common shares outstanding excludes common stock
equivalents, because their inclusion would be anti-dilutive. The dilutive effect of stock options and warrants is reflected by application of the treasury stock
method. The potential tax benefit derived from exercise of non-qualified stock options has been
excluded from the treasury stock calculation as the Company is uncertain that the benefit will be
realized. Certain Risks and Concentrations In 2003 and 2004, a substantial portion of our revenue was generated in Hong Kong (see Note 14).
Various factors could harm our business in Hong Kong, such as worsening economic conditions or
other events that are out of our control. Our financial results could be harmed if our products,
business opportunity or planned growth initiatives fail to retain and generate continued interest
among our distributors and consumers in this market. Three major product lines  Skindulgence®, Alura, and Premium Noni Juice- generated the majority
of the Companys sales for 2003 and 2004. We obtain these products from three different suppliers.
All three of the suppliers entered into our standard supply agreements. We believe that, in the
event we were unable to source
products from these suppliers or other suppliers of our products, our revenue, income and cash flow
could be adversely and materially impacted. The Company maintains its cash in bank accounts which, at times, may exceed federally insured
limits. Accounts in the United States are guaranteed by the Federal Deposit Insurance Corporation
(FDIC) up to $100,000. A portion of the Companys cash balances at December 31, 2004 exceeds the
insured limits. The Company has not experienced any losses in such accounts. 68




---



##### Table of Contents



Fair Value of Financial Instruments The carrying amounts of the Companys financial instruments, including cash and cash equivalents,
accounts receivable, accounts payable, accrued expenses, and debt, approximate fair value because
of their short maturities. Recent Accounting Pronouncements In November 2004, the FASB issued Statement of Financial Accounting Standards No. 151, Inventory
Costs. This statement requires that certain costs such as idle facility expense, excessive
spoilage, double freight, and re-handling costs be recognized as current-period charges and that
allocation of fixed production overheads to the costs of conversion be based on the normal capacity
of the production facilities. The provisions of the statement shall be effective for inventory
costs incurred during fiscal years beginning after June 15, 2005. Adoption of this statement is
not anticipated to have a significant impact on the Companys financial condition, results of
operations, or cash flows. In December 2004, the FASB issued Statement of Financial Accounting Standards No. 123 (Revised
2004), Share-Based Payment. This statement is a revision of FASB Statement No. 123, Accounting
for Stock-Based Compensation and supersedes APB Opinion No. 25, Accounting for Stock Issued to
Employees. This Statement requires that we record compensation expense for stock options issued
based on the estimated fair value of the options at the date of grant. This statement is effective
as of the first interim period beginning after June 15, 2005. We currently are not required to
record stock-based compensation charges if the employees stock option exercise price is equal to
or exceeds the fair value of the stock at the date of grant. We have not yet determined what
impact, if any, the proposed pronouncement would have on our financial statements. 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS During the quarters ended September 30 and December 31, 2003, the Company re-evaluated its
financial statements for the years ended December 31, 2001 and 2002, and quarterly periods included
in such years and the quarterly periods ended March 31, June 30 and September 30, 2003. As a
result of such review, the Company determined that it inadvertently applied the incorrect
accounting treatment with respect to the following items:  1.
    Revenue recognition with respect to enrollment package revenue;2.
    Revenue cut-off between 2002 and 2003;3.
    Accounts receivable reconciliation to supporting documents;4.
    Reserves established for product returns and refunds;5.
    Gain recorded in connection with the sales of a subsidiary in 2001; 69




---



##### Table of Contents



6.
    Income tax provisions; and7.
    Stock-based compensation Consequently, the Company
amended and restated its financial statements for each quarter in
2001 and 2002, the first three quarters in 2003, as well as for the years ended December 31, 2001 and 2002. The cumulative effect of
the restatements for 2001 and 2002 resulted in a net increase in accumulated deficit of
approximately $3,520,000 as of December 31, 2002. On March 23, 2005, the Company filed a Current Report on Form 8-K to report, after consultantion
with its audit committee, that an amendment to its financial statements for the year ended December
31, 2003 and for the first quarter of 2004 is warranted as certain commission and
transportation-related expenses incurred as of December 31, 2003 were under-accrued and certain
revenues not earned until 2004 were improperly recorded as revenue by its Eastern European
business, KGC Networks Ptd. Ltd., for the year ended December 31, 2003. The restatement of the
financial statements for the year ended December 31, 2003 will reduce the Companys revenue by
approximately $310,000, increase cost of goods sold by approximately $180,000, increase distributor
commission expense by approximately $460,000, reduce minority interest expense by approximately
$300,000, and reduce after-tax net income by approximately $650,000 for the quarter as well as the
year ended December 31, 2003. For the quarter ended March 31, 2004, the restatement will increase the Companys revenue by
approximately $310,000, reduce cost of goods sold by approximately $180,000, reduce distributor
commission expense by approximately $460,000, increase minority interest expense by approximately
$300,000, and increase after-tax net income by approximately $650,000 for the quarter ended March
31, 2004. Although the financial statements for the three month periods ended June 30, 2004 and September 30,
2004 are unaffected by this error, the consolidated financial statements for the second and third
quarters of 2004 include inaccurate information on a year to date basis because they include the
erroneous information from the first quarter of 2004 which financial statements should not be
relied upon. The Company also intends to file in the near future an amended annual report on Form
10-KSB for the year ended December 31, 2003, and amended quarterly reports on Form 10-Q for the
first three quarters of 2004. A reconciliation of the amounts as previously reported and as restated for the year ended December
31, 2003 is as follows: AsPreviouslyReported
    
    
    Adjustments
    
    
    As RestatedNet sales
    
    $
    62,886
    
    
    $
    (310
    )1
    
    $
    62,576Gross profit
    
    
    49,390
    
    
    
    (490
    )2
    
    
    48,900Distributor commissions
    
    
    27,096
    
    
    
    459
    3
    
    
    27,555Selling, general and administrative expenses
    
    
    15,770
    
    
    
    
    
    
    
    15,770Income from operations
    
    
    6,524
    
    
    
    (949
    )
    
    
    5,575Net income
    
    
    5,378
    
    
    
    (650
    )4
    
    
    4,728Diluted income per share
    
    $
    0.95
    
    
    
    
    
    
    $
    0.83Diluted weighted-average number of shares outstanding:
    
    
    5,688
    
    
    
    
    
    
    
    5,668
   1
    
    Revenues not earned until 2004 were improperly recorded as revenue by the
Companys Eastern European business, KGC Networks Ptd. Ltd., for the year ended December 31,
2003.2
    
    Includes certain transportation-related expenses incurred but not accrued as of
December 31, 2003.3
    
    Reflects distributor commissions incurred but not accrued as of December 31, 2003.4
    
    Includes minority interest related to the restatement adjustments. 70




---



##### Table of Contents



3.
    OTHER INCOME (EXPENSE) Other income (expense) consist of the following (in thousands): Year Ended December 31,2002
    
    
    2003
    
    
    2004As RestatedGain (loss) on foreign exchange
    
    $
    21
    
    
    $
    (77
    )
    
    $
    215Interest income
    
    
    10
    
    
    
    5
    
    
    
    19Interest expense
    
    
    (71
    )
    
    
    (68
    )
    
    
    (101
    )Other
    
    
    73
    
    
    
    139
    
    
    
    4$
    33
    
    
    $
    (1
    )
    
    $
    137
  4.
    BALANCE SHEET COMPONENTS Selected balance sheet components are as follows (in thousands): December 31,2003
    
    
    2004As RestatedProperty and equipment:Office equipment and software
    
    $
    629
    
    
    $
    772Furniture and fixtures
    
    
    434
    
    
    
    422Leasehold improvements
    
    
    281
    
    
    
    311Property and equipment, at cost
    
    
    1,344
    
    
    
    1,505Accumulated depreciation and amortization
    
    
    (461
    )
    
    
    (926
    )$
    883
    
    
    $
    579Other accrued expenses:Sales returns
    
    $
    381
    
    
    $
    1,541Employee-related expense
    
    
    212
    
    
    
    355Professional fees
    
    
    16
    
    
    
    182Incentive trips
    
    
    
    
    
    
    306Litigation
    
    
    
    
    
    
    236Other
    
    
    403
    
    
    
    630$
    1,012
    
    
    $
    3,250Deferred revenue:Unshipped product
    
    $
    4,259
    
    
    $
    4,842Enrollment package revenue
    
    
    2,684
    
    
    
    4,709$
    6,943
    
    
    $
    9,551
 71




---



##### Table of Contents



5.
    GOODWILL AND OTHER INTANGIBLE ASSETS The changes in the carrying amount of goodwill for the year are as follows (in thousands): Balance, December 31, 2003 (As Restated)
    
    $
    208Goodwill acquired during the year
    
    
    13,937Balance, December 31, 2004
    
    $
    14,145
 Intangible assets consist of the following (in thousands): December 31, 2003
    
    
    December 31, 2004Gross
    
    
    
    
    
    
    
    
    
    
    GrossCarrying
    
    
    Accumulated
    
    
    
    
    
    
    Carrying
    
    
    AccumulatedAmount
    
    
    Amortization
    
    
    Net
    
    
    Amount
    
    
    Amortization
    
    
    NetAs RestatedComputer software and programs
    
    $
    
    
    
    $
    
    
    
    $
    
    
    
    $
    5,600
    
    
    $
    600
    
    
    $
    5,000Distributor database
    
    
    624
    
    
    
    115
    
    
    
    509
    
    
    
    790
    
    
    
    316
    
    
    
    474$
    624
    
    
    $
    115
    
    
    $
    509
    
    
    $
    6,390
    
    
    $
    916
    
    
    $
    5,474
 Amortization expense for intangible assets was $44, $115, and $801 for 2002, 2003, and 2004,
respectively. Estimated amortization expense for the five succeeding fiscal years is as follows
(in thousands): 2005
    
    $
    9582006
    
    
    9582007
    
    
    9582008
    
    
    8002009
    
    
    800Thereafter
    
    
    1,000$
    5,474
  6.
    ACQUISITIONS MarketVision Communications Corp. On March 31, 2004, the Company entered into a merger agreement with MarketVision. MarketVision is
the exclusive developer and service provider of direct selling internet technology used by the
Company since 2001. Pursuant to the merger agreement, the Company acquired all of the outstanding
capital stock of MarketVision in exchange for the issuance of 690,000 shares of restricted common
stock (the Issued Shares), promissory notes in the aggregate principal amount of approximately
$3,203,000 (see Note 7), a cash payment of approximately $1,337,000 in April 2004, less
pre-acquisition net payables due to MarketVision of approximately $646,000, for a total purchase
price of approximately $17,583,000, including acquisition costs of approximately $153,000. The
Issued Shares were valued at $13,536,000 based on the average closing price of $23.08 a few days
before and after the acquisition was announced discounted by 15% due to certain restrictions
contained in the purchase agreement. 72




---



##### Table of Contents



MarketVision hosts and maintains the internet technology for the Company and charges an annual fee
for this service based upon the number of enrolled distributors of the Companys products.
MarketVision earned revenues for this service of approximately $1,839,000 and $579,000 for the year
ended December 31, 2003 and three months ended March 31, 2004, respectively. Management believes that this transaction was in the best interests of the Company because (i) the
success of the Companys business is dependent upon MarketVisions direct selling software and (ii)
the Company projects enrolling a significant number of new distributors in the future, which would
be very expensive under the former compensation agreement between the Company and MarketVision.
Since the former owners of MarketVision include Terry LaCore, a member of the Companys board of
directors and the Chief Executive Officer of Lexxus International, Inc., a wholly-owned subsidiary
of the Company (Lexxus U.S.) , the board of directors hired the independent appraisal firm of
Bernstein, Conklin & Balcombe to assess the fairness of the transaction with MarketVision from a
financial point of view. In March 2004, Bernstein, Conklin & Balcombe delivered its opinion to the
Companys board of directors that the MarketVision transaction is fair to the Company from a
financial point of view. In addition, the Company entered into a shareholders agreement with the former stockholders of
MarketVision. Such agreement contained customary terms and conditions, including restrictions on
transfers of the Issued Shares, rights of first refusal and indemnification. Further, the
shareholders agreement contains a one time put right related to 240,000 Issued Shares for the
benefit of the former stockholders of MarketVision (other than Mr. LaCore) that requires the
Company, during the six month period commencing eighteen months following the earlier of (i) the
first anniversary of the closing date, or (ii) the date on which the Issued Shares are registered
with the Securities and Exchange Commission (the SEC) for resale to the public, to repurchase
all or part of such shares still owned by the such stockholders for $4.00 per share less any
amount previously received by such stockholders from the sale of their Issued Shares. The Company
has recorded this obligation of $960,000 as mezzanine common stock in the consolidated balance
sheet. The estimated fair value of the put right based on the Black-Scholes option pricing model,
as determined by the independent valuation firm, of approximately $133,000 was not included in the
cost of MarketVision due to materiality. The agreement also provided the former stockholders of MarketVision with piggyback registration
rights in the event the Company files a registration statement with the SEC, other than on Forms
S-4 or S-8, stock option grants for the former stockholders (other than Mr. LaCore) as well as
three-year employment agreements for the former stockholders, other than Mr. LaCore. In the event
that the Company defaults on its payment obligations under the notes or the employment agreements,
an entity owned by the former stockholders of MarketVision (other than Mr. LaCore) has certain
rights to use, develop, modify, market, distribute and sublicense the MarketVision software to
third parties. 73




---



##### Table of Contents



The transaction was accounted for using the purchase method of accounting and the purchase price
was allocated among the assets acquired based on their estimated fair market values. The purchase price was allocated among assets acquired based on their estimated fair market values
as follows (in thousands): Property and equipment
    
    $
    25Computer software and programs
    
    
    5,600Goodwill
    
    
    11,958Deferred tax liabilities
    
    
    (1,904
    )Deferred tax assets recognized by the Company resulting from
offset against MarketVisions deferred tax liabilities
    
    
    1,904Total purchase price allocation
    
    $
    17,583
 Goodwill includes but is not limited to the synergistic value and potential competitive
benefits that could be realized by the Company from the acquisition and any future services that
may arise from MarketVisions internet technology. The goodwill amount is not deductible for tax
purposes. The results of operations of MarketVision have been included in the Companys consolidated
statements of operations since the completion of the acquisition on March 31, 2004. The following
unaudited pro forma information presents a summary of the results of operations of the Company
assuming the acquisition of MarketVision occurred on January 1, 2003 (in thousands, except per
share data): Year Ended December 31,2003
    
    
    2004As RestatedNet sales
    
    $
    62,576
    
    
    $
    133,225Net income
    
    $
    4,533
    
    
    $
    1,342Income per share:Basic
    
    $
    0.86
    
    
    $
    0.21Diluted
    
    $
    0.71
    
    
    $
    0.18
 Acquisitions of Minority Interests On March 29, 2004, the Company purchased 4,900 shares of common stock owned by the minority
stockholders of Lexxus U.S., a Delaware corporation, representing the 49% interest in Lexxus U.S.
not owned by the Company, in exchange for 100,000 shares of restricted common stock. The total
purchase price, including acquisition related costs of approximately $7,000, was approximately
$1,969,000 based upon the average closing price of the Companys common stock of $23.08 a few days
before and after the acquisition was announced discounted by 15% due to the restrictions contained
in the purchase agreement. The entire purchase price was allocated to goodwill. On April 19, 2004, the Company purchased 510,000 shares of common stock owned by the minority
stockholders of Lexxus International Co., Ltd. (Taiwan), a Taiwan limited 74




---



##### Table of Contents



liability corporation (Lexxus Taiwan), representing the 30% interest in Lexxus Taiwan not owned
by the Company, in exchange for approximately $136,000 in cash. The cash consideration given
approximated the book value of the shares acquired and no goodwill resulted from the transaction.
All Lexxus Taiwan minority stockholders were unrelated to the Company.  7.
    DEBT Debt consists of the following (in thousands): December 31,2003
    
    
    2004As RestatedMarketVision promissory note
    
    $
    
    
    
    $
    682Notes payable a distributor, due upon
demand, interest at 1% per annum
    
    
    102
    
    
    
    86Note payable to a governmental agency,
monthly installments of $2,200, interest at
7% per annum, maturing May 2006
    
    
    57
    
    
    
    34Notes payable to a vendor, monthly
installments of $580, interest at 25.49%
per annum, maturing October 2008
    
    
    
    
    
    
    16Note payable to a vendor, due upon demand,
non-interest bearing
    
    
    40
    
    
    
    199
    
    
    
    818Current maturities
    
    
    (168
    )
    
    
    (796
    )Debt
    
    $
    31
    
    
    $
    22
 On March 31, 2004, the Company issued two six month promissory notes in the aggregate
principal amount of approximately $2,203,000, bearing interest at 4% per annum, and a twenty-one
month promissory note in the principal amount of $1,000,000, bearing interest at 4.5% per annum, in
connection with the acquisition of MarketVision (see Note 6). The Company repaid the two six month
notes in full on October 12, 2004. The twenty-one month note requires monthly payments of
approximately $58,200 commencing June 30, 2004. The note is payable in full on December 31,
2005.  8.
    COMMITMENTS AND CONTINGENCIES Operating Leases The Company has entered into non-cancelable operating lease agreements for locations within the
U.S. and for its international subsidiaries, with expirations through December 2009. Rent expense
in connection with operating leases was approximately $518,000, $1,137,000, and $1,400,000 during
2002, 2003, and 2004, respectively. 75




---



##### Table of Contents



Future minimum lease obligations as of December 31, 2004, are as follows (in thousands): 2005
    
    $
    7202006
    
    
    1662007
    
    
    1142008
    
    
    1102009
    
    
    96Total minimum lease obligations
    
    $
    1,206
 Purchase Commitment The Company maintains an annual purchase commitment with one of its suppliers to purchase its
Aluraproduct. Pursuant to the agreement, the Company is required to purchase from this supplier
a minimum volume of 15 barrels of product per quarter. The cost of the annual purchase commitment
is $1,350,000 before any volume discounts. Employment Agreements The Company has employment agreements with certain members of its management team, the terms of
which expire at various times through December 2009. Such agreements provide minimum salary
levels, as well as incentive bonuses that are payable if specified management goals are attained.
The aggregate commitment for future salaries at December 31,
2004, assuming continued employment and excluding bonuses, was
approximately $4,358,000. Legal Matters During the fall of 2003, the customs agency of the government of South Korea brought a charge
against LXK, Ltd. (LXK), the Companys wholly-owned subsidiary operating in South Korea, with
respect to the importation of the Companys Alura product. The customs agency alleges that Alura is
not a cosmetic product, but rather should be categorized and imported as a pharmaceutical product.
On February 18, 2005, the Seoul Central District Court ruled against LXK and fined it a total of
approximately $200,000. LXK also incurred related costs of approximately $40,000 as a result of
the judgment. The Company recorded a reserve for the entire $240,000 at December 31, 2004 and is
currently evaluating whether to appeal the ruling. The failure to sell Alura in South Korea is not
anticipated to have a material adverse effect on the financial condition, results of operations,
cash flow or business prospects of LXK. On or around March 31, 2004, Lexxus U.S. received a letter from John Loghry, a former Lexxus
distributor, alleging that Lexxus U.S. had wrongfully terminated an alleged oral distributorship
agreement with Mr. Loghry and that the Company had breached an alleged oral agreement to issue
shares of the Companys common stock to Mr. Loghry. After Mr. Loghry threatened to commence suit
against Lexxus U.S. and the Company in Nebraska, on May 13, 2004, Lexxus U.S. and the Company filed
an action for declaratory relief against Mr. Loghry in the United States District Court for the
Northern District of Texas seeking, inter alia, a declaration that Mr. Loghry was not wrongfully 76




---



##### Table of Contents



terminated and is not entitled to recover anything from Lexxus U.S. or the Company. Mr. Loghry has
filed counterclaims against the Company and Lexxus U.S. asserting his previously articulated
claims. In September 2004, Mr. Loghry filed third party claims against certain officers of the
Company and Lexxus U.S., including against Terry LaCore and Mark Woodburn for fraud, LaCore,
Woodburn, and a certain Lexxus distributor for conspiracy to commit the same and tortious
interference with contract. In February 2005, the court dismissed all of Mr. Loghrys claims
against the individual defendants, except the claims for fraud and conspiracy to commit fraud.
Discovery is ongoing and the Company intends to vigorously defend itself in this case. On November 1, 2004, Toyota Jidosha Kabushiki Kaisha (d/b/a Toyota Motor Corporation) and Toyota
Motor Sales, U.S.A. filed a complaint against the Company and Lexxus U.S. in United States District
Court for the Central District of California (CV04-9028). The complaint alleges trademark and
service mark dilution, unfair competition, trademark and service mark infringement, and trade name
infringement, each with respect to Toyotas Lexus trademark. Toyota seeks to enjoin the Company
and Lexxus U.S. from using the Lexxus mark and otherwise competing unfairly with Toyota, to
transfer the ownership of the mylexxus.com and lexxusinternational.com internet sites to Toyota,
and reimbursement of costs and reasonable attorney fees incurred by Toyota in connection with this
matter. The Company filed a motion to dismiss all counts in the complaint, which was denied by the
court. The Company intends to vigorously defend this action. In the event that the Company is
unsuccessful in defending this action, the Company may be required to change the name of some or
all of its Lexxus subsidiaries and domain names which could have a material adverse effect on the
financial condition, results of operations, cash flow or business prospects of the Company. On November 12, 2004, Dorothy Porter filed a complaint against the Company in the United States
District Court for the Southern District of Illinois alleging that she sustained a brain hemorrhage
after taking Formula One, an ephedra-containing product marketed by Kaire Nutraceuticals, Inc., a
former subsidiary of the Company, and, thereafter, eKaire. Ms. Porter has sued the Company for
strict liability, breach of warranty and negligence. The Company intends to defend this case
vigorously and on December 27, 2004 filed an answer denying the allegations contained in the
complaint. Recently, the plaintiff demanded $2 million in damages to settle the case. On March 7,
2005, a Notice of Tag-Along Action was filed by Ms. Porter with the Judicial Panel on Multidistrict
Litigation. It is anticipated that this case will be place on the next Conditional Transfer Order
and, ultimately, transferred to the consolidated Ephedra Products Liability proceedings in the
United States District Court for the Southern District of New York. The Company does not believe
that the plaintiff can demonstrate that its products caused the alleged injury and intends to
vigorously defend this action. On January 13, 2005, Natures Sunshine Products, Inc. and Natures Sunshine Products de Mexico S.A.
de C.V. (collectively Natures Sunshine) filed suit against the Company in the Fourth Judicial
District Court, Utah County, State of Utah seeking injunctive relief and unspecified damages
against the Company, Lexxus U.S., the Companys Mexican subsidiary, and the Companys Mexico
management team, Oscar de 77




---



##### Table of Contents



la Mora Romo and Jose Villarreal Patino, alleging among other things that the Companys employment
of De la Mora and Villarreal violated or could lead to the violation of certain non-compete,
non-solicitation, and confidentiality agreements allegedly in effect between De la Mora and
Villarreal and Natures Sunshine. Upon request by Natures Sunshine, the state court entered a
temporary restraining order against De la Mora and Villarreal on January 14, 2005 restraining them
from violating the non-compete, non-solicitation and confidentiality provisions of the agreements,
including continuing their employment with the Company, and restrained the Company from interfering
with the agreements alleged by Natures Sunshine to exist with De la Mora and Villarreal. On
January 17, 2005, the Company removed the case from Utah state court to the United States District
Court for the Northern District of Utah. The restraining order expired on its own terms and on
January 20, 2005 the federal judge declined to extend the restraining order entered in state court.
On January 21, 2005, the Company, De la Mora, Villarreal, and Natures Sunshine entered into a
stipulation and agreed order restraining De la Mora and Villarreal from using or disclosing any
confidential information of Natures Sunshine, restraining the Company from attempting to obtain
any confidential information of Natures Sunshine, and restraining all parties from soliciting
Natures Sunshine employees and distributors. De la Mora and Villarreal were not restrained from
their continued employment with the Company, however, Natures Sunshine may seek such restraint at
any future point in the litigation, whether in federal court or, if the federal court remands the
case to state court as Natures Sunshine has requested, by the state court. On January 19, 2005,
Natures Sunshine requested the federal court to remand the case to state court on the basis on
alleged lack of federal court jurisdiction. On February 17, 2005, the federal court denied Nature
Sunshines motion to remand. On March 15, 2005, Natures Sunshine filed an Amended Complaint
against De la Mora and Villarreal and purportedly the Companys Mexican subsidiary, although not
properly named. The previously asserted claims against the Company and Lexxus U.S. were dropped by
Natures Sunshine. The Company intends to vigorously defend this case on its own behalf, to the
extent the Company remains a party, and on behalf of De la Mora and Villarreal. If the Company or
De la Mora and Villarreal are unsuccessful in defending this action, the Company may be required to
change its Mexico management team, at least during the unexpired term of any enforceable
non-compete period. Currently, there is no other significant litigation pending against the Company other than as
disclosed in the paragraphs above. From time to time, the Company may become a party to litigation
and subject to claims incident to the ordinary course of the Companys business. Although the
results of such litigation and claims in the ordinary course of business cannot be predicted with
certainty, the Company believes that the final outcome of such matters will not have a material
adverse effect on the Companys business, results of operations or financial condition. Regardless
of outcome, litigation can have an adverse impact on the Company because of defense costs,
diversion of management resources and other factors. 78




---



##### Table of Contents



9. MEZZANINE COMMON STOCK On March 31, 2004, in connection with the Companys acquisition of MarketVision, the Company
entered into a shareholders agreement with the former stockholders of MarketVision. Such agreement
contained customary terms and conditions, including restrictions on transfers of the Issued Shares,
rights of first refusal and indemnification. Further, the shareholders agreement contains a one
time put right related to 240,000 Issued Shares for the benefit of the former stockholders of
MarketVision (other than Mr. LaCore) that requires the Company, during the six month period
commencing eighteen months following the earlier of (i) the first anniversary of the closing date,
or (ii) the date on which the Issued Shares are registered with the Securities and Exchange
Commission (the SEC) for resale to the public, to repurchase all or part of such shares still
owned by the such stockholders for $4.00 per share less any amount previously received by such
stockholders from the sale of their Issued Shares. The Company has recorded this obligation of
$960,000 as mezzanine common stock in the consolidated balance sheet. The agreement also provided
the former stockholders of MarketVision with piggyback registration rights in the event the Company
files a registration statement with the SEC, other than on Forms S-4 or S-8. 10. STOCKHOLDERS EQUITY Authorized Shares The Company is authorized to issue two classes of capital stock consisting of up to 1,500,000
shares of preferred stock, $1,000 par value, and 500,000,000 shares of common stock, $0.001 par
value. Stock Split The Company effected a 1-for-100 reverse stock split in March 2003 of all outstanding shares of
capital stock and unexercised stock options and warrants. All references to share and per share
data have been adjusted to reflect the stock split. Private Placement of Units On October 6, 2004, the Company entered into a securities purchase agreement (and subscription
agreements with respect to certain Canadian investors) with certain institutional and accredited
investors as well as certain officers and directors of the Company. Pursuant to the purchase and
subscription agreements, the Company sold 1,369,704 units at a price of $12.595 per unit. Each
unit consist of one share of the Companys common stock and one stock purchase warrant exercisable
for one share of the Companys common stock at any time through October 6, 2009 at an exercise
price of $12.47 per share. Proceeds were approximately $16,067,000, net of transaction fees. 79




---



##### Table of Contents



Pursuant to the registration rights agreement, the Company has agreed to register the shares
included in the units and the shares issuable upon exercise of the warrants for resale. The
registration rights agreement provides for the payment of certain liquidated damages in the event
that delays are experienced in the Securities and Exchange Commissions declaring that registration
statement effective. The Company agrees to use commercially reasonable effort to effect and
maintain the effectiveness of a registration statement. If the registration statement is not
effective 180 days after the closing date, or approximately April 4, 2005, the Company will pay the
buyers approximately $85,000, which also applies to any of Companys possible failure to maintain
the effectiveness of the registration statement after its initial effectiveness. The Company does
not expect an effective registration statement within the required 180 day period. The
registration rights agreement also provides indemnification and contribution remedies to the buyers
in connection with the resale of shares pursuant to such registration statement. Stock Options The Company maintains the 2002 Stock Option Plan (the Plan) which provides for the granting of
incentive and nonqualified stock options to employees, directors and officers of the Company,
members of the board of directors, or consultants. The terms of any particular grant are
determined by the board of directors or a committee appointed by the board of directors. The maximum number of shares of common stock that may be issued under the Plan is 1,225,000
shares. As of December 31, 2004, the Company had 880,876 shares available to be granted under the
Plan. 2002
    
    
    2003
    
    
    2004Weighted
    
    
    
    
    
    
    Weighted
    
    
    
    
    
    
    WeightedAverage
    
    
    
    
    
    
    Average
    
    
    
    
    
    
    AverageExercise
    
    
    
    
    
    
    Exercise
    
    
    
    
    
    
    ExerciseShares
    
    
    Price
    
    
    Shares
    
    
    Price
    
    
    Shares
    
    
    PriceAs RestatedOutstanding,
beginning of year
    
    
    61,500
    
    
    $
    1.10
    
    
    
    1,321,500
    
    
    $
    1.05
    
    
    
    1,331,500
    
    
    $
    1.06Granted
    
    
    1,260,000
    
    
    
    1.05
    
    
    
    10,000
    
    
    
    1.80
    
    
    
    344,124
    
    
    
    17.44Exercised
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    (1,500
    )
    
    
    1.10Outstanding, end of
year
    
    
    1,321,500
    
    
    
    1.05
    
    
    
    1,331,500
    
    
    
    1.06
    
    
    
    1,674,124
    
    
    
    4.42Exercisable at end
of year
    
    
    1,241,496
    
    
    $
    1.00
    
    
    
    1,291,504
    
    
    $
    1.03
    
    
    
    1,640,000
    
    
    $
    4.28
 The following table summarizes information about options outstanding and exercisable at December 31, 2004: Options Outstanding
    
    
    Options ExercisableWeightedWeighted
    
    
    Average
    
    
    
    
    
    
    WeightedAverage
    
    
    Remaining
    
    
    
    
    
    
    AverageShares
    
    
    Exercise
    
    
    Contractual
    
    
    Shares
    
    
    ExerciseRange of Exercise Prices
    
    Outstanding
    
    
    Price
    
    
    Life
    
    
    Exercisable
    
    
    Price$1.00 to $1.80
    
    
    1,330,000
    
    
    $
    1.06
    
    
    7.2 years
    
    
    1,330,000
    
    
    $
    1.06$11.40 to $18.11
    
    
    344,124
    
    
    
    17.44
    
    
    6.6 years
    
    
    310,000
    
    
    
    18.11$1.00 to $18.11
    
    
    1,674,124
    
    
    
    4.42
    
    
    7.1 years
    
    
    1,640,000
    
    
    
    4.28
 Common Stock Purchase Warrants On June 23, 2004, warrants to purchase 2,000 shares of common stock were exercised at an exercise
of $5.00 per share. At December 31, 2004, warrants to purchase 1,371,123 shares of common stock were outstanding, of
which 1,369,704 were a component of the units sold on October 6, 2004 (see Private Placement of
Unitsabove). Such warrants are exercisable for one share of the Companys common stock at any
time through October 6, 2009 at an exercise price of $12.47 per share. The remaining
1,419 warrants are exercisable until March 31, 2005 at 80




---



##### Table of Contents



an exercise price of $141.00 per share. The weighted-average remaining contractual life of
outstanding warrants as of December 31, 2004 was 4.8 years. Restricted Stock On October 7, 2004, the Company entered into employment agreements with two members of its Mexican
management team whereby each member is entitled to receive a bonus payable in restricted shares of
the Companys common stock based upon the Mexican subsidiary achieving certain (1) net sales and
(2) net income before interest, taxes, depreciation and amortization (collectively EBITDA). The
maximum aggregate amount payable in restricted shares is $14.5 million, assuming net sales of $300
million and EBITDA of $30 million. The shares will be issued by no later than April
15th in the year following satisfaction of both targets. Income Per Share Year Ended December 31,2002
    
    
    2003
    
    
    2004(In Thousands, Except Per Share Data)As RestatedNet income
available to common
stockholders
    
    $
    2,069
    
    
    $
    4,727
    
    
    $
    1,241Basic
weighted-average
number of shares
outstanding
    
    
    3,118
    
    
    
    4,609
    
    
    
    5,580Effect of dilutive
stock options and
warrants
    
    
    
    
    
    
    1,079
    
    
    
    1,242Diluted
weighted-average
number of shares
outstanding
    
    
    3,118
    
    
    
    5,688
    
    
    
    6,822Income per share
from continuing
operations:Basic
    
    $
    (0.11
    )
    
    $
    1.03
    
    
    $
    0.22Diluted
    
    $
    (0.11
    )
    
    $
    0.83
    
    
    $
    0.18
 Options and warrants to purchase 1,324,919 shares of common stock were outstanding during 2002
but were not included in the computation of diluted earnings per share as those potential common
shares were anti-dilutive. Options and warrants to purchase 1,681,123 shares of common stock were outstanding during 2004 but
were not included in the computation of diluted earnings per share because the exercise prices were
greater than the average market price of the common shares. The options, which expire on March 31,
2011, and the warrants, which fully expire on October 6, 2009, were still outstanding at the end of
2004. 81




---



##### Table of Contents



11. INCOME TAXES The components of income before income taxes consist of the following (in thousands): Year Ended December 31,2002
    
    
    2003
    
    
    2004As RestatedDomestic
    
    $
    (924
    )
    
    $
    4,482
    
    
    $
    (2,108
    )Foreign
    
    
    1,195
    
    
    
    1,092
    
    
    
    4,468Income before income taxes
    
    $
    271
    
    
    $
    5,574
    
    
    $
    2,360
 The components of the provision for income taxes consist of the following (in thousands): Year Ended December 31,2002
    
    
    2003
    
    
    2004As RestatedCurrent taxes:Federal
    
    $
    58
    
    
    $
    256
    
    
    $
    248State
    
    
    8
    
    
    
    40
    
    
    
    171Foreign
    
    
    234
    
    
    
    564
    
    
    
    759300
    
    
    
    860
    
    
    
    1,178Deferred taxes
    
    
    
    
    
    
    
    
    
    
    (515
    )Provision for income taxes
    
    $
    300
    
    
    $
    860
    
    
    $
    663
 A reconciliation of the reported provision for income taxes to the amount that would result
from applying the domestic federal statutory tax rate to pretax income is as follows (in
thousands): Year Ended December 31,2002
    
    
    2003
    
    
    2004As RestatedIncome tax at federal statutory rate
    
    $
    92
    
    
    $
    1,895
    
    
    $
    802Effect of permanent differences
    
    
    6
    
    
    
    37
    
    
    
    709Increase (decrease) in valuation allowance
    
    
    291
    
    
    
    (1,066
    )
    
    
    (602
    )Foreign rate differential
    
    
    (94
    )
    
    
    (32
    )
    
    
    (471
    )State income taxes, net of federal benefit
    
    
    5
    
    
    
    26
    
    
    
    113Other reconciling items
    
    
    
    
    
    
    
    
    
    
    112Income tax provision
    
    $
    300
    
    
    $
    860
    
    
    $
    663
 82




---



##### Table of Contents



Deferred income taxes consist of the following (in thousands): December 31,2003
    
    
    2004As RestatedDeferred tax assets:Net operating losses
    
    $
    3,596
    
    
    $
    3,144Stock-based compensation
    
    
    488
    
    
    
    488Accrued expenses
    
    
    89
    
    
    
    255Tax credits
    
    
    87
    
    
    
    80Other
    
    
    11
    
    
    
    12Total deferred tax assets
    
    
    4,271
    
    
    
    3,979Valuation allowance
    
    
    (4,004
    )
    
    
    (1,492
    )267
    
    
    
    2,487Deferred tax liabilities:Intangible assets
    
    
    (173
    )
    
    
    (1,861
    )Depreciation
    
    
    (22
    )
    
    
    (34
    )Prepaids
    
    
    (44
    )
    
    
    (50
    )Other
    
    
    (28
    )
    
    
    (27
    )Total deferred tax liabilities
    
    
    (267
    )
    
    
    (1,972
    )Deferred tax assets, net
    
    $
    
    
    
    $
    515
 As of December 31, 2004, the current portion of the net deferred tax assets totaling $81,000
is presented in other current assets. A valuation allowance was established for the entire amount of the net deferred tax assets at
December 31, 2003, as the Company was unable to determine that the more likely than not criteria
had been met. The Company reduced the valuation allowance during 2004 as it expects to utilize a
portion of its net operating loss carryforward in connection with the implementation of a foreign
holding and operating company restructure. At December 31, 2004, the Company has net operating loss carryforwards of approximately $9,246,000
that begin to expire in 2018, if not utilized. A portion of the net operating loss carryforward is
subject to an annual limitation as defined by Section 382 of the Internal Revenue Code. The
Company has not provided for U.S. federal and foreign withholding taxes on the undistributed
earnings of its foreign subsidiaries as of December 31, 2004. Such earnings are intended to be
reinvested indefinitely. In June of 2001, the Company sold the stock of its wholly-owned subsidiary, Kaire Neutraceuticals,
Inc. to focus on the Lexxus business. No income tax expense or benefit was allocated to
discontinued operations. 83




---



##### Table of Contents



12. SUPPLEMENTAL CASH FLOW INFORMATION Year Ended December 31,2002
    
    
    2003
    
    
    2004As RestatedCash paid during the year for:Income taxes
    
    $
    90
    
    
    $
    42
    
    
    $
    552Interest
    
    
    20
    
    
    
    50
    
    
    
    86Non-cash investing and financing
activities:Conversion of preferred stock to
common stock
    
    
    2,128
    
    
    
    16
    
    
    
    Conversion of debt and related
accrued interest to common stock
    
    
    280
    
    
    
    
    
    
    
    Preferred stock dividends
    
    
    70
    
    
    
    1
    
    
    
    Common stock issued for acquisitions
    
    
    
    
    
    
    433
    
    
    
    15,665Debt issued for acquisitions
    
    
    
    
    
    
    
    
    
    
    3,203Preferred stock redeemed for debt
    
    
    180
    
    
    
    
    
    
    
    Common stock issued for services
    
    
    36
    
    
    
    53
    
    
    
    
 13. RELATED PARTY TRANSACTIONS In August 2001, the Company entered into a written lease agreement and an oral management agreement
with S&B Business Services, an affiliate of Brad LaCore, the brother of Terry LaCore, Chief
Executive Officer of Lexxus U.S. and a director of the Company, and Sherry LaCore, Brad LaCores
spouse. Under the terms of the two agreements, S&B Business Services provides warehouse facilities
and certain equipment, manages and ships inventory, provides independent distributor support
services and disburses payments to independent distributors. In exchange for these services, the
Company pays $18,000 annually for leasing the warehouse, $3,600 annually for the lease of warehouse
equipment and $120,000 annually for the management services provided, plus an annual average of
approximately $12,000 for business related services. The Company paid S&B Business Services
approximately $156,000, $150,000, and $160,000 during 2002, 2003, and 2004, respectively. In September 2001, the Company entered into an oral consulting agreement with William Woodburn, the
father of Mark Woodburn, President of the Company and a director, pursuant to which William
Woodburn provided the Company with management advice and other advisory assistance. In exchange
for such services, the Company starting June 8, 2001 paid to Ohio Valley Welding, Inc., an
affiliate of Mr. Woodburn, $6,250 on a bi-weekly basis. The Company paid $162,500, $168,750 and
$118,750 during 2002, 2003, and 2004, respectively, to Ohio Valley Welding, Inc. The consulting
agreement between the Company and William Woodburn was terminated as of September 30, 2004. The Companys former controller is married to Mark Woodburn, the Companys president. Her
employment with the Company ended in August 2004. The Company paid her approximately $100,000 in
each of 2002, 2003, and 2004. 84




---



##### Table of Contents



On March 31, 2004, the Company entered into a merger agreement with MarketVision, pursuant to which
the Company acquired all of the outstanding capital stock of MarketVision (see Note 6). As a
founding stockholder of Marketvision, Terry LaCore, Chief Executive Officer of Lexxus U.S. and a
director of the Company, received 450,000 shares of the Companys common stock and is entitled to
receive approximately $840,000 plus interest from promissory notes issued by the Company. As of
December 31, 2004, the outstanding balance due Mr. LaCore was approximately $307,000. On October 6, 2004, certain members of the Companys board of directors and certain of the
Companys officers invested approximately $25,000 and purchased 1,984 units upon the same terms and
conditions as the other buyers in the private placement. See Note 10. 14. SEGMENT INFORMATION The Company operates in one reportable operating segment by selling products to a distributor
network that operates in a seamless manner from market to market. The Companys net sales and
long-lived assets by market are as follows (in thousands): Year Ended December 31,2002
    
    
    2003
    
    
    2004As RestatedNet sales to external customers:North America
    
    $
    13,452
    
    
    $
    10,668
    
    
    $
    16,914Hong Kong
    
    
    6,067
    
    
    
    30,763
    
    
    
    74,293Taiwan
    
    
    5,579
    
    
    
    3,097
    
    
    
    3,261Southeast Asia
    
    
    556
    
    
    
    1,570
    
    
    
    1,786Eastern Europe
    
    
    8,999
    
    
    
    13,157
    
    
    
    30,248South Korea
    
    
    
    
    
    
    2,492
    
    
    
    5,524Australia/New Zealand
    
    
    2,144
    
    
    
    654
    
    
    
    1,158Other
    
    
    171
    
    
    
    175
    
    
    
    41Total net sales
    
    $
    36,968
    
    
    $
    62,576
    
    
    $
    133,225
 December 31,2002
    
    
    2003
    
    
    2004As RestatedLong-lived assets:North America
    
    $
    481
    
    
    $
    1,203
    
    
    $
    20,124Hong Kong
    
    
    181
    
    
    
    217
    
    
    
    247Taiwan
    
    
    341
    
    
    
    271
    
    
    
    117Southeast Asia
    
    
    165
    
    
    
    202
    
    
    
    133Eastern Europe
    
    
    42
    
    
    
    
    
    
    
    South Korea
    
    
    
    
    
    
    389
    
    
    
    398Australia/New Zealand
    
    
    38
    
    
    
    46
    
    
    
    35Other
    
    
    46
    
    
    
    51
    
    
    
    36Total long-lived assets
    
    $
    1,294
    
    
    $
    2,379
    
    
    $
    21,090
 Due to system constraints, it
is impracticable for the Company to separately disclose product and
enrollment package revenue for the years presented. 85




---



##### Table of Contents



15. QUARTERLY FINANCIAL DATA (UNAUDITED) Quarter EndedMarch 31
    
    
    June 30
    
    
    September 30
    
    
    December 31(In Thousands, Except Per Share Data)As RestatedFiscal 2003:Net sales
    
    $
    11,240
    
    
    $
    11,984
    
    
    $
    16,740
    
    
    $
    22,612Gross profit
    
    
    8,994
    
    
    
    10,012
    
    
    
    12,832
    
    
    
    17,062Distributor commissions
    
    
    4,581
    
    
    
    4,929

    
    
    
    6,988
    
    
    
    11,057Selling, general and administrative expenses
    
    
    2,673
    
    
    
    3,737
    
    
    
    3,896
    
    
    
    5,464Income from operations
    
    
    1,740
    
    
    
    1,346
    
    
    
    1,948
    
    
    
    541Net income
    
    
    1,373
    
    
    
    947
    
    
    
    1,276
    
    
    
    1,132Income per
share:Basic
    
    $
    0.30
    
    
    $
    0.20
    
    
    $
    0.27
    
    
    $
    0.24Diluted
    
    $
    0.28
    
    
    $
    0.17
    
    
    $
    0.22
    
    
    $
    0.19Weighted-average number of shares outstanding:Basic
    
    
    4,511
    
    
    
    4,628
    
    
    
    4,656
    
    
    
    4,656Diluted
    
    
    4,908
    
    
    
    5,628
    
    
    
    5,821
    
    
    
    5,812
 Quarter EndedMarch 31
    
    
    June 30
     
    
    
    September 30
    
    
    December 31(In Thousands, Except Per Share Data)As RestatedFiscal 2004:Net sales
    
    $
    38,745
    
    
    $
    17,686
    
    
    $
    40,482
    
    
    $
    36,312Gross profit
    
    
    30,491
    
    
    
    12,823
    
    
    
    31,612
    
    
    
    28,978Distributor commissions
    
    
    19,745
    
    
    
    12,578
    
    
    
    17,422
    
    
    
    18,834Selling, general and administrative expenses
    
    
    5,968
    
    
    
    8,194
    
    
    
    8,288
    
    
    
    10,652Income from operations
    
    
    4,779
    
    
    
    (7,949
    )
    
    
    5,902
    
    
    
    (508
    )Net income
    
    
    3,761
    
    
    
    (6,746
    )
    
    
    5,028
    
    
    
    (802
    )Income per share:Basic
    
    $
    0.81
    
    
    $
    (1.24
    )
    
    $
    0.92
    
    
    $
    (0.12
    )Diluted
    
    $
    0.64
    
    
    $
    (1.24
    )
    
    $
    0.75
    
    
    $
    (0.12
    )Weighted-average number of shares outstanding:Basic
    
    
    4,667
    
    
    
    5,447
    
    
    
    5,450
    
    
    
    6,745Diluted
    
    
    5,909
    
    
    
    5,447
    
    
    
    6,692
    
    
    
    6,745
 A reconciliation of the amounts as previously reported and as restated is as follows: Quarter Ended December 31, 2003AsPreviouslyReported
    
    
    Adjustments
    
    
    As RestatedNet sales
    
    $
    22,922
    
    
    $
    (310
    )1
    
    $
    22,612Gross profit
    
    
    17,552
    
    
    
    (490
    )2
    
    
    17,062Distributor commissions
    
    
    10,598
    
    
    
    459
    3
    
    
    11,057Selling, general and administrative expenses
    
    
    5,464
    
    
    
    
    
    
    
    5,464Income from operations
    
    
    1,490
    
    
    
    (949
    )
    
    
    541Net income
    
    
    1,782
    
    
    
    (650
    )4
    
    
    1,132Income per
share:Basic
    
    $
    0.38
    
    
    
    
    
    
    $
    0.24Diluted
    
    $
    0.31
    
    
    
    
    
    
    $
    0.19Weighted-average number of shares outstanding:Basic
    
    
    4,656
    
    
    
    
    
    
    
    4,656Diluted
    
    
    5,812
    
    
    
    
    
    
    
    5,812
 86




---



##### Table of Contents



Quarter Ended December 31, 2003AsPreviouslyReported
    
    
    Adjustments
    
    
    As RestatedNet sales
    
    $
    38,435
    
    
    $
    310
    1
    
    $
    38,745Gross profit
    
    
    30,001
    
    
    
    490
    2
    
    
    30,491Distributor commissions
    
    
    20,204
    
    
    
    (459
    )3
    
    
    19,745Selling, general and administrative expenses
    
    
    5,968
    
    
    
    
    
    
    
    5,968Income from operations
    
    
    3,830
    
    
    
    949
    
    
    
    4,779Net income
    
    
    3,111
    
    
    
    650
    4
    
    
    3,761Income per
share:Basic
    
    $
    0.67
    
    
    
    
    
    
    $
    0.81Diluted
    
    $
    0.53
    
    
    
    
    
    
    $
    0.64Weighted-average number of shares outstanding:Basic
    
    
    4,667
    
    
    
    
    
    
    
    4,667Diluted
    
    
    5,909
    
    
    
    
    
    
    
    5,909
   1
    
    Revenues not earned until 2004 were improperly recorded as revenue by the
Companys Eastern European business, KGC Networks Ptd. Ltd., for the year ended December 31,
2003.2
    
    Includes certain transportation-related expenses incurred but not accrued as of
December 31, 2003.3
    
    Reflects distributor commissions incurred but not accrued as of December 31, 2003.4
    
    Includes minority interest related to the restatement adjustments 
  Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL
DISCLOSURE On December 22, 2003, the Company filed a Form 8-K disclosing that the Audit Committee and
Board of Directors of the Company had approved the dismissal of Sherb & Co., LLP (Sherb) as the
Companys independent auditors of the Companys financial statements for the year ended December
31, 2003. The Company disclosed that the reports of Sherb on the Companys financial statements
within the two most recent fiscal years or any subsequent interim periods contained no adverse
opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope
or accounting principles; with the exception that Sherbs independent auditors report for the year
ended December 31, 2001 raised substantial doubt about the Companys ability to continue as a going
concern due to historic losses and the need for additional funding. The Form 8-K further disclosed
that for the two most recent fiscal years and any subsequent interim period preceding Sherbs
dismissal, there were neither disagreements with Sherb nor any reportable events. The Form 8-K filed on December 17, 2003 also disclosed that the Companys Audit Committee and
Board of Directors had approved the engagement of BDO Seidman, LLP (BDO) as it new independent
auditors as of December 31, 2003. 
 Item 9A. CONTROLS AND PROCEDURES Evaluation of Disclosure Controls and Procedures We maintain disclosure controls and procedures that are designed to ensure that information
required to be disclosed in our Exchange Act reports is recorded, processed, 87




---



##### Table of Contents



summarized and reported within the time periods specified in the Securities and Exchange
Commissions rules and forms and that such information is accumulated and communicated to our
management, including our President and Chief Financial Officer, as appropriate, to allow for
timely decisions regarding required disclosure. In designing and evaluating the disclosure
controls and procedures, management recognizes that any controls and procedures, no matter how well
designed and operated, can provide only reasonable assurance of achieving the desired control
objectives, and management is required to apply its judgment in evaluating the cost-benefit
relationship of possible controls and procedures. During the quarters ended September 30 and December 31, 2003, the Company re-evaluated its
financial statements for the years ended December 31, 2002 and 2001, the quarterly periods included
in such years and the quarterly periods ended March 31, June 30 and September 30, 2003. As a result
of such review, the Company determined that it inadvertently applied the incorrect accounting
treatment with respect to the following items:  (i)
    revenue recognition with respect to administrative enrollment fees;(ii)
    revenue cut-off between 2002 and 2003;(iii)
    accounts receivable reconciliation to supporting documents;(iv)
    reserves established for product returns and refunds;(v)
    the gain recorded in connection with the sale of a subsidiary in 2001;(vi)
    income tax provisions; and(vii)
    stock option based compensation. Consequently, the Company amended and restated its financial statements for each quarter in
2001 and 2002, the first three quarters in 2003, as well as for the years ended December 31, 2001 and 2002 with respect to each
of the foregoing items (collectively, the Restatement Items). During its review of its financial statements for the quarter ended March 31, 2004, the
Company learned that commission and transportation-related expenses incurred as of December 31,
2003 were under-accrued by approximately $640,000 (on a pre-tax basis) for the quarter and year
ended December 31, 2003. Adjusting entries of approximately $640,000 were included as expenses in
the financial statements for the quarter ended March 31, 2004. At that time, the Company concluded that the error was not material, and therefore, did not
warrant a restatement of the 2003 financial statements. Based upon the Companys pre-tax income of
approximately $4.0 million for the first quarter of 2004 combined with the Companys historical
sales and net income growth rates, the Company believed that the recording of $640,000 of pre-tax
expenses during the first quarter of 2004 would not have a material effect on the Companys net
income for the 2004 fiscal year. 88




---



##### Table of Contents



However, while sales continued to grow significantly, net income for the 2004 fiscal year
declined substantially. As a consequence, the adjusting entries made in the first quarter of 2004
are now considered by management to materially affect the Companys net income for fiscal 2004. During its review of its financial statements for the year ended December, 31, 2004, the
Company discovered that certain revenues not earned until 2004 were improperly recorded as revenue
by its Eastern European business, KGC Networks Ptd. Ltd., for the year ended December 31, 2003. The
amount of revenues that was over-stated for the 2003 fiscal year was approximately $310,000. On March 23, 2005, the Audit Committee of the Companys Board of Directors determined that the
inclusion of the aforementioned two items in the financial statements for the quarter ended March
31, 2004 would materially affect the Companys net income for the year ended December 31, 2004, and
the Company believes that an amendment to its financial statements for the year ended December 31,
2003 is warranted. The restatement of the adjustments into the financial statements for the year ended December
31, 2003 reduced the Companys revenue by approximately $310,000, increased cost of goods sold by
approximately $180,000, increased distributor commission expense by approximately $460,000, reduced
the minority interest expense by approximately $300,000, and reduced after-tax net income for
approximately $650,000 for the quarter as well as the year ended December 31, 2003. For the quarter ended March 31, 2004, the restatement increased the Companys revenue by
approximately $310,000, reduced cost of goods sold by approximately $180,000, reduced distributor
commission expense by approximately $460,000, increased the minority interest expense by
approximately $300,000, and increased after-tax net income for approximately $650,000 for the
quarter ended March 31, 2004. The Company, after consultation with its Audit Committee, concluded that the consolidated
financial statements for the quarter and the year ended December 31, 2003 as well as the first
quarter of 2004 should no longer be relied upon, including the consolidated financial statements
and other financial information in the Companys Annual Report on Form 10-KSB for the year ended
December 31, 2003 and the Quarterly Report on Form 10-Q for the first quarter ended March 31, 2004.
Although the financial statements for the three month periods ended June 30, 2004 and September
30, 2004 are unaffected by this error, the consolidated financial statements for the second and
third quarters of 2004 include inaccurate information on a year to date basis because they include
the erroneous information from the first quarter of 2004 which financial statements should not be
relied upon. 89




---



##### Table of Contents



The Companys Audit Committee and management have discussed these matters with BDO Seidman LLP
(BDO), the Companys independent registered public accounting firm. The Company recognizes that the improper accounting for commission and transportation-related
expenses and revenue recognition for the year ended December 31,
2003 reflected a material
control weakness in the Companys internal control over
financial reporting that existed at December 31, 2003, such
control weakness has been subsequently remedied during 2004. The
Company recognizes there are certain disclosures required in this
Form 10-K, including sales-related disclosures, that are
impracticable to produce due to system constraints. We are
implementing system changes that will enable us to provide this
information on a prospective basis. An evaluation of the Companys disclosure controls and procedures (as defined in Section
13(a)-14(c) of the Exchange Act) as of December 31, 2004 was carried out under the supervision and
with the participation of the Companys President, Chief Financial Officer, Chief Accounting
Officer and other members of the Companys senior management. The Companys President, Chief
Financial Officer and Chief Accounting Officer concluded that the Companys disclosure controls and
procedures as currently in effect are effective in ensuring that the information required to be
disclosed by the Company in the reports it files or submits under the Exchange Act is (i)
accumulated and communicated to the Companys management (including the President and Chief
Financial Officer) in a timely manner, and (ii) recorded, processed, summarized and reported within
the time periods specified in the Securities and Exchange Commissions rules and forms. Changes in Internal Controls During the twelve months ended December 31, 2004, the Company made changes to improve its
internal controls over financial reporting with respect to (i) each of the Restatement Items, and
(ii) monthly financial reports provided to the Company by its subsidiaries. The Company hired a new
Chief Financial Officer in August 2004, a new Chief Accounting Officer in September 2004, a
regional Chief Financial Officer for Greater China and Southeast Asia in October 2004 and is still
hiring additional accounting staff to upgrade the financial organization. In addition, the Company
has commenced its documentation required under the Sarbanes-Oxley Act of 2002 and is developing
additional policies and procedures to further strengthen its international reporting, including the
areas of revenue recognition, sales and expense cut-off and sales returns. The Company hired a
reporting specialist in November 2004 to coordinate the world-wide Sarbanes-Oxley compliance work.
In December 2004, the Company hired a general counsel, who subsequently was given additional
responsibilities as the Chief Operating Officer, to enhance compliance and control. 90




---



##### Table of Contents



The Company plans to implement additional controls and procedures sufficient to accurately
report financial performance on a timely basis. There have been no other changes in the Companys
internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that
occurred during the quarter ended December 31, 2004, that have materially affected, or are
reasonably likely to materially affect, the Companys internal control over financial reporting. The Company intends to continually review and evaluate the design and effectiveness of its
disclosure controls and procedures and to improve its controls and procedures over time and to
correct any deficiencies that it may discover in the future. The goal is to ensure that senior
management has timely access to all material financial and non-financial information concerning the
Companys business. While the Company believes the present design of its disclosure controls and
procedures is effective to achieve its goal, future events affecting its business may cause the
Company to modify its disclosure controls and procedures. 
 Item 9B. OTHER INFORMATION None. 
 Part III The information required by Items 10, 11, 12, 13 and 14, is incorporated
by reference from the Proxy Statement to be filed with the SEC within 120 days of the end of the
fiscal year covered by this report. 91




---



##### Table of Contents



Part IV 
 Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES Documents filed as part of this Form 10-K:  1.
    Financial Statements. See index to Consolidated Financial Statements under
Item 8 of Part II.2.
    Financial Statement Schedules. Financial statement schedules have been
omitted because they are not required or are not applicable, or because the required
information is shown in the financial statements or notes thereto.3.
    Exhibits. The following exhibits are filed with this Form 10-K: ExhibitNumber
    
    Exhibit Description4.1
    
    Articles of Incorporation, as amended.*4.2
    
    By-Laws of Natural Health Trends Corp.*4.3
    
    Specimen Certificate for shares of common stock, $.001 par value per share, of Natural
Health Trends Corp.*4.4
    
    Form of Common Stock Purchase Warrant issued in October 2004 Private Placement.*10.1
    
    2002 Stock Plan, as amended.*10.2
    
    Option Agreement dated as October 14, 2002 granting 570,000 options to the LaCore and
Woodburn Partnership.*10.3
    
    Option Agreement dated as October 14, 2002 granting 570,000 options to Terry LaCore.*10.4
    
    Option Agreement dated as July 2, 2002 granting 60,000 options to Sir Brian Wolfson.10.5
    
    Option Agreement dated as July 2, 2002 granting 60,000 options to Randall A. Mason.10.6
    
    Distributorship Agreement dated March 1, 2002 between the Company and 40Js*10.7
    
    Founder Compensation Agreement by and among Lexxus International, Inc., Natural Health
Trends Corp., Rodney Sullivan and Pam Sullivan, Michael Bray and Jeff Provost.10.8
    
    Database Purchase Agreement, dated as of January 31, 2003, by and among NuEworld.com
Commerce, Inc., a Delaware corporation, Lighthouse Marketing Corporation, a Delaware
corporation), and the Company.10.9
    
    KGC Agreement dated March 17, 2004 between the Company and Bannks Foundation.10.10
    
    Stock Purchase Agreement dated March 29, 2004 between Michael Bray, Jeff Provost, Rodney
Sullivan and Pam Sullivan and the Company.10.11
    
    Agreement and Plan of Merger, dated as of March 31, 2004, by and among the Company,
MergerCo and MarketVision.*10.12
    
    Stockholders Agreement, dated as of March 31, 2004, by and among the Company, John
Cavanaugh, Terry LaCore and Jason Landry.*10.13
    
    Employment Agreement, dated as of March 31, 2004, between MarketVision and John Cavanaugh.*10.14
    
    Employment Agreement, dated as of March 31, 2004, between MarketVision and Jason Landry.*10.15
    
    Guaranty of the Employment Agreements dated as of March 31, 2004 executed by Lexxus U.S.*10.16
    
    Software License Agreement dated as of March 31, 2004 among the Company, MergerCo and
MarketVision Consulting Group, LLC.*10.17
    
    Employment Agreement, dated as of August 1, 2004, by and between the Company and Chris
 92




---



##### Table of Contents



ExhibitNumber
    
    Exhibit DescriptionSharng.*10.18
    
    Employment Agreement, dated as of October 7, 2004, by and between Lexxus International
(Mexico), S.A. and Jose Raul Villarreal Patino10.19
    
    Employment Agreement, dated as of October 7, 2004, by and between Lexxus International
(Mexico), S.A. and Oscar de la Mora10.20
    
    Employment Agreement, dated as of November 1, 2004, by and between the Company, Lexxus
Japan and Richard Johnson.10.21
    
    Securities Purchase Agreement dated October 6, 2004 by and among the Company and the
investors signatory thereto.*10.22
    
    Subscription Agreement (Canada) dated October 6, 2004 by and among the Company and the
investors signatory thereto.*10.23
    
    Form of Registration Rights Agreement between the Company and the investors in the
Companys October 2004 private placement.*10.24
    
    Amendment No. 1 to Registration Rights Agreement dated February 23, 2005 between the
Company and the investors in the Companys October 2004 private placement.10.25
    
    Amendment No. 1 to Founder
Compensation Agreement by and among Lexxus International, Inc.,
Natural Health Trends Corp., Rodney Sullivan and Pam Sullivan,
Michael Bray, and Jeff Provost.10.26
    
    Royalty Agreement dated March 1, 2005 by and among Steve Francisco, Dan Catto, and the
Company.14.1
    
    Code of Business Conduct.14.2
    
    Code of Ethics for Senior Financial Officers.21.1
    
    Subsidiaries of the Company.31.1
    
    Certification of the President pursuant to Rule 13a-14(a) of the Securities Exchange Act of
1934, as amended (the Exchange Act).31.2
    
    Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act.32.1
    
    Certification of the President pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.32.2
    
    Certification of the Chief Financial Officer pursuant to Rule 13a-14(b) of the Exchange Act
and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
   *
    
    Previously filed. 93




---



##### Table of Contents



SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized, in the city of Dallas, State of Texas, on
March 31, 2005. NATURAL HEALTH TRENDS CORP.By:
    /s/ Mark D. WoodburnName:
    Mark D. WoodburnTitle:
    President Pursuant to the requirements of the Securities Act of 1933, this registration statement has
been signed by the following persons in the capacities and on the dates indicated. Signature
    
    Title
    
    Date/s/ Sir Brian Wolfson

Sir Brian Wolfson
    
    Chairman of the Board
    
    March 31, 2005/s/ Mark D. Woodburn

Mark D. Woodburn
    
    President and Director
(Principal Executive Officer)
    
    March 31, 2005/s/ Terry LaCore

Terry LaCore
    
    Chief Executive Officer of
Lexxus U.S. and Director
    
    March 31, 2005/s/ Chris T. Sharng

Chris Sharng
    
    Executive Vice President and
Chief Financial Officer
(Principal Financial Officer)
    
    March 31, 2005/s/ Timothy S. Davidson

Timothy S. Davidson
    
    Chief Accounting Officer
(Principal Accounting Officer)
    
    March 31, 2005/s/ Robert H. Hesse

Robert H. Hesse
    
    Director
    
    March 31, 2005/s/ Randall A. Mason

Randall A. Mason
    
    Director
    
    March 31, 2005
 94